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1 Introduction 
1.1 Epigenetics  
The term “epigenetics” (literally: outside traditional genetics) was originally coined by Conrad 
Waddington who defined epigenetics as “the branch of biology, which studies the casual 
interactions between genes and their products, which bring the phenotype into being” 
(Waddington, 1942). In other words, this term stands for the mechanisms turning genotypes 
into phenotypes during development. About 50 years later, epigenetics was typically defined 
as the study of heritable changes in genome function that are not due to alterations in the 
DNA sequence (Probst et al., 2009; Riggs et al., 1996). This definition persists until today. 
The epigenetic code thus represents a second level of gene regulation on top of the genetic 
code. DNA methylation, histone modifications and noncoding RNAs are the most prominent 
actors of epigenetic phenomena. The classical view that certain epigenetic marks indicate 
either an “on” or an “off” state turned out to be too simple and functional integration of 
different marks emerged as critical factor for gene regulation (Berger, 2007; Weissmann and 
Lyko, 2003). 
 
 
1.1.1 Molecular Building Blocks of Epigenetics 
1.1.1.1 Histone Modifications 
Epigenetic activation or silencing is not mediated by one event alone, but is a series of 
complex processes that cause remodelling of the chromatin structure. 
In eukaryotes, genomic DNA is packaged into chromatin. The nucleosome represents the 
fundamental unit of chromatin and is composed of an octamer of the four core histones 
(H2A, H2B, H3 and H4) around which 147 bp of DNA are wrapped (Kornberg, 1974; 
Kornberg and Lorch, 1999) (Figure 1-1). Linker histone H1 plays a significant role in the 
higher-order packaging of chromatin and is located outside the histone octamer at the 50 bp 
linker DNA. The positioning of nucleosomes is a reversible ATP-dependent process which 
contributes to the variable, dynamic, compact and yet stable chromatin architecture.  
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Figure 1-1 DNA packaging 
In eukaryotes, DNA is packed into a chromatin structure consisting of repeating nucleosome units. Nucleosomes 
comprise 147 base pairs (bp) of DNA that are wrapped around a histone octamer formed by two copies of each 
H2A, H2B, H3 and H4. 
 
 
Histones are alkaline nuclear proteins whose N-terminal tails are subject to a large number of 
post-translational modifications (Bernstein et al., 2007; Kouzarides, 2007). There are at least 
eight different types of histone modifications including acetylation, methylation and 
phosphorylation which represent the best studied ones. Figure 1-2 shows some of the more 
than sixty histone residues that are known to be modified.  
 
 
 
Figure 1-2 Histone modifications 
Schematic presentation of the best characterized histone modifications including acetylation (A), methylation (M) 
and phosphorylation (P) on lysine (K), arginine (R) and serine (S) residues. Post-translational modifications of 
histones occur primarily on N-terminal tails of the core histones H2A, H2B, H3 and H4.  
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Furthermore, lysine and arginine methylation may occur in different states that are 
interdependent: mono- (me1), di- or trimethylation (me3) at lysine residues and mono- or 
dimethylation on arginine residues. Such variable methylation states further contribute to the 
complexity of histone modifications and their biological consequences (Kouzarides, 2007). 
 
About ten years ago, it has been hypothesized that specific histone tail modifications and/or 
their combinations constitute the histone-code, that determines the transcriptional state of the 
gene (de, X et al., 2005). According to this hypothesis, “multiple histone modifications, acting 
in a combinatorial or sequential fashion on one or multiple tails, specify unique downstream 
functions” (Strahl and Allis, 2000). This hypothesis has been supported and refined by the 
experimental identification of enzymes that induce, recognize or erase histone modifications. 
Further affirmation arises from data, revealing that one histone mark may either have 
repressive or activating consequences, depending on the context of surrounding 
modifications. Methylation of histone 3 lysine 9 (H3K9me) can initiate transcriptional 
silencing. However, in the context of methylated H3K4 and H4K20, it contributes to the 
maintenance of active marks (de, X et al., 2005). Consequently, the histone-code does not 
provide a simple “on or off” decision. The biological outcome is dependent on the dynamic 
cooperation of various epigenetic marks as well as on their translation and is therefore 
adaptable to diverse biological requirements. Furthermore, modifications on the same 
(cis effect) or different (trans effect) histone tails may be interdependent. The activating role 
of H3K4 is mediated via preventing the binding of the remodelling and deacetylating complex 
NuRD (nucleosome remodelling histone deacetylase complex) as well as through blocking 
H3K9 methylation, representing an example for cis effects. Among others, trans effects were 
observed between H2B and H3, as ubiquitination of H2BK123 is required for efficient H3K4 
methylation (de, X et al., 2005). 
 
Development of the chromatin immunoprecipitation technique (ChIP) using 
modification-specific antibodies and its adaptation to DNA microarrays (chip) permitted 
insights into the genome-wide distribution of histone modifications. Generally, histone 
acetylation is associated with transcriptional activation, whereas histone methylation may be 
linked to either activation or repression, depending on the position and state of the methyl 
mark. Promoter regions of active genes are characterized by histone acetylation and histone 
H3 lysine 4 (H3K4) methylation (Bernstein et al., 2005; Kim et al., 2005). Methylation of 
H3K27, however, seems to correlate with transcriptional repression (Boyer et al., 2006; Lee 
et al., 2006; Roh et al., 2006). High resolution profiling using ChIP-Seq (ChIP-Sequencing; 
direct sequencing of ChIP DNA) revealed typical histone methylation patterns for promoters, 
enhancers, insulators and transcribed regions (Barski et al., 2007). Actively transcribed 
 Introduction 
 - 4 -    
regions, e.g., are characterized by high levels of H3K36me3 (trimethylation of histone H3 
lysine 36), H3K27me1 (monomethylation of H3 lysine 27), H3K9me1, H4K20me1 and 
H2BK5me1. Additionally, H3K4 methylation shows increased signals surrounding the 
transcription start sites (TSS) of known genes and positively correlates with gene expression. 
H3K4me3 presence is highest near the TSS at -300 and +100 bp whereas the major peaks 
for H3K4me1 and H3K4me2 were detected more than 500 bp away from the TSS (Barski et 
al., 2007). 
 
The comprehensive ChIP-Seq technique provides more sensitive and detailed information 
about the global incidence of histone modifications and their association to regulatory 
elements than ChIP-on-chip assays (ChIP combined to microarray analysis). This might be 
one reason for minor discrepancies about the functional role of several modifications in 
literature. Based on ChIP-on-chip analyses, Heintzman et al. postulated that active promoter 
regions may be distinguished from active enhancers by high levels of H3K4me3, whereas 
enhancers are marked by high levels of H3K4me1 (Heintzman et al., 2007). However, using 
the ChIP-Seq technique, Barski et al, found that all three methylation states of H3K4 are 
highly enriched at both active promoters and active enhancers. They in turn characterize 
active promoter regions by high levels of H3K27me1, H3K36me3, H3K9me1, H4K20me1 
and H2BK5me1 downstream of TSSs (Barski et al., 2007). Up to now, relatively little is 
known about the extent to which such combinatorial patterns of histone modifications exist in 
the human genome. First progress was made by Wang et al who identified a common 
modification module consisting of 17 histone modifications at 25% of human promoters  
(Wang et al., 2008). Genes exhibiting this modification module tended to have higher 
expression levels. However, histone modifications themselves do not uniquely determine 
expression levels, they rather function cooperatively in order to prepare chromatin for 
transcriptional activation (Wang et al., 2008). The conclusions drawn of those 
high-throughput analyses are in concordance with other studies suggesting a cross-talk 
between different histone modifications (Berger, 2007; Fischle et al., 2003; Schreiber and 
Bernstein, 2002). 
 
Setting, Reading and Erasing Histone Modifications 
Numerous enzymes that catalyze the addition and removal of histone modifications have 
been identified (examples are shown in Table 1-1). Among all histone modifying enzymes, 
methyltransferases and lysine demethylases belong to the most specific ones. This might be 
one reason why methylation is the best characterized modification to date (Kouzarides, 
2007). Although several histone acetyltransferases (HAT) seem to have a preference for 
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individual residues, target specificity of both acetyltransferases and histone deacetylases 
(HDAC) has not been extensively explored. However, just recently, SIRT6 was shown to be 
crucial for H3K9 deacetylation (Kawahara et al., 2009). During this work, analyses were 
limited to lysine acetylations and methylations. Therefore, further descriptions are focused on 
factors affecting those modifications. 
 
Table 1-1 Examples for histone modifying enzymes (writers and erasers) along with several sites they 
modify 
Histone modifying enzyme Resulting modification Enzymes erasing the methyl mark 
Histone Acetyltransferases (HAT) Acetylation Histone deacetylases (HDAC)  
PCAF/GCN5 H3K9 SIRT6 
CBP/P300, PCAF/GCN5 H3K14 Not specified 
HB01, TIP60, CBP/P300 H4K8 Not specified 
HAT1, HB01, TIP60 H4K12 Not specified  
Methyltransferases (HMT) Methylation Histone demethylases 
MLL1-5, SET1A, SET1B H3K4  LSD1 
G9a, SUV39H1, SUV39H2 ESET H3K9  JHDM2a, JHDM2b, JMJD2B, JMJD2D 
EZH2 H3K27  JMJD3 
SET2, NSD1 H3K36  JHDM1a, JHDM1b 
DOT1 H3K79  Not specified 
PR-SET7/8, SUV4 20H1/H2 H4K20 Not specified 
 
 
In order to serve as a mark with the potential to distinguish between different regions of the 
genome, a modification has to be directed to specific loci. There are several possibilities of 
targeting histone modifying enzymes to their sites of action. First, sequence specific 
transcription factors including nuclear hormone receptors were shown to recruit histone 
modifying enzymes to promoter regions (Imhof, 2006; Rice et al., 2007; Robert et al., 2004). 
For example, the yeast Hst1 histone deacetylase is recruited by the transcriptional repressor 
Sum1 (Robert et al., 2004). Likewise, glucocorticoid receptors are able to recruit the ATP 
dependent BRG1 chromatin remodelling complex to the MMTV (mammary tumor virus) 
promoter (Hebbar and Archer, 2003). Second, histone deacetylases may be recruited by 
methyl-binding proteins (MBD) to sites of DNA methylation (Ballestar and Wolffe, 2001); see 
also section 1.1.1.2). Another targeting possibility involves interactions with non-coding 
RNAs from the corresponding gene locus (Imhof, 2006; Rinn et al., 2007). For example, 
recruitment of a histone methyltransferase complex responsible for H3K27 methylation at the 
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inactive X chromosome of females depends on the non-coding Xist ( X inactive specific 
transcript) RNA (Plath et al., 2003). 
 
The question arising now is, how are the combinations of histone marks recognized and 
transformed into a biological function. Histone modifications may influence the higher-order 
chromatin structure by affecting the contacts between adjacent nucleosomes or between 
histones and DNA. Among all known histone modifications, acetylation holds the highest 
potential to unfold chromatin, as it neutralizes the positive charge of lysine residues and 
thereby weakens the interactions with the negatively charged DNA. Furthermore, the 
interpretation of the histone code is carried out by chromatin-binding domains that are able to 
recognize distinct histone modifications on specific residues (Figure 1-3A). Chromodomains 
(chromatin organization modifier domain) bind to methylated histone residues whereas 
bromodomains (first reported in Drosophila brahma proteins, from which its name derived in 
analogy to the chromodomain) recognize histone acetylation (Kouzarides, 2007). Figure 1-3B 
illustrates examples for histone-code reading proteins which fulfil effector functions like (i) 
ATP-dependent remodelling of the chromatin fiber (BPTF, CHD1, HP1), (ii) induction of 
further histone modifications (ING2, HP1, PC2, EAF3, JMJD2A, GCN5, TAF1), (iii) allowing 
transcriptional elongation (CHD1, proposed for BRD2 (LeRoy et al., 2008)) or (iv) recruitment 
of the DNA repair machinery (53BP1) (Daniel et al., 2005; Kouzarides, 2007; Lee and 
Shilatifard, 2007; Lomberk et al., 2006; Sims, III et al., 2007; Taverna et al., 2007). 
 
 
 
Figure 1-3 Reading the histone code 
(A) Domains used for recognition of methylated (me) or acetylated (ac) lysines (K) at histone tails. (B) Examples 
for proteins that recognize specific histone modifications. 
 
 
Notably, chromatin modifications are not only involved in transcriptional regulation but also 
play important roles during DNA replication, repair and condensation (Kouzarides, 2007). 
Additionally, evidence for a linkage between histone modifications and DNA methylation 
emerged during the past decade as histone deacetylation and primarily H3K9 methylation 
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seem to be a necessary prerequisite for CpG methylation in fungi, plants and mammals  
(Fuks, 2005). This relationship is further emphasised through direct interactions of DNMTs as 
well as MBDs with histone modifying complexes (see also section 1.1.1.2) (D'Alessio et al., 
2007; Klose and Bird, 2006). 
 
1.1.1.2 DNA Methylation 
DNA methylation is the longest known epigenetic modification. In mammals, this modification 
predominantly occurs on cytosine residues that are followed by a guanine and is therefore 
also termed as methylation of CpG dinucleotides (Figure 1-4). Methylated cytosines, 
however, bear the risk of deamination resulting in cytosine to thymine transitions. Probably, 
due to this tendency of methylated cytosines to deaminate, the overall frequency of CpGs 
within the genome is less than statistically expected (Herman and Baylin, 2003). Despite 
their relative underrepresentation, CpG dinucleotides can be accumulated in small stretches 
of DNA called CpG islands (CGI). CGIs are often associated with gene promoter regions and 
are usually unmethylated. In contrast, about 80% of the CpG dinucleotides outside CpG 
islands are methylated (Bird, 2002; Herman and Baylin, 2003). 
 
 
Figure 1-4 Methylation of CpG dinucleotides 
DNA methyltransferases (DNMTs) transfer methyl-groups from the methyl-group donor S-Adenosylmethionine 
(SAM) to the carbon 5 position of cytosine residues. In mammals, DNA methylation occurs mainly on cytosines 
followed by a guanine residue. 
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Controlled DNA methylation is crucial for gene regulation during embryonic development 
(Okano et al., 1999), X-chromosomal inactivation (Goto and Monk, 1998), parental imprinting 
as well as for cellular differentiation (Mohn and Schubeler, 2009). Furthermore, silencing of 
repetitive and retroviral sequences is achieved by DNA methylation (Robertson and Wolffe, 
2000; Walsh et al., 1998). Altered levels of cytosine methylation may lead to neoplastic 
development and eventually to cancer (Costello and Plass, 2001; Esteller et al., 2002; 
Esteller, 2007; Plass and Soloway, 2002). 
The setting of methyl marks is carried out by DNA methyltransferases (DNMT), which 
transfer methyl groups from methyl group donors to the carbon 5 position of cytosines 
(Figure 1-4). In 1988, Bestor et al. identified the first eukaryotic DNA methyltransferase, 
named DNMT1 (Bestor et al., 1988). DNMT1 seemed to have a preference for 
hemimethylated DNA and was therefore assigned to function in maintenance methylation 
during DNA replication by catalyzing the methylation of the nascent, unmethylated strand 
(Bestor, 2000; Yoder et al., 1997). Two other enzymes, DNMT3a and DNMT3b, are thought 
to be responsible for de novo methylation (i.e. methylation of completely unmethylated DNA) 
that plays a crucial role during early development (Okano et al., 1998; Okano et al., 1999). 
However, a strict functional division does not exist, as both enzymes seem to participate in 
both de novo and maintenance methylation (Bestor, 2000; Bird, 2002; Szyf, 2009). 
CpG methylation often leads to gene silencing (Figure 1-5). Transcriptional repression may 
either be achieved directly, by preventing the binding of transcription factors or the basal 
transcription machinery to the methylated DNA sequence or indirectly, by the recruitment of 
methyl-binding proteins (MBD) which in turn induce a silent chromatin state (Bestor, 2000; 
Bird, 2002; Bird and Wolffe, 1999; Clouaire and Stancheva, 2008; Kass et al., 1997). 
 
 
 
Figure 1-5 Schematic presentation of transcriptional silencing by DNA methylation 
White lollipops represent unmethylated CpG dinucleotides and black ones stand for methylated CpGs. Arrows 
represent the transcription start site. Methyl-binding proteins (MBD) bind to methylated cytosines and recruit 
histone deacetylases (HDAC) that contribute to turning open chromatin (euchromatin) into a compact and 
inaccessible structure (heterochromatin). Histone acetyltransferases are indicated by HAT and promote an 
accessible chromatin structure. 
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MeCP2, for example, serves as a bridge that links DNA methylation with chromatin 
remodelling by recruiting histone deacetylases through the corepressor mSin3A (Jones et al., 
1998; Nan et al., 1998) and histone methyltransferases like SUV39H1 (Fuks et al., 2003; 
Lunyak et al., 2002). 
 
Compared to the DNMT-dependent methylation processes, the mechanisms responsible for 
the removal of methylated cytosines are less well understood. The failure of maintenance 
DNMTs to methylate a newly synthesized daughter strand during cell-cycle represents a 
non-enzymatic, passive way of erasing the 5-methylcytosine (5-MeC) mark that requires at 
least two cycles of replication for complete DNA demethylation. The existence of 
replication-independent DNA demethylation processes implies the presence of demethylating 
enzymes that actively remove either the methyl group, the methylated cytosine or whole 
nucleotides (Gehring et al., 2009). Since the last 15 years, DNA repair enzymes have been 
discussed as important factors during active demethylation. In flowering plants, the active 
demethylation process is well characterized. DME (DEMETER) and ROS1 (REPRESSOR 
OF SILENCING 1) are 5-methylcytosine glycosylases/lyases (Agius et al., 2006; Morales-
Ruiz et al., 2006) catalyzing the first step of an active demethylation process that is linked to 
base excision repair (BER) in plants (Figure 1-6). The base excision repair process removes 
incorrect (mismatched) bases resulting from deamination (T:G or U:G) as well as methylated 
bases such as 3-methyladenine (Niehrs, 2009). DNA glycosylases and apurinic/apyrimidinic 
endonucleases hydrolyse the N-glycosidic bond, resulting in an abasic site that is filled and 
sealed by DNA polymerases and ligases, respectively (Fromme and Verdine, 2004). The use 
of DNA repair mechanisms for demethylating purposes in animal cells was first suggested in 
the early 90s when Jost and colleagues reported evidence for an enzymatic system replacing 
5-methylcytosine by cytosine. Nuclear extracts from chicken embryos promoted 
demethylation of selectively mCpGs in hemimethylated DNA through formation of specific 
nicks 5’ from 5-methyldeoxycytidine (Jost, 1993). Later on, the responsible enzyme was 
identified as a thymine DNA glycosylase (TDG) (Jost et al., 1995). Recently, it was shown 
that loss of methylation at an estrogen responsive element coincides with the recruitment of 
DNMT3a/b, TDG and other BER enzymes confirming the implication of base excision repair 
(Metivier et al., 2008). Additionally, the authors assigned deaminating activities to both DNA 
methyltransferases under special conditions. However, this deaminating role resulting in 
DNA demethylation remains controversial (Gehring et al., 2009; Ooi and Bestor, 2008). 
 
Assuming that DNA repair mechanisms represent the basis of active DNA demethylation, 
one question arises: which signal prompts the DNA repair machinery to operate at a certain 
locus at a defined developmental time point? GADD45a (growth arrest and DNA damage 
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inducible alpha) emerged as linking element between DNA repair machineries and active 5-
MeC demethylation. This protein seems to support the active demethylation process by (i) 
localizing to specific sites of demethylation through TAF12 (TBP-associated factor) 
interaction and recruitment of the nucleotide excision repair (NER) machinery through XPG 
(Barreto et al., 2007; Schmitz et al., 2009) or (ii) by facilitating the AID (activation induced 
deaminase) mediated 5-meC deamination and subsequent BER via MBD4 (Rai et al., 2008) 
(summarized in Figure 1-6). The nucleotide excision repair machinery recognizes DNA 
lesions, affecting multiple bases like those caused by UV irradiation. The NER pathway is a 
multistep process comprising the recognition of DNA damage, followed by incisions at sites 
flanking the lesion and removal of the about 29 bp oligonucleotide containing the lesion 
(Hakem, 2008). DNA polymerases then fill in the resulting gap using the undamaged strand 
as template (Niehrs, 2009). 
 
 
Figure 1-6 DNA repair mechanisms during active DNA demethylation 
DNA double strands are indicated in blue. Methylated CpG dinucleotides may be demethylated by (i) substitution 
of the methylated cytosine through base excision repair (BER), (ii) nucleotide excision repair (NER) or (iii) by 
deamination of methylated cytosines followed by base excision or mismatch repair. In the NER example, N 
represents any of the 4 DNA bases and Nn indicates up to 20 bp that may be excised. 
 
 
In the course of time, other factors than repair components have been described to function 
as “demethylases” such as RNA molecules (Weiss et al., 1996). However, the demethylating 
role of such a ribozyme-like enzyme was re-evaluated later (Swisher et al., 1998). Similarly, 
the demethylase activity of methyl-binding domain 2 (MBD2) reported by Bhattacharya et al. 
(Bhattacharya et al., 1999) could not be reproduced (Kress et al., 2006; Ng et al., 1999). 
 
In summary, the mechanisms of active DNA demethylation still remain unclear, even though 
active events were detected in different cell systems (Table 1-2) and some promising factors 
have already been identified. Surprisingly, relatively little is described about the correlation 
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between histone modifications and nucleosome remodelling during active DNA 
demethylation. Especially regarding the question how repair machineries are recruited to 
sites of 5-meC demethylation, it would be interesting to analyse if that information roots in the 
histone code. 
 
Table 1-2 Examples for active DNA demethylation events in mammalian cell systems 
(reviewed in Niehrs, Differentiation 2009) 
Demethylated gene Cell / tissue Evidence for an active process 
Immune cells 
Interleukin 2 T lymphocytes Fast kinetics 
Th2 cytokine locus control region CD4 T helper cells Non-dividing cells 
Embryonal cells 
Oct4 Xenopus oocytes Non-dividing cells 
Genome Mouse primordial germ cells Fast kinetics 
Neural cells 
Glucocorticoid receptor Hippocampal neurons Post-mitotic cells 
BDNF Primary mouse neurons Transfected DNA, post-mitotic cells 
Cancer cells 
Oct4 HEK293T cell line Transfected DNA 
pS2 MDAMB231, MCF7 cell lines Fast kinetics, TDG dependence 
 
1.1.1.3 Non-Coding RNA 
Recently, RNA molecules, particularly non-coding RNAs such as miRNA and siRNA, 
emerged as important factors in the field of epigenetic signalling. Non-coding RNAs are 
known to cooperate with histone modifications and DNA methylation machineries in order to 
achieve long-term silencing that is heritable through cell divisions. The most famous and best 
understood example for their role in gene silencing is dosage compensation mediated by the 
Xist (X inactive specific transcript) RNA in mammals and the roX (RNA on X) RNA in 
Drosophila  (Bernstein and Allis, 2005). Recently, the functional interaction of non-coding 
RNA and other epigenetic mechanisms could have been demonstrated in yeast and 
invertebrates. However, in mammals relatively little is known about this crosstalk (Li and 
Zhao, 2008). Although, the knowledge about the influence of non-coding RNA on 
transcriptional changes is far away from being complete, those molecules are considered to 
be important epigenetic regulators. 
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1.2 Epigenetics in Hematopoiesis 
1.2.1 Hematopoiesis 
Hematopoiesis describes the generation of all blood cells. Initially, during fetal development, 
hematopoiesis occurs in blood islands of the yolk sac and the paraaortic mesenchym and 
later on in liver and spleen (Abbas et al., 2007). Postnatally, development of blood cells takes 
place in the bone marrow (BM) where hematopoietic stem cells (HSC) as well as a complex 
mix of dividing and maturing cells of different lineages can be found.  
 
 
Figure 1-7 Hierarchy of hematopoietic cells 
LT-HSC: long term self-renewing hematopoietic stem cell; ST-HSC: short term hematopoietic stem cell; MPP: 
multipotent progenitor; CMP: common myeloid progenitor; CLP: common lymphoid progenitor; MEP: 
megakaryocyte/erythroid progenitor; GMP: granulocyte-macrophage progenitor. CD: Cluster of differentiation. 
Cell-types relevant for this work are indicated in blue; their cell-type or lineage specific surface antigens (CD 
antigens) are illustrated in grey. The in vivo origin of dendritic cells still remains unclear (see section 1.2.2.2), 
illustrated by the grey broken lines towards the dendritic cell. 
 
As illustrated in Figure 1-7, there is a continuum of progenitors at different stages between 
the HSC and completely differentiated cells. Dependent on various stimuli, those progenitors 
divide and progress towards certain lineages (Larsson and Karlsson, 2005). 
Hematopoietic stem cells (HSC) may either develop towards the myeloid or the lymphoid 
lineage. Common myeloid progenitors give then rise to granulocytes, macrophages as well 
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as erythrocytes and megakaryocytes, whereas common lymphoid progenitors finally 
differentiate into B cells, T cells or natural killer cells (Figure 1-7) (Orkin, 2000). In this work, 
epigenetic analyses were limited to lymphocytes and mononuclear phagocytes. Therefore, 
further description is focused on those lineages. 
For precise proliferation and differentiation processes, controlled expression of lineage- and 
cell type-specific transcription factors (TF) is essential. PU.1, for example, is a key regulator 
for the myeloid development (McKercher et al., 1996; Scott et al., 1994), whereas GATA1 is 
required for the erythroid and megakaryocytic lineage (Rice et al., 2007; Zhu and Emerson, 
2002). Lymphoid development and especially further T cell differentiation are dependent on 
Ikaros (Georgopoulos et al., 1997; Quirion et al., 2009) while Pax5 assumes a key regulator 
function during B cell differentiation (Adams et al., 1992; Urbanek et al., 1994). 
 
1.2.2 The Mononuclear Phagocyte System 
The mononuclear phagocyte system (MPS) comprises non-granulocytic, myeloid cells that 
play crucial roles during innate and adaptive immune responses as well as in tissue 
remodelling and homeostasis (van Furth and Cohn, 1968; Varol et al., 2009). Circulating 
CD14 positive monocytes account for 5 to 10% of peripheral leukocytes in humans and 
represent the key members of the MPS. Depending on the cytokine environment, monocytes 
have the capacity to differentiate into various immune cells with distinct functions including 
macrophages, dendritic cells and osteoclasts (Seta and Kuwana, 2007).  
 
1.2.2.1 Macrophages in the Immune Response 
Macrophages represent the most ancient cell type in the hematopoietic system and comprise 
numerous subpopulations with various functions. Up to now, this heterogeneity including the 
resulting diverse functions during immune response and tissue remodelling as well as the 
interplay with other inflammatory cells is not completely understood (Ricardo et al., 2008). 
Following infection, circulating monocytes are recruited to affected sites, enter the injured 
tissue and differentiate into macrophages whose phenotype and function is determined by 
the present stimuli (Abbas et al., 2007). Phagocytosis and destruction of a variety of 
pathogens are mediated by receptor molecules, expressed on the macrophage‘s cell 
surface. Apart from eliminating microbes, macrophages govern many other functions in 
defence against infections. Production of cytokines like TNF (tumor necrosis factor) or IL-1 
(interleukin 1) leads to activation of endothelial cells and neutrophils whereas IL-12 secretion 
results in stimulation of natural killer (NK) cells and T cells, reinforcing the immune response. 
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On the other hand, activated macrophages also produce growth factors for fibroblasts and 
endothelial cells, contributing to tissue remodelling after injury or infection (Abbas et al., 
2007).  
 
1.2.2.2 Dendritic Cells in the Immune Response 
Dendritic cells (DC) were initially described in the 1970s (Steinman and Cohn, 1973) and 
since then numerous subpopulations differing in surface markers, localization and 
immunological function have been described. Although the generation of different subtypes is 
a consequence of diverse infectious and inflammatory stimuli, all DC subpopulations share 
the ability to capture, process and present antigens to T cells (Conti and Gessani, 2008). 
DCs are predominantly located in lymphoid organs and at sites of possible pathogen entry 
like mucosal surfaces and epidermis (Abbas et al., 2007). Intrinsically, DCs reside in a 
resting, immature state and their main function is to capture antigens. Following encounter 
with microbes, DC undergo maturation while they migrate to the draining lymph nodes. 
Mature dendritic cells finally settle in T cell zones of the lymph node where they efficiently 
present the captured antigens and stimulate naïve T cells (Abbas et al., 2007). 
Until today, it is unclear where and when commitment to DC development occurs in vivo. 
Additionally, the precursor-to-progeny relationship between monocytes and DCs has been 
discussed since the identification of DCs (Liu et al., 2009). It is even unclear, if different DC 
subtypes really originate from the same hematopoietic precursor. Initially, Sallusto and 
Lanzavecchia identified monocytes as potential precursors of immature dendritic cells in vitro 
by supplementing cultures of human peripheral blood monocytes with the 
granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin 4 (IL-4) 
(Sallusto and Lanzavecchia, 1994). The resulting immature DCs may then be matured by 
addition of toll-like receptor ligands such as LPS or by addition of TNF (De Smedt et al., 
1996). Although various protocols describe how to trigger monocyte differentiation towards 
dendritic cells (reviewed in (Conti and Gessani, 2008)), the “Sallusto cytokine combination” is 
the best characterized and most utilized one. Another in vitro model that is based on the 
transendothelial migration of monocytes without the addition of cytokines, supported the idea 
that monocytes may also differentiate towards DCs under physiological conditions (Randolph 
et al., 1998). Randolph et al postulated that DCs arise from monocytes crossing the 
endothelium, whereas macrophages develop from monocytes remaining in the 
subendothelial matrix. 
Finally, it has to be mentioned that the in vivo existence of dendritic cells as a separate cell 
type is controversially discussed (Hume, 2008). According to Hume, dendritic cells just 
represent a heterogeneous subpopulation of mononuclear phagocytes as neither pathways 
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of development, markers, nor functions in antigen presentation exist, which definitely 
distinguish them from macrophages. 
 
1.2.3 The Lymphoid Lineage 
While macrophages and dendritic cells participate in innate immunity (also called natural or 
native immunity) that provides initial defence against microbes, lymphocytes mediate 
adaptive immunity. Adaptive immunity or specific immunity is characterized by its 
antigen-specificity for distinct macromolecules and by a memory which enables the 
lymphocytes to react much faster and more vigorously to a repeated encounter with the 
same pathogen (Abbas et al., 2007). Lymphocytes are divided in distinct subtypes due to 
different functions and gene products. B lymphocytes (or B cells) mature in the bone marrow 
and are responsible for antibody production upon infection. B cells express high levels of the 
cell surface marker CD19 that is used to distinguish them from other leukocytes. 
T lymphocytes (T cells) refer to thymus-derived lymphocytes as their precursors migrate from 
the bone marrow to the thymus where they differentiate into T cells. CD4 expressing T helper 
cells (CD4+ T cells) contribute to B cell differentiation and macrophage activation whereas 
CD8 expressing cytotoxic T lymphocytes (CD8+ T cells) are responsible for killing tumor cells 
or cells infected with microbes (Abbas et al., 2007). The CD56 positive natural killer (NK) 
cells are responsible for destruction of virus-infected and damaged cells. Although they fulfil 
similar effector functions as cytotoxic T cells, NK cells rather contribute to innate immune 
defence than to adaptive immunity. 
 
1.2.4 Role of Epigenetic Modifications for Lineage Commitment  
Throughout hematopoiesis, multipotent and proliferating progenitor cells differentiate into 
specialized effector cells thereby losing their proliferation potential. How these cell fate 
decisions are made and which regulatory processes trigger differentiation towards one 
lineage or the other is not completely understood. One important factor for differentiation 
processes is the proper balance and timing of transcription factor (TF) expression (Akashi, 
2005; Bonifer et al., 2006). However, transcription factors are dependent on the present 
chromatin architecture at the corresponding binding sites because DNA accessibility is 
determined by histone modifications and CpG methylation. The chromatin structure of 
multiple lineage specific genes is believed to keep hematopoietic precursors in a kind of 
“primed” state (Bonifer et al., 2006; Bottardi et al., 2007; Reiner, 2005). In hematopoietic 
progenitor cells, several lineage-specific genes reside within transcriptionally potent 
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(accessible) chromatin and are therefore prepared for a potentiated expression when the 
proper signals and factors are present (Bottardi et al., 2007). The human ß-globin locus of 
hematopoietic progenitors, for example, is characterized by H3 hyperacetylation and H3K4 
dimethylation. However, high-level globin expression is only achieved in erythroid cells where 
the proper signal and transcription factor environment is given (Bottardi et al., 2007). The 
promiscuous (epi)genetic program of hematopoietic precursors, resulting from coexpression 
of various lineage-specific genes (albeit to a low level), allows differentiation into distinct cell 
types at the multipotent stage (Akashi, 2005). 
 
The importance of proper epigenetic regulation and orchestration in different cell types is 
emphasised by the fact that differential methylation patterns of lineage determinants may 
contribute to severe malignancies like shown for the GATA genes in lung cancer (Guo et al., 
2004) or for PU.1 hypomethylation in B cell lymphomas (Ivascu et al., 2007). The reasons for 
abnormal methylation patterns are currently not understood but aberrant expression of the 
methylating enzymes, DNA-methyltransferases (DNMT), seems to play a crucial role during 
those processes (Rice et al., 2007). More and more publications link abnormal methylation 
patterns to cancer development, but up to date comparatively little is known about the 
regulating role of DNA methylation during differentiation of healthy somatic cells. It is known 
that DNA methylation is crucial for the expression of cytokines like IL-4 during T cell 
activation and also for event memorization resulting in a faster and more vigorous immune 
response in case of a second encounter with a pathogen (Murayama et al., 2006; Reiner, 
2005). Furthermore, several methylation patterns have been linked to transcriptional 
activation of lineage specific transcription factors (Ivascu et al., 2007), but there is no 
systematic analysis, helping to clarify the global role of DNA methylation and its interplay with 
other chromatin modifications during lineage commitment and cell fate decision in the 
hematopoietic system.  
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2 Research Objectives 
Defined methylation patterns are crucial for the normal progression of vital biological 
processes including embryogenesis and development. Alterations in methylation profiles and 
the associated dysregulation of affected genes are implicated in various diseases like 
neoplastic transformation. However, surprisingly little is known about the function of DNA 
methylation in normal somatic cells. A major aim of this thesis was to investigate methylation 
changes during differentiation processes of post-proliferative monocytes. This system is 
particularly well suited to study active, proliferation-independent DNA demethylation events, 
a process which is currently not well documented in mammals and controversially discussed. 
Based on an earlier identified example for active demethylation in differentiating monocytes, 
other examples should be identified to enable the further characterization of the active 
demethylation process. To find regions subjected to demethylation, novel methodological 
approaches had to be developed, since existing techniques were not well suited to study this 
phenomenon. Finally, the active demethylation process should be characterized at several 
regions and for several donors, e.g. in terms of timing, its relation to mRNA expression and 
other epigenetic marks, to shed light on possible mechanisms. 
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3 Material and Equipment 
3.1 Equipment 
8-Channel PipettorImpact2 Equalizer 384 Thermo Fisher Scientific, Hudson, US 
Autoclave      Technomara, Fernwald, Germany 
Bioanalyzer 2100    Agilent Technologies, Böblingen, Germany 
BioPhotometer     Eppendorf, Hamburg, Germany 
Centrifuges      Heraeus, Hanau; Eppendorf, Hamburg, Germany 
Densitometer     Molecular Dynamics, Krefeld, Germany 
Electrophoresis equipment    Biometra, Göttingen; BioRad, Munich, Germany 
FACS Calibur     BD, Heidelberg, Germany 
Heat sealer (Fermant 400)    Josten & Kettenbaum, Pensberg, Germany 
Heat sealer     Eppendorf, Hamburg, Germany 
Heatblock     Stuart Scientific, Staffordshire, UK 
Incubators      Heraeus, Hanau, Germany 
J6M-E centrifuge    Beckmann, Munich, Germany 
Laminar air flow cabinet    Heraeus, Hanau, Germany 
Luminometer (Sirius)     Berthold Detect. Systems, Pforzheim, Germany 
MassARRAY Compact System   Sequenom, Hamburg, Germany 
MassARRAY MATRIX Liquid Handler  Sequenom, Hamburg, Germany 
MassARRAY Phusio chip module  Sequenom, Hamburg, Germany 
Megafuge 3,0 R    Heraeus, Osterode, Germany 
Microarray hybridization chambers SureHyb Agilent Technologies, Böblingen, Germany 
Microarray scanner; 5 micron resolution  Agilent Technologies, Böblingen, Germany 
Microarray slide holder    Agilent Technologies, Böblingen, Germany 
Microscopes     Zeiss, Jena, Germany 
Multifuge 3S-R     Heraeus, Osterode, Germany 
Multipipettor Multipette plus   Eppendorf, Hamburg, Germany  
NanoDrop     PeqLab, Erlangen, Germany 
PCR-Thermocycler PTC-200   MJ-Research/Biometra, Oldendorf, Germany 
PCR-Thermocycler Veriti 384 well  Applied Biosystems, Foster City, USA 
pH-Meter      Knick, Berlin, Germany 
Picofuge     Heraeus, Osterode, Germany 
Power supplies     Biometra, Göttingen; Germany 
Realplex Mastercycler epGradient S  Eppendorf, Hamburg, Germany 
Sigma 2 – Sartorius    Sartorius, Göttingen, Germany 
Sonifier 250     Branson, Danbury, USA 
Sorvall RC 6 plus    Thermo Fisher Scientific, Hudson, USA 
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Speed Vac     Christ, Osterode, Germany 
Thermomixer     Eppendorf, Hamburg, Germany 
Typhoon™      Amersham Biosciences, Germany 
Ultracentrifuge Optima L-70    Beckman, Munich, Germany 
Waterbath     Julabo, Seelstadt, Germany 
Water purification system    Millipore, Eschborn, Germany 
 
 
3.2  Consumables 
384-well PCR plates    Thermo Fisher Scientific, Hudson, USA 
8-channel pipettor tips Impact 384  Thermo Fisher Scientific, Hudson, USA 
Adhesive PCR sealing film   Thermo Fisher Scientific, Hudson, USA 
Cell culture flasks and pipettes   Costar, Cambridge, USA 
CLEAN resin     Sequenom, Hamburg, Germany 
Cryo tubes     Nunc, Wiesbaden, Germany 
Filter tubes: Millipore Ultrafree-MC  Millipore, Eschborn, Germany 
Heat sealing film    Eppendorf, Hamburg, Germany 
Luminometer vials    Falcon, Heidelberg, Germany 
MATRIX Liquid Handler D.A.R.Ts tips  Thermo Fisher Scientific, Hudson, USA 
Micro test tubes (0.5, 1.5, 2 ml)   Eppendorf, Hamburg, Germany 
Microarray gasket slides   Agilent Technologies, Santa Clara, USA 
Multiwell cell culture plates and tubes  Falcon, Heidelberg, Germany 
nProteinA Sepharose 4 FastFlow  GE Healthcare, Munich, Germany 
PCR plate Twin.tec 96 well   Eppendorf, Hamburg, Germany 
rProteinA Sepharose 4 FastFlow  GE Healthcare, Munich, Germany 
Sepharose Cl-4 beads    Sigma-Aldrich, Munich, Germany 
SpectroCHIP bead array   Sequenom, Hamburg, Germany 
Syringes and needles    Becton Dickinson, Heidelberg, Germany 
Sterile combitips for Eppendorf multipette Eppendorf, Hamburg, Germany 
Sterile micropore filters    Millipore, Eschborn, Germany 
Sterile plastic pipettes    Costar, Cambridge, USA 
Teflon foils     Heraeus, Hanau, Germany 
 
 
 
 
 Material and Equipment 
 - 20 -    
3.3  Chemicals 
All reagents used were purchased from Sigma-Aldrich (Taufkirchen, Germany) or Merck 
(Darmstadt, Germany) unless otherwise noted. Oligonucleotides for Real-Time PCR were 
synthesized and high-pressure liquid chromatography purified by Metabion (Planegg-
Martinsried, Germany). Oligonucleotides adapted to methylation analysis with the 
MassARRAY system (see section 4.2.5.15) were purchased from Sigma-Aldrich 
(Taufkirchen, Germany). 
 
 
3.4  Enzymes and Kits 
aCGH Hybridization Kit    Agilent Technologies, Waldbronn, Germany 
Alkaline phosphatase    Roche, Mannheim, Germany 
Aprotinin     Roche, Mannheim, Germany 
BioPrime Purification Module   Invitrogen, Karlsruhe, Germany 
BioPrime Total Genomic Labelling System Invitrogen, Karlsruhe, Germany 
Blood & Cell Culture DNA Midi Kit  Qiagen, Hilden, Germany 
Blood and Tissue Culture Kit   Qiagen, Hilden, Germany 
DNA Ladder 1 kb plus    Invitrogen, Karlsruhe, Germany 
DNA molecular weight standard   Invitrogen, Karlsruhe, Germany 
dNTPs      NEB, Frankfurt, Germany 
Dual-Luciferase Reporter Assay System Promega, Madison, USA 
EpiTect Bisulfite Kit    Qiagen, Hilden, Germany 
EZ DNA methylation kit    Zymo Research, Orange, USA 
FatsStart TaqDNA polymerase   Roche, Mannheim, germany 
Gene expression hybridization Kit  Agilent, Waldbronn, Germany 
HhaI Methylase     NEB, Frankfurt, Germany 
HpaII Methylase    NEB, Frankfurt, Germany 
Human Cot-1 DNA    Invitrogen, Karlsruhe, Germany 
Klenow Enzyme    NEB, Frankfurt, Germany 
Klenow exo- (3’-5’ exo minus)   NEB, Frankfurt, Germany 
Lipofectamin transfection reagent  Invitrogen, Karlsruhe, Germany 
Linear Amp. Kit plus, one colour  Agilent Technologies, Waldbronn, Germany 
NucleoSpin Plasmid Quick Pure  Macherey-Nagel, Düren, Germany 
NucleoSpin® Extract II    Macherey-Nagel, Düren, Germany 
Pepstatin     Roche, Mannheim, Germany 
Plasmid Midi Kit    Qiagen, Hilden, Germany 
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Proteinase K     Roche, Mannheim 
QIAquick PCR Purification Kit   Qiagen, Hilden, Germany 
QuantiFast SYBR green   Qiagen, Hilden, Germany 
Repli-G Midi Kit     Qiagen, Hilden, Germany 
Restriction endonucleases   NEB, Frankfurt; Roche, Mannheim; Germany 
Reverse Transkriptase SuperSkript II  Promega, Madison, USA 
RNA 6000 Nano Kit    Agilent Technologies, Waldbronn, Germany 
RNA Spike-in Kit    Agilent Technologies, Waldbronn, Germany 
RNeasy Midi and Mini Kit   Qiagen, Hilden, Germany 
S-Adenosyl-Methionin (SAM)   NEB, Frankfurt, Germany 
Shrimp Alkaline Phosphatase (SAP)  Sequenom, Hamburg, Germany 
SssI CpG methylases    NEB, Frankfurt, Germany 
T-Cleavage MassCleave Reagent kit  Sequenom, Hamburg, Germany 
TaqDna Polymerase    Roche, Mannheim, Germany 
T4 DNA Ligase     Promega, Madison, USA 
T4 DNA Ligase buffer    NEB, Frankfurt, Germany 
 
 
3.5 Oligonucleotides 
3.5.1 cDNA Primer 
C9ORF78   Forward: 5' CAGATGAAGACAGGTGGTATGGTGGA 3'  
    Reverse: 5' CCTCATCCCTTCGGTTGGTTTCTG 3' 
CCL13    Forward: 5' GAAGATCTCCTTGCAGAGGCT 3'  
    Reverse: 5' GGGTCAGCACAGATCTCCTTG3' 
 
GADD45A   Forward: 5' TCCTGCTCTTGGAGACCGAC 3'  
    Reverse: 5' GACTTAAGGCAGGATCCTTCCATTGAG 3' 
 
GADD45B   Forward: 5' AGTCGGCCAAGTTGATGAATGTG 3'  
    Reverse: 5' GATGAGCGTGAAGTGGATTTGCAG 3’ 
 
GADD45G    Forward: 5' CAGGACACAGTTCCGGAAAGCA 3' 
    Reverse: 5' ACACAGAAGGTCACATTGTCGG 3' 
 
HPRT    Forward: 5' AAGTTTGTTGTAGGATATGCCC 3'  
    Reverse: 5' GAACATTGATAATTTTACTGGCG 3' 
 
JDP2    Forward: 5' GAAGAACAAAGTCGCAGCAGCC 3’ 
    Reverse: 5' CTCCTCAATCTGGGTCTTCAGCTC 3’ 
 
MLXIPL    Forward: 5' CATGTTTGATGACTACGTCCGAACC 3’ 
    Reverse: 5' GACACCATCCCGTTGAAGGAC 3’ 
 
STAT5A   Forward: 5' CAGCCAGGACCACAATGCCA 3'  
    Reverse: 5' CAGCACTTTGTCAGGCACGG 3' 
 
 Material and Equipment 
 - 22 -    
STAT5B   Forward: 5' AACAACTGCTGCGTCATGGA 3'  
    Reverse: 5' TTCTGTCACCGACTCTGCCC 3' 
 
TCEA3    Forward: 5' GCTTATAGCCAAGATGACGGCAG 3’ 
    Reverse: 5' GGGTCATGGCATTCCTCAACTC 3’ 
 
USP20    Forward: 5' CCTTTGCCCTCACCTTGACTC 3'  
    Reverse: 5' CAGACAGGCCCATAGGTTTGGT 3' 
 
VDR    Forward: 5' CTCATGGCCATCTGCATCGT 3’ 
    Reverse: 5' CTGGATGGCCTCAATCAGCG 3’ 
 
3.5.2 ChIP/MCIP Primer 
C9ORF78/USP20  Forward: 5' AGTACGCGTGTTTGGATTTGGG 3’ 
    Reverse: 5' TGCTCTGAACACTCAGCTCCAC 3’ 
 
CCL13    Forward: 5' CTAGAAAAGTCTTTGGTGCCCAG 3'  
    Reverse: 5' CTTGGAACTCTCAGAGGACCTTG 3' 
 
CCL23    Forward: 5' GTGTTTACCAGCAGAGATCACAG 3'  
    Reverse: 5' CACCTTCAGATGCTCAAATAGCC 3' 
 
CD207    Forward: 5' TGCCCTCTCATTGGTCCCAG 3'  
    Reverse: 5' TACCTACCTCAGCCTGCATTTCCA 3' 
 
CLEC10A   Forward: 5' TCTCCCTGCTTCCTCTGACATCC 3'  
    Reverse: 5' AATCACACCCTCCAGACCTCCC 3' 
 
DNase1L3   Forward: 5' GGGCTCACCTTCACAATGACATCC 3'  
    Reverse: 5' TCTGCTCCTTCAACGTCAGGTC 3' 
 
P2RY6    Forward: 5' CTGCTGACACCGACACAGAG 3'  
    Reverse: 5' GAGCTGGCAAGAGATGAGAGTCC 3' 
 
STAT5    Forward: 5' GCACAGACTCTGCATCCTCTTCTC 3'  
    Reverse: 5' AGTCCTGCTTCCTCTGCCCA 3' 
 
Upstream   Forward: 5' CAGACAAGCCTTATCGGTATCACCT 3’ 
    Reverse: 5' AATCGCTATCTCATTACGATGTTGGG 3’ 
 
3.5.3 Primer for in vivo Footprinting 
Mcp1s    biotin-ACAGCTCCTTTATGGCTTCC 
Mcp2s    CATGGTGAATGGCTGGGGCG 
 
Mcp1as    biotin-ATGTTGAAGGTTAAGAGTTGG 
Mcp3as    TGTTTCTTTGCCTCTCTGCTCCTCTGG 
 
LP25 linker primer  Cy5-GCGGTGACCCGGGAGATCTGAATTC 
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3.5.4 Primer for Cloning Experiments 
CPM_S    5' TGACAGATCTGGAGTGGGCCGGAGCGAC 3’ 
CPMpi_AS   5’ ATGACCATGGCCATGTTCTAGAGATGAATAAAAATAAGAAGAACC 3’ 
 
3.5.5 Bisulfite Amplicon Generation (Nested PCR) 
M4-CpGas_outer  Forward: 5’ ACCAACTTTCTCTTCTAACTTTCC 3’ 
    Reverse: 5’ AGATTTTTATGTTGAAGGTTAAGAG 3’ 
 
M4-CpGas_inner  Forward: 5’ TTCTCTTCTAACTTTCCCTCTC 3’ 
    Reverse: 5’ GGTTAAGAGTTGGAGATTTTATAATG 3’ 
 
3.5.6 Bisulfite Amplicon Generation (MassARRAY) 
Epi00100_SPI1.1_10F  aggaagagagGATTGGGTTAGGGTTTTAGATAGGA 
Epi00100_SPI1.1_T7R  cagtaatacgactcactatagggagaaggctCCAAACCCCTTAAACTTAACCATAC  
 
Epi00103_STAT5A.1_10F  aggaagagagAGTTGTTTGGTTTTGTGTGTTTTTT 
Epi00103_STAT5A.1_T7R cagtaatacgactcactatagggagaaggctAAAAAAATCCTACTTCCTCTACCCA  
 
Epi00104_STAT5A.2_10F  aggaagagagAAAGTGATTTTTTTGAAGAGTGGTG 
Epi00104_STAT5A.2_T7R cagtaatacgactcactatagggagaaggctTCCAAAAAAACAAATCAAAACCTAA  
 
Epi00105_SLC27A3.1_10F aggaagagagGAAGGGATTTGGTTTTGGTTATTAT 
Epi00105_SLC27A3.1_T7R cagtaatacgactcactatagggagaaggctAAAAAAACATCTCTATCCCTCCCTA  
 
Epi00106_SLC27A3.2_10F aggaagagagGGAGAGTTTTTTGGTTATGTTGTTG 
Epi00106_SLC27A3.2_T7R cagtaatacgactcactatagggagaaggctAACCCCTAACCCATTTAATTCTACA  
 
Epi00107_SLC27A3.3_10F aggaagagagGGAGAGTATTTGTTGGTTGGTTTTA 
Epi00107_SLC27A3.3_T7R cagtaatacgactcactatagggagaaggctAACCCCTAACCCATTTAATTCTACA  
 
Epi00108_STAT5A.1_10F  aggaagagagTTTATAGGGAGGTATTAGGGTTTGG 
Epi00108_STAT5A.1_T7R cagtaatacgactcactatagggagaaggctTCCCTTCTTCAAAAAAAATTCCTAT 
 
Epi00109_CCL13.1_10F  aggaagagagTTTGTGGTTTGAATAGTTAGAAGGA 
Epi00109_CCL13.1_T7R  cagtaatacgactcactatagggagaaggctCAACAAACACAAAAACACTACAAAAA 
 
Epi00110_CCL13.2_10F  aggaagagagTTTATGGTTTTTTATGGTGAATGGT 
Epi00110_CCL13.2_T7R  cagtaatacgactcactatagggagaaggctAAAATAACTTACCTAACTAAACAAATCCC 
 
Epi00111_P2RY6.1_10F  aggaagagagTTTGGTTATGTTTGGAGTTTGTAGA 
Epi00111_P2RY6.1_T7R  cagtaatacgactcactatagggagaaggctAAAAAAATACCCTTACCAACCATTT 
 
Epi00112_P2RY6.2_10F  aggaagagagGAGTGTAAATGGTTGGTAAGGGTAT 
Epi00112_P2RY6.2_T7R  cagtaatacgactcactatagggagaaggctAAATCCCAAATATCTTCAAAAAACC 
 
Epi00116_CD207.2_10F  aggaagagagATTTTTGGATTTTTATGTTTGGGAT 
Epi00116_CD207.2_T7R  cagtaatacgactcactatagggagaaggctAACCCAAAATTCCATACCTTTACTC 
 
Epi00117_CBR3.1_10F  aggaagagagAGTTGATTGGTGAGTATGGGTTTTA 
Epi00117_CBR3.1_T7R  cagtaatacgactcactatagggagaaggctAAAATTAACCACCCCAATAAAAAAA 
 
Epi00123_DNASE1L3.1_10F aggaagagagTTTTTTAGGAAAGGGGTTTATTTTT 
Epi00123_DNASE1L3.1_T7R cagtaatacgactcactatagggagaaggctAAAATCCAACACTCCAAACACTACT 
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Epi00124_DNASE1L3.2_10F aggaagagagGGAGGAGAAGTAGTAGTGGGGTTAG 
Epi00124_DNASE1L3.2_T7R cagtaatacgactcactatagggagaaggctCACCCCAAATACCCTCTAAAATAAA 
 
Epi00125_DNASE1L3.3_10F aggaagagagTGGTTTATTTTAGAGGGTATTTGGG 
Epi00125_DNASE1L3.3_T7R cagtaatacgactcactatagggagaaggctTCTCTAACAACACACTCCTAATATTTATAC 
 
Epi00128_ANGEL1.1_10F aggaagagagTTGATTTGATTATTGATGTTTTGAA 
Epi00128_ANGEL1.1__T7R cagtaatacgactcactatagggagaaggctATCAATTTTCTTCTACCCAACTCTTC 
 
 
Epi00129_ANGEL1.2_10F aggaagagagGAAGAGTTGGGTAGAAGAAAATTGAT 
Epi00129_ANGEL1.2_T7R cagtaatacgactcactatagggagaaggctAACTCAAAAACCACTTTCATTTCAT 
 
Epi00131_CHI3L1.1_10F  aggaagagagGTAGAGTAGGGTAGGGTGTGGTTTT 
Epi00131_CHI3L1.1_T7R  cagtaatacgactcactatagggagaaggctTTCCACCTAACCAAAAACCTAAAAT 
 
Epi00132_CHI3L1.2_10F   aggaagagagGTTTTTAGGTTGGGTAAGGGTTAGA 
Epi00132_CHI3L1.2_T7R  cagtaatacgactcactatagggagaaggctCATCAAACTTAAATTCCAAAACCTC 
 
Epi00133_CHI3L1.3_10F  aggaagagagAGAGGGAAAGATAGGGAAATTTTTA 
Epi00133_CHI3L1.3_T7R  cagtaatacgactcactatagggagaaggctTCTTAAAAAACCCTTAAACCCATTC 
 
 
Epi00136_CCL13.2.1_10F aggaagagagTTGTGATTTTGTGTTAATATTGAGTGT 
Epi00136_CCL13.2.1_T7R cagtaatacgactcactatagggagaaggctTCTTACAAACCAAACAAAAATAAACC 
 
Epi00143_MIA.2_10F  aggaagagagGGTGGTTTTATGTTTAAGTTGGTTG 
Epi00143_MIA.2_T7R  cagtaatacgactcactatagggagaaggctCCTCAAATCTTCCCTTCATAAAAAT 
 
Epi00147_C9ORF78.2_10F aggaagagagAGAGGTTTTTGTGAGGAAGTTTTTT 
Epi00147_C9ORF78.2_T7R cagtaatacgactcactatagggagaaggctACTACCCACACACTTCTATATCTCCTC 
 
Epi00148_C1ORF78.3_10F aggaagagagGGAATTTTGTTATTTTTTAGGGTGG 
Epi00148_C1ORF78.3_T7R cagtaatacgactcactatagggagaaggctAAAACCACCATCCTCTAACTCTC 
 
Epi00150_ZNF642.1_10F  aggaagagagTTTTGGTTTTATTTGGGTTTAAGGT 
Epi00150_ZNF642.1_T7R  cagtaatacgactcactatagggagaaggctAAAACTTATAAAAAATATCCCACCCC 
 
Epi00153_ADPGK.1_10F  aggaagagagAGGTTATGTTTAAAGGTTAGAGTTAGAGT 
Epi00153_ADPGK.1_T7R  cagtaatacgactcactatagggagaaggctCTCATAAATCCCTACCAAACAAAAA 
 
Epi00154_ADPGK.2_10F  aggaagagagGTTTTTGTTTGGTAGGGATTTATGA 
Epi00154_ADPGK.2_T7R  cagtaatacgactcactatagggagaaggctATTAAAAAACAAACTTCCCATTTCC 
 
Epi00156_C14ORF8.1_10F aggaagagagATTGAAATAGTGGTTGGAAGTAAGA 
Epi00156_C14ORF8.1_T7R cagtaatacgactcactatagggagaaggctCACTCCCAACTCCCTAACCTTAATA 
 
Epi00159_RAP1GAP.2_10F aggaagagagTAGTTTTATAGGGGTTGGGGATTAG 
Epi00159_RAP1GAP.2_T7R cagtaatacgactcactatagggagaaggctTCCTAAACAAAAAATCAAAAAACCC 
 
Epi00162_MMP7.1_10F  aggaagagagGGAATTTTAAGTAAGTGGGTTGTGA 
Epi00162_MMP7.1_T7R  cagtaatacgactcactatagggagaaggctACAATCACTAACAAAAAACACCAAA 
 
Epi00165_CCL17.1_10F  aggaagagagTTGAGAATATATTGTAGGGGGTAAGG 
Epi00165_CCL17.1_T7R  cagtaatacgactcactatagggagaaggctCCCCCAAATCTAAAACTAAATTTCT 
 
Epi00166_CCL17.2_10F  aggaagagagAGAAATTTAGTTTTAGATTTGGGGG 
Epi00166_CCL17.2_T7R  cagtaatacgactcactatagggagaaggctATTTTAAATTCAACTCTCCCATCAA 
 
Epi00167_CCL17.3_10F  aggaagagagTTGAGGTTTAGAGAGAAGTGATTTTG 
Epi00167_CCL17.3_T7R  cagtaatacgactcactatagggagaaggctAACACCTCCCTCATCAACTACATAC 
 
Epi00170_BACH2.1_10F  aggaagagagGTGTTAGTGTTGTGTTGGTGTTTGT 
Epi00170_BACH2.1_T7R  cagtaatacgactcactatagggagaaggctCAACACCTTCAACTTACTTTCAACC 
 
Epi00171_BACH2.2_10F  aggaagagagTGGTTGAAAGTAAGTTGAAGGTGTT 
Epi00171_BACH2.2_T7R  cagtaatacgactcactatagggagaaggctTTTATCCTAAAAAACACCAAACCAA 
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Epi00172_BACH2.3_10F  aggaagagagAATTTTTGGTTTGTTTTGGTTAGGT 
Epi00172_BACH2.3_T7R  cagtaatacgactcactatagggagaaggctTCTCAAAATAAAAAAACTCCAATCT 
 
Epi00176_PLLP.1_10F  aggaagagagGAAAGTAAAGAAGAATTTTGGGAGATT 
Epi00176_PLLP.1_T7R  cagtaatacgactcactatagggagaaggctAACCTCCCATCTTCTAAATAACCCC 
 
Epi00178_KIAA0430.1_10F aggaagagagTTAGTGAGAGTGGTTGAAGTTTTAGA 
Epi00178_KIAA0430.1_T7R cagtaatacgactcactatagggagaaggctCCCTAATAAAACCCTCCAAAAATAA 
 
Epi00179_KIAA0430.2_10F aggaagagagTTGTGTATTTTATTTTTGGAGGGTT 
Epi00179_KIAA0430.2_T7R cagtaatacgactcactatagggagaaggctAAAAACAATATCCCCTCTTTCCC 
 
Epi00181_TPP2.1_10F  aggaagagagGGGGTGGGTAGAGGTTAGAGTTAG 
Epi00181_TPP2.1_T7R  cagtaatacgactcactatagggagaaggctAAAAAATCCCTAAAACCAAAAAAAA 
 
Epi00182_TPP2.2_10F  aggaagagagGGGGAAGTTTGGGTTTTTTTT 
Epi00182_TPP2.2_T7R  cagtaatacgactcactatagggagaaggctTTACCTATCTAATATCTCCACCCCA 
 
Epi00184_CLEC10A.1_10F aggaagagagGAAGATAAGGTTGGAAATGGGTTAT 
Epi00184_CLEC10A.1_T7R cagtaatacgactcactatagggagaaggctACCTCTAATCCTTACAACACAACCA 
 
 
Epi00185_CLEC10A.2_10F aggaagagagTATTATTATTTGTGGGAGGTTTGGA 
Epi00185_CLEC10A.2_T7R cagtaatacgactcactatagggagaaggctAACAAAACTAACCTCAAACCCAACT 
 
Epi00188_MAPKAPK3.1_10F aggaagagagGGGTGTAGAGGATAGTTTTAGAAATGA 
Epi00188_MAPKAPK3.1_T7R cagtaatacgactcactatagggagaaggctCTCTTCTCCCCTAACTAACAAAACC 
 
Epi00189_MAPKAPK3.2_10F aggaagagagGGTTTTGTTAGTTAGGGGAGAAGAG 
Epi00189_MAPKAPK3.2_T7R cagtaatacgactcactatagggagaaggctATAAACCCTACAACCTCTCCAAATC 
 
Epi00191_TRIM15.1_10F  aggaagagagGGTTATTATGGGTAGATGTGGTGAG 
Epi00191_TRIM15.1_T7R  cagtaatacgactcactatagggagaaggctAATACCAACACAAAAAAACCACCTA 
 
Epi00192_TRIM15.2_10F  aggaagagagAAGGTGTGTTTATAGGGAATGGTTA 
Epi00192_TRIM15.2_T7R  cagtaatacgactcactatagggagaaggctCCAACCACTATAATCTACAAATTCCA 
 
 
3.6 Antibiotics 
Ampicillin   Ratiopharm, Ulm, Germany 
Hygromycin   Clontech, Mountain View, USA 
Zeozin    Invitrogen, Karlsruhe, Germany 
 
 
3.7 Plasmids 
pCpG-mcs   Invivogen, San Diego, USA 
pGL3-Basic   Promega, Mannheim, Germany 
phRL-TK   Promega, Mannheim, Germany 
pMOD-LucShS   Invivogen, San Diego, USA 
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3.8 E.coli Strains 
PIR1(F- ∆lac169 rpoS(Am) robA1 creC510 Invitrogen, Karlsruhe, Germany 
hsdR514 endA recA1 uidA[∆mluI]:pir-116) 
 
 
3.9 Antibodies 
Chromatin Immunoprecipitation (ChIp) 
Anti-acetyl-Histone H3    Millipore, Temecula, USA 
Anti-acteyl-Histone H4    Millipore, Temecula, USA 
Anti-dimethyl-Histone H3 (Lys4)  Millipore, Temecula, USA 
Anti-trimethyl-Histone H3 (Lys4)  Millipore, Temecula, USA 
Rabbit polyclonal to Histone H3   abcam, Cambridge, UK 
(monomethyl K4) 
Rabbit polyclonal to RNA pol II   abcam, Cambridge, UK 
CTD repeat YSPTSPS (phosphor S5) 
STAT6      Santa Cruz Biotechnology Inc., Santa Cruz, USA 
FACS Staining 
Anti CD1a_PE     BD, Heidelberg, Germany 
Anti CD14_FITC    BD, Heidelberg, Germany 
Anti CD3_FITC     BD, Heidelberg, Germany 
Anti CD20_FITC    Beckmann Coulter; Fullerton, USA 
Anit IgGgesamt_FITC    Beckmann Coulter; Fullerton, USA 
Western Blot 
Goat anti IgG F(c), HRP conjugated  Rockland, Gilbertsville, USA 
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3.10 Cell Lines 
Human Cell Lines  
THP-1      Human acute monocytic leukemia (DSMZ ACC 16) 
HepG2      Human hepatocellular carcinoma (DSMZ ACC 180) 
U-937      Human hystiocytic lymphoma (DSZM no. ACC5) 
Murine Cell Lines 
NIH3T3      Swiss mouse embryo fibroblast (DSMZ no. ACC 59) 
RAW      Mouse monocyte-macrophage BALB/c (ATCC TIB-71) 
Insect Cell Lines 
Drosophila Schneider2 (S2) cells Derived from a primary culture of late stage 
Drosophila melanogaster embryos (20-24h) (ATCC 
CRL-1963) 
 
 
3.11 Databases and Software 
Agilent feature extraction 9.5.1   Agilent Technologies, Waldbronn, Germany 
BLAT      http://genome.brc.mcw.edu 
EpiTYPER 1.0     Sequenom, Hamburg, Germany 
Generunner version 3.05 
Genespring 10.0.2    Agilent Technologies, Waldbronn, Germany 
Perlprimer version 1.1.14   
PubMed      www.ncbi.nlm.nih.gov/entrez 
Spotfire descision site 7.0  
UCSC Genome. Browser    www.genome.ucsc.edu 
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4 Methods 
4.1 General Cell Culture Methods 
For washing and harvesting, mammalian cells were centrifuged using the general cell 
program: 8 min, 300×g, 4°C. 
 
4.1.1 Cell Line Culture 
4.1.1.1 Culture Conditions and Passaging 
If not otherwise indicated, cells were cultured in RPMI 1640 (HyClone) or DMEM (Gibco) 
(Table 4-1) routinely supplemented with 10% inactivated FCS, L-glutamine (2 mM), sodium 
pyruvate (1 mM), antibiotics (50 U/ml penicillin and 50 µg/ml streptomycin), 2 ml vitamins, 
non essential amino acids and 50 µM ß-mercaptoethanol. Media supplements were 
purchased from Gibco and Biochrome (L-glutamine) respectively. 
FCS was heat inactivated for 30 min at 56°C before use. Exceeding incubation times and 
higher temperatures should be avoided because heat sensitive growth factors could be 
damaged. Each batch of FCS as well as each RPMI batch was tested before use. 
 
Cells were cultured at 37°C, 5% CO2 and with 95% relative humidity in an incubator. 
 
Table 4-1 Culturing and passaging conditions 
Cell Line Culture medium Passaging 
U937 RPMI 1640 Cells in suspension 
THP-1 RPMI 1640 Cells in suspension 
HepG2 RPMI 1640 Splitting by trypsination 
RAW264.7 RPMI 1640 Splitting by scraping 
NIH3T3 DMEM Splitting by trypsination 
 
 
Cell cultures were split 1:4 to 1:8 in fresh medium every 2-4 days. Adherent cells were 
washed once with PBS and either scraped or disaggregated by incubation with 0.05% 
Trypsin/0.02% EDTA/PBS (3 ml per 75 cm2 culture vessel area) at 37°C for 5 min until cells 
detached. Trypsin was then inactivated by adding 6 ml medium with 10% FCS. 
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4.1.1.2 Culturing of Stably Transfected Drosophila S2 Cells and Production of 
MBD-Fc 
MBD-Fc stands for a fusion protein composed of the methyl-CpG binding domain (MBD) of 
human MBD2 (methyl-CpG binding domain protein 2) and the Fc-tail of human IgG1. The 
MBD-Fc vector was stably transfected into Drosophila S2 cells using Effectene transfection 
reagent (Qiagen) and hygromycin selection. A detailed description of the design and the 
generation of the fusion protein is given in (Gebhard et al., 2006b; Gebhard et al., 2006a). 
 
Expansion in Cell Culture Bottles 
MBD-Fc S2 cells were seeded at a density of 1-2×106 cells/ml in Insect-Xpress medium 
(Lonza) including 50 U/ml penicillin and 50 µg/ml streptomycin but without FCS at 21-23°C. 
400 µg hygromycin were added for selection of plasmid containing cells. Cells were splitted 
once a week, without exceeding 10×106 cells/ml. 
 
Protein Production 
Cells were transferred into 2000 ml roller bottles and cultured at a density of 4×106 cells/ml in 
up to 400 ml Insect-Xpress medium supplemented with penicillin, streptomycin and 
hygromycin as described above. Cells should never exceed a density of 10×106 cells/ml. For 
large-scale protein production, after 3-5 days the culture media was exchanged and 
5×106 cells/ml were seeded in 400 ml Insect-Xpress. Instead of hygromycin, 0.5 mM CuSO4 
were added to stimulate the metal-inducible promoter of the used vector. The MBD-Fc 
containing culture medium was harvested after 4 days like described in section 4.3.1. For 
recovery, cells were cultured again in Insect-Xpress medium containing standard antibiotics 
and selection antibiotic for 3-5 days. The cycle of production was repeated until protein 
quality and amount clearly decreased. 
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4.1.1.3 Assessing Cell Number and Vitality 
The number of viable and dead cells was determined by Trypan blue exclusion. Cell 
suspensions were diluted with Trypan blue solution and cells were then counted in a 
Neubauer haemocytometer. The concentration of viable cells was then calculated using the 
following equation: 
 Number of viable cells/ml  C=N×D×104 
      With N:  average of unstained cells per 
        corner square 
        (1 mm² containing 16 sub- 
        squares) 
       D: dilution factor 
Required solutions and materials: 
 Trypan blue solution:   0.2% (w/v)  Trypan blue in 0.9% NaCl solution 
 
 Neubauer haemocytometer slide with coverslip 
 
4.1.1.4 Freezing and Thawing Cells 
Cells were harvested and suspended at 5-10×106 cells/ml in 800 µl ice cold medium, 
including 10% FCS. After inverting the mix and transferring it into cryo-vials, 160 µl DMSO 
(10% final) and 640 µl FCS (40% final) were added. Tubes were rapidly inverted to mix cells 
properly. To allow gradual freezing at a rate of 1°C/min, the cryo-vials were placed into 
isopropanol-filled cryo-containers (Nalgene) and frozen at -80°C for 24 h. For long-term 
storage, the tubes were transferred in liquid nitrogen (-196°C) for.  
 
4.1.1.5 Mycoplasma Assay 
Cell lines were routinely checked for mycoplasma contamination by the MycoAlert® 
Mycoplasma detection assay (Cambrex, Rockland, USA) according to the manufacturer’s 
instructions. 
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4.1.2 Transient Transfection of Mammalian Cells 
4.1.2.1 Lipofectamine Transfection 
HepG2 as well as RAW264.7 were most efficiently transfected using the 
LipofectamineTM 2000 reagent from Invitrogen (Karlsruhe, Germany) following the 
manufacturer’s instructions with slight modifications. In brief, adherent cells were seeded 
(0.5×106 cells/ml; 2 ml) in 6-well plates using growth medium without antibiotics one day 
before transfection. For each transfection sample complexes were prepared as follows 
(referring to 6-well plates): 
 
Solution A: 3 µg vector DNA were incubated with 100 ng Renilla vector (pHRL-TK, control 
reporter; usually 1/20 – 1/50 of the amount of the reporter of interest) and 
100 µl Opti-MEM for 5 min at RT 
Solution B: 7 µl lipofectamine were mixed with 100 µl Opti-MEM 
 
Combined together, solutions A + B were incubated for 20 min at RT. Subsequently, the 
whole mixture was dropped slowly onto the cells followed by gently rocking the plate back 
and forth to mix the cells with the complexes. After approximately 24 hours, the cells were 
ready for measuring transgene expression via luciferase expression. 
 
4.1.2.2 Transfection Using DEAE Dextran 
To transfect THP-1 cells, one of the oldest transfection methods called “Transfection with 
DEAE Dextran” was used. The underlying principle is the binding of DNA to poly-cations 
resulting in DNA-Dextran-complexes that are dropped on cell suspensions. Those complexes 
were then taken up via endocytosis. 
One day before transfection, cells were seeded at a density of 0.5×106 cells/ml calculating 
with 3×106 cells per transfection sample. 70 µl 1×STBS buffer were mixed with 10 ng Renilla 
control reporter (pHRL-TK ) and 200 ng plasmid DNA in an Eppendorf cup. Just prior to use, 
DEAE dextran was dissolved in STBS buffer and 70 µl were added to each prepared plasmid 
sample. Complexes were then gently dropped onto cells and incubated for 20 min at 37°C in 
an incubator. To stop the reaction, 1×STBS buffer was added before centrifugation. Cells 
were then washed twice with 1×STBS and finally transferred to cell culture dishes in 6 ml 
RPMI including 10% FCS. After 48 hours cells were ready for lysis and measuring luciferase 
activity. 
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Required buffers and solutions: 
 10×STBS buffer 25 ml 1 M   (25 mM)  Tris pH 7.4 
    8 g   (137 mM)  NaCl 
    6.372 g   (5 mM)  KCl 
    0.160 g   (0.6 mM) Na2HPO4 7H2O 
    0.102 g   (0.7 mM) CaCl2 
    Add ddH2O to 1000 ml 
 
 DEAE Dextran:  10 mg/ml in STBS 
 
4.1.2.3 Measuring Luciferase Activity 
Luciferase activity was tested with the Dual-Luciferase Reporter Assay System (Promega) 
following the manufacturer’s instructions. Briefly, 24-48 hours after transfection, cells were 
transferred to 14 ml polystyrene round-bottom tubes (Falcon), centrifuged at 300×g for 10 
minutes and washed with PBS. After discarding the supernatant, cells were lysed by adding 
100 µl – 150 µl diluted lysis buffer and incubation for at least 10 min at RT. The lysate was 
cleared and Firefly as well as Renilla luciferase activities were measured on a Sirius 
photometer. Firefly luciferase activity of individual transfections was normalised against 
Renilla luciferase activity. 
 
4.1.3 Primary Cells 
4.1.3.1 Isolation of Monocytes 
Peripheral blood mononuclear cells (PB-MNCs) were separated by leukapheresis of healthy 
donors (Graw, Jr. et al., 1971), followed by density gradient centrifugation over 
Ficoll/Hypaque (Johnson, Jr. et al., 1977). Monocytes were then isolated from MNCs by 
counter current centrifugal elutriation (Sanderson et al., 1977). 
Elutriation was performed in a J6M-E centrifuge equipped with a JE 5.0 elutriation rotor and a 
50 ml flow chamber (Beckman, Munich, Germany). After sterilising the system with 6% H2O2 
for 20 min, the system was washed with PBS. Following calibration at 2500 rpm and 4°C with 
Hanks BSS, MNCs were loaded at a flow rate of 52 ml/min. Fractions were collected and the 
flow through rate was sequentially increased according to Table 4-2. 
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Table 4-2 Elutriation parameter and cell types 
Fraction Volume (ml) Flow rate (ml/min) Main cell type contained 
Ia 1000 52 platelets 
Ib 1000 57 
IIa 1000 64 
IIb 500 74 
IIc 400 82 
IId 400 92 
B- and T- lymphocytes, NK cells 
III 800 130 monocytes 
 
 
Monocytes represent the largest cells within the MNCs and are therefore mainly obtained in 
the last fraction. Monocytes were >85% pure as determined by morphology and CD14 
antigen expression. Low amounts of monocytes may be also detected in the IId fraction. 
Monocytes (fraction III) were centrifuged (8 min, 300×g, 4°C), resuspended in RPMI culture 
medium and counted. Monocyte yields were donor dependent, typically between 10-20% of 
total MNCs. Supernatants of monocyte cultures were routinely collected and analysed for the 
presence of interleukin-6 (IL-6), which was usually low, indicating that monocytes were not 
activated before or during elutriation. 
 
4.1.3.2  Cultivation of Monocytes 
4.1.3.2.1 Dendritic Cells 
Immature monocyte-derived dendritic cells (DCs) were generated by culturing 1×106/ml 
elutriated monocytes in RPMI containing 10% FCS, 20 U/ml recombinant human IL-4 
(Promokine, Heidelberg, Germany) and 280 U/ml GM-CSF (Berlex, Seattle, USA) as 
described earlier (Meierhoff et al., 1998). Note that culture concentrations of IL-4 and 
GM-CSF may vary when the company is changed. 
 
4.1.3.2.2 Macrophages 
In order to generate macrophages in vitro, 1×106/ml monocytes were cultured in RPMI 1640 
in presence of 2% human pooled AB-group serum on teflon foils. For harvesting, 
macrophages were cooled to 4°C for 30 min and subsequently detached by carefully 
“juddering” the teflon foils (Andreesen et al., 1983). 
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4.2 General Molecular Biology 
4.2.1 Bacterial Culture 
4.2.1.1 Bacterial Growth Medium 
E.coli strains were streaked out on solid LB-agar with appropriate antibiotics and grown 
overnight (O/N) at 37°C. Single colonies were then picked into liquid LB-medium containing 
the corresponding antibiotics (see section 3.6) and grown overnight at 37°C with shaking at 
200 rpm. 
 LB-medium: 10 g  NaCl 
   10 g  Bacto Tryptone (Difco) 
   5 g  Yeast extract 
   Add ddH2O to 1000 ml, autoclave 
 
 LB-agar plates: 15 g  Agar 
   10 g  NaCl 
   10 g  Bacto Tryptone (Difco) 
   5 g  Yeast extract 
Add ddH2O to 1000 ml, autoclave, cool to 50°C and add the appropriate 
antibiotic 
   Pour the agar solution into 10 cm Petri dishes, and store inverted at 4°C 
 
4.2.1.2 Transformation of Chemically Competent E.coli 
Chemically competent E.coli (50 µl) were thawed on ice, 1-25 ng plasmid DNA in 2-5 µl 
volume was added and the suspension was mixed gently and incubated on ice for 30 min. 
Cells were heat-shocked in a water bath at 42°C for 30 s, immediately cooled on ice for 
2 min and 250 µl SOC medium was added. To express the resistance, bacteria were 
incubated for 1 h at 37°C with shaking and 50-150 µl of the transformation were plated and 
incubated overnight at 37°C on LB-agar containing the antibiotic necessary for selection of 
transformed cells. 
 
 SOC medium 20 g (2%)  BactoTrypton (Difco) 
   5 g (0.5%)  BactoYeastExtract (Difco) 
   0.6 g (10 mM) NaCl 
   0.2 g (3 mM)  KCl 
   Add ddH2O to 1000 ml, autoclave and add to the cooled solution: 
 
   10 ml (10 mM) MgCl2 (1 M), sterile filtered 
   10 ml (10 mM) MgSO4 (1 M),sterile filtered 
   10 ml (20 mM) Glucose (2 M), sterile filtered 
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4.2.1.3 Glycerol Stock 
For long-term storage, bacteria were stored at -80°C in 20% glycerol by adding 600 µl liquid 
culture to 200 µl of 80% glycerol. 
 
4.2.2 Plasmid Isolation from E.coli 
To check if the isolated single E.coli colonies contained the correct plasmid, a DNA mini-prep 
was carried out using NucleoSpin® Plasmid Quick Pure Kit from Macherey-Nagel following 
the supplied instructions. To isolate larger amounts of ultra pure DNA (100 µg) for 
transfection experiments, plasmids were isolated using the endotoxin-free QIAGEN Plasmid 
Midi Kit. 
 
4.2.3 Molecular Cloning 
DNA fragments to be cloned were prepared by PCR from genomic DNA or cDNA. For 
directional cloning, restriction sites were introduced by adding the appropriate recognition 
sequences to the primer sequences. Excised fragment and vector were gel-purified and 
combined in a 10 µl ligation reaction at a 3- to 5-fold molar excess of insert to vector, using 
25-50 ng of vector. Ligation was carried out overnight at 16°C with 1 U T4 DNA ligase and 
1 µl 10×T4 DNA ligase buffer. 2 µl of the reaction were used to transform chemically 
competent E.coli (see section 4.2.1.2). Successful insertion of the fragment into the vector 
was controlled by preparing plasmid DNA from liquid cultures (see sections 4.2.1.1 and 
4.2.2.). To control correct insertion and sequence integrity, plasmid constructs were 
sequenced by Geneart (Regensburg, Germany) using vector-specific primers. 
 
4.2.3.1 Construction of the pCpGL-basic Vector 
The enhancer/promoter region of the CpG-free plasmid pCpG-mcs (Invivogen) was excised 
using Pst I/Nhe I (see also sections 4.2.5.5 to 4.2.5.9) and replaced by a short CpG-free 
linker, representing the multiple cloning site (MCS; with Pst I, Spe I, BamHI, Bgl II, Hind III 
and Nco I sites): 
5’-CTG CAG GAC TAG TGG ATC CAG ATC TTA AGC TTA GTC CAT GGA CAA TTG CTA GC-3’ 
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The CpG-free luciferase coding region was released from pMOD-LucShS (Invivogen) by 
restriction with Mfe I (blunted using Klenow polymerase) and Nco I. The fragment was then 
subcloned into the Nhe I (also blunted with Klenow polymerase) and Nco I digested, linker 
ligated CpG-free backbone. After controlling the insert by sequencing, the newly synthesized 
CpG-free reporter vector, called pCpGL-basic, was now ready for subcloning promoters of 
interest or for in vitro methylation, directly followed by transient transfection. A physical map 
of this vector is given in Figure 5-2. 
The plasmid uses a modified E.coli R6K gamma origin of replication (R6Kori) and therefore 
has to be grown in cells expressing the pir gene that encodes the R6K specific initiator 
protein. All following cloning experiments using the pCpGL-backbone, were performed with 
E.coli PIR1 bacteria under zeocin selection (25 µg/ml). 
 
4.2.3.2 Cloning of Reporter Vectors  
pGL3-EF1:  Reporter construct with 286 CpGs in the vector backbone 
 The human EF1A-promoter was released from pCpG-mcs (Invivogen) 
using Spe I and Hind III and inserted into Nhe I/Hind III sites of 
pGL3-basic. 
 
pCpGL-CMV:  CpG-free control promoter-enhancer construct 
The human EF1A-promoter/CMV-enhancer cassette was released 
from pCpG-mcs using Pst I/Hind /// and inserted into equivalent sites of 
pCpGL-basic 
 
pCpGL-CPM:  CpG-island containing promoter construct (40 CpGs) 
The CPM-promoter was amplified from gDNA using the CPM_S and 
CPMpi_AS primers (see section 3.5.4) and subcloned into 
pCpGL-basic vector via Nco I and Bgl II sites. 
 
pCpGL-CHI3L1: Low CpG-density promoter construct (8 CpGs) 
The Nhe I/Bgl II fragment of a previously described CHI3L1 reporter 
vector (HC-377; (Rehli et al., 2003)) was cloned into Spe I/Bgl II sites 
of pCpGL-basic. 
 
 
 
 Methods 
 - 37 -    
4.2.4 In Vitro Methylation of Plasmid DNA 
Luciferase reporter constructs were methylated in vitro using Sss I, Hha I and Hpa II 
methylases according to the manufacturer’s recommendation. Briefly, 10-20 µg plasmid DNA 
were incubated with 2.5 U/µg methylase in the presence of 160 µM S-Adenosylmethionine 
(SAM; methyl group donor) for four hours at 37°C. After 2 hours the reaction was supplied 
with another 160 µM SAM. Simultaneously, control reactions were treated as above but 
without addition of SAM and methylating enzymes. After the methylation reaction, plasmids 
were purified using the NucleoSpin® Plasmid Quick Pure Kit from Macherey-Nagel or by 
phenol-chloroform extraction followed by ethanol precipitation and finally quantified using a 
NanoDrop Spectrophotometer. Completeness of methylation was controlled by digesting 
both methylated and unmethylated DNA using the methylation sensitive restriction enzymes 
Hha I and Hpa II as well as the methylation insensitive Msp I. 
 
4.2.5 Preparation and Analysis of DNA 
4.2.5.1 Isolation and Quality Control of Genomic DNA 
Genomic DNA (gDNA) was isolated using the Qiagen Blood & Cell Culture DNA Midi Kit or, 
for smaller cell numbers, the Blood and Tissue Culture Kit (Qiagen). gDNA concentration 
was then determined with the NanoDrop spectrophotometer and quality was assessed by 
agarose gel electrophoresis. 
 
4.2.5.2 Precipitation of DNA Using PEG (Polyethylene Glycol) 
To precipitate DNA from small volumes, e.g. PCR reactions or endonuclease digestion, one 
volume of PEG-mix was added to the DNA-containing solution, vortexed and incubated for 
15 min at RT. After centrifugation (15 min, 13000 rpm, RT), the supernatant was discarded 
and the precipitated DNA was washed by carefully adding 200 µl 100% EtOH to the tube wall 
opposite of the (often invisible) pellet. Following centrifugation (10 min, 13000 rpm, RT), the 
supernatant was carefully removed. The pellet was dried and resuspended in H2O in half to 
three-quarters of the initial volume. 
 
 PEG-mix 26.2 g  (26.2%) PEG 8000 
   20 ml  (0.67 M) NaOAc (3 M) pH 5.2 
   660 µl  (0.67 mM) MgCl2 (1 M) 
   Add ddH2O to 250 ml 
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4.2.5.3 Purification of DNA with Phenol Chloroform Extraction 
1 Volume (V) Phenol-Chloroform-Isoamylalcohol (25:24:1; pH 8) was mixed with the DNA 
containing solution. After centrifugation the DNA containing, aqueous phase was transferred 
into new Eppendorf cups, mixed with 1 V Chloroform-Isoamylalcohol (49:1) and centrifuged 
again. The aqueous phase was transferred again into a new cup and precipitated with 0.1 V 
3 M NaAc (pH 5.2) and 2.5 V 100% EtOH for at least 1 hour at -20°C. Precipitated DNA was 
then washed with 80% EtOH and dissolved in 1×TE buffer. 
 
Required buffers: 
 1×TE pH 8.0  1 ml  (1 M)  Tris (1 M; pH 8.0) 
    0.2 ml  (1 mM)  Na2EDTA (0.5 M; pH 8.0) 
    Add ddH2O to 100 ml 
 
4.2.5.4 Agarose Gel Electrophoresis 
The required amount of agarose as determined according to Table 4-3, was added to the 
corresponding amount of 1×TAE. The slurry was heated in a microwave oven until the 
agarose was completely dissolved. Ethidium bromide was added after cooling the solution to 
50-60°C. The gel was cast, mounted in the electrophoresis tank and covered with 1×TAE. 
DNA-containing samples were diluted 4:1 with DNA loading dye (5×), mixed and loaded into 
the slots of the submerged gel. Depending on the size and the desired resolution, gels were 
run at 40-100 Volt for 30 min to 3 h 
 
Table 4-3 Agarose concentration for different separation ranges 
Efficient range of separation (kb) % agarose in gel 
0.1 – 2 2.0 
0.2 – 3 1.5 
0.4 – 6 1.2 
0.5 – 7 0.9 
0.8 - 10 0.7 
genomic DNA 0.5 
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Required buffers: 
 TAE (50×)  252.3 g  (2 M)  Tris 
    20.5 g   (250 mM) NaOAc/HOAc, pH 7.8 
    18.5 g  (50 mM) EDTA 
    Add ddH2O to 1000 ml 
 
 EDTA (0.5 M)  18.6 g  (0.5 M)  EDTA/NaOH, pH 8.0 
    Add ddH2O to 100 ml 
 
 DNA loading dye 500 µl  (50 mM) Tris/HCl, pH 7.8 
 DNA-LD (5×)  500 µl  (1%)  SDS (20%) 
    1 ml  (50 mM) EDTA (0.5 M), pH 8.0 
    4 ml  (40%)  Glycerol 
    10 mg  (1%)  Bromphenol blue 
    Add ddH2O to 10 ml, store at 4°C 
 
 1.0% Agarose  1 g  (1%)  Agarose (Biozym)  
   Add 1× TAE to 100 ml and heat in a microwave until agarose is 
    completely dissolved 
    Cool to 50°C and add 2.5 µl Ethidium bromide (10 mg/ml) (Sigma) 
 
4.2.5.5 Restriction Endonuclease Digestion 
To verify the presence and orientation of plasmid-inserts, or to clone insert DNA into a 
plasmid, DNA was digested with appropriate restriction enzymes. Enzymes and their buffers 
were purchased from Roche or New England Biolabs (Germany). The digestion of plasmid 
DNA or PCR products was carried out using 10 U enzyme/1 µg DNA in 20 µl at 37°C for 
2 hours. Digestion of genomic DNA was performed overnight with 1.5 U/µg DNA in 30 µl 
reaction volume. 
 
4.2.5.6 Dephosphorylation of DNA with Alkaline Phosphatase 
To prevent self ligation, digested vectors were treated with AP (calf intestinal alkaline 
phosphatase, Roche) at 37°C for 30 min before gel extraction. 
 
4.2.5.7 Fill in 5’-Overhangs with Klenow-DNA-Polymerase 
To ligate two DNA fragments cut with two incompatible enzymes, blunt ends were generated 
by filling the 5’- or the 3’-overhangs. To fill in 5’-overhanging ends of DNA fragments, 
digested DNA was mixed with 1 µl of dNTPs (0.5 mM each), 4 U Klenow fragment and H2O 
to a total volume of 20 µl, and incubated for 15 min at 30°C. The inactivation of Klenow was 
done by heating for 10 min at 75°C. The DNA fragment with blunt ends was then either 
digested with a second enzyme or purified and used for ligation. 
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4.2.5.8 Generation of Blunt Ends with T4 DNA Polymerase 
To fill in 3’-overhanging ends of DNA, T4 polymerase was used. Digested DNA was 
incubated with T4 polymerase at 11°C for 20 min. T4 polymerase was then inactivated for 
20 min at 70°C. 
 
4.2.5.9 Purification of DNA Fragments by Gel Extraction 
DNA fragments were purified by running on an ethidium bromide-containing agarose gel. The 
band containing the fragment of interest was excised under UV illumination. Fragments were 
then purified by gel extraction using QIAEX II Gel Extraction Kit (Qiagen) or NucleoSpin® 
Extract II following the manufacturer's instructions. 
 
4.2.5.10 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) allows in vitro synthesis of large amounts of DNA by 
primed, sequence-specific polymerization of nucleotide triphosphates, catalysed by DNA 
polymerase (Mullis et al., 1986). PCRs were generally performed in “thick” PCR tubes with a 
reaction volume of 20-100 µl in a MJ research PTC 200 thermocycler (Biozym). The 
"calculated temperature" feature was used to decrease temperature hold times. The 
nucleotide sequences of the utilised primers are given in section 3.5. The primer annealing 
temperatures varied between 57 and 65°C. General parameter settings for analytical PCR 
are summarized in Table 4-4. 
 Reaction set up: 0.04 – 0.67 U/µl Taq DNA polymerase or Expand High Fidelity 
       polymerase mix with the supplied reaction 
       buffer 
    0.2 – 1 µM  Sense-/antisense primer (10 – 100 µM) 
    0.2 – 0.25 mM  dATP, dCTP, dGTP, dTTP 
 
 
Table 4-4 Reaction parameter for analytical PCR 
PCR step Cycling parameter 
Initial melting 95°C    2 min 
Melting 95°C    15 s 
Annealing 65°C    15 s 20 - 35 cycles 
Extension 72°C    60 s 
Final extension 72°C    5 -7 min 
Cool to 15°C 
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Real Time PCR 
Quantitative Real Time PCR (qPCR) was used for quantification of cDNA after reverse 
transcription (4.2.6.3) as well as for analysis after chromatin immunoprecipitation (4.2.8). 
PCR reactions were performed using the QuantiFast SYBR Green Kit from Qiagen in 96-well 
format adopted to the Eppendorf Realplex Mastercycler EpGradient S (Eppendorf, Hamburg, 
Germany). The relative amount of amplified DNA is measured through the emission of light 
by the SYBR green dye, when it is intercalated in double stranded DNA. 
 Reaction setup: 5 µl SYBR Green mix (2×) (QuantiFast, Qiagen) 
    2 µl ddH2O 
    0.5 µl primer forward (10 µM) 
    0.5 µl primer reverse (10 µM) 
    2 µl DNA 
 
Table 4-5 Reaction parameter for real time PCR 
PCR step Cycling parameter 
Initial melting 95°C, 5 min 
Melting 95°C, 8 s 
45 cycles Combined annealing and 
extension 60°C, 20 s 
Melting 95°C, 15 s 
Final cycle Combined annealing and 
extension 60°C, 15 s 
Melting curve 10 – 20 min 
 95°C 15 sec  
 
 
To calculate amplification efficiency, a dilution series (1:10; 1:50; 1:100, 1:1000) of a suitable 
sample was additionally measured for each primer pair. Realplex software calculated 
automatically DNA amounts based on the generated slope and intercept. Specific 
amplification was controlled by melting-curve analysis and data were imported and 
processed in Microsoft Excel 2003. All samples were measured in duplicates and normalised 
to the ß-Actin or the HPRT housekeeper when analysing mRNA Expression. Duplicates of 
ChIP samples were normalised to the input or a control region. 
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4.2.5.11 Bisulfite Sequencing 
Modification of gDNA with sodium bisulfite, leading to conversion of unmethylated cytosine 
residues into uracil while not affecting 5-methylcytosine (Frommer et al., 1992), was 
performed using the Qiagen EpiTect Bisulfite Kit as recommended by the manufacturer. 10 µl 
of bisulfite treated DNA were used for the first nested PCR reaction. 
 Outer PCR set up: 5 µl   (1×)  Taq-PCR-buffer (10×) 
    1 µl  (0.2 mM) dNTP (10 mM each) 
    2 µl  (0.4 µM) sense primer (1s; 10 µM) 
    2 µl  (0.4 µM) anti-sense primer (1as; 10 µM) 
    2.5 U  (0.5 µl)  TaqDNA Polymerase 
    27.5 µl     ddH2O 
    10 µl  (1 µg)  Bisulfite treated DNA 
 
Table 4-6 Reaction parameter for outer nested PCR 
PCR step Cycling parameter 
Initial melting 93° C, 5 s 
Melting 93°C, 15 s 
Annealing 55°C, 15 s 31 cycles 
Elongation 72°C, 70 s 
Final elongation 72 °C, 5 min 
Cooling 4°C for ever 
 
After finishing the first PCR, amplification products were directly used for the second, inner 
PCR step: 
 Inner PCR set up 5 µl   (1×)  FastStart Taq PCR-buffer (10×) 
    1 µl  (0.2 mM) NTP (10 mM each) 
    2 µl  (0.4 µM) sense primer (2s; 10 µM) 
    2 µl  (0.4 µM) anti-sense primer (2as; 10 µM) 
    0.5 µl  (2.5 U)  FastStart TaqDNA Polymerase 
    39 µl     ddH2O 
    0.5 µl     outer PCR product 
 
Table 4-7 Reaction parameter for inner nested PCR 
PCR step Cycling parameter 
Initial melting 94° C, 3 min  
Melting 94°C, 15 s 
Annealing 55°C, 15 s 31 cycles 
Elongation 72°C, 80 s 
Final elongation 72 °C, 5 min 
Cooling 4°C for ever 
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After the second amplification reaction, products were PEG-purified (see section 4.2.5.2) and 
analysed on an agarose gel to control the assay. Samples were then send to Entelechon for 
sequencing. 
 
4.2.5.12 DNA Sequencing and Sequence Analysis 
DNA sequencing was done by Entelechon (Regensburg, Germany) with ABI sequencing 
technology based on the Sanger didesoxy method. Sequence files were analysed and 
aligned with Generunner or with the BLAT function of the UCSC genome browser (see 
section 3.11 for the web address). 
 
4.2.5.13 Methyl-CpG-Immunoprecipitation (MCIp) 
Production of the recombinant MBD-Fc protein and MCIp of single DNA loci was carried out 
as previously described using Mse I digestion for fragmentation (Gebhard et al., 2006a; 
Gebhard et al., 2006b) (see also section 4.3.1). For global methylation analyses that were 
combined to microarray hybridization, MCIp was performed with slight modifications. Briefly, 
genomic DNA was sonicated to a mean fragment size of 350-400 bp using a Branson 
Sonifier 250 (Danbury, CT). 4 µg of each sample were rotated with 200 µl protein 
A-Sepharose 4 Fast Flow beads (GE Healthcare) coated with 70 µg purified MBD-Fc protein 
in 2 ml Ultrafree-MC centrifugal devices (Amicon/Millipore) for 3 h at 4°C in a buffer 
containing 250 mM NaCl (Buffer A). Beads were centrifuged to recover unbound DNA 
fragments (250 mM fraction) and subsequently washed with buffers containing increasing 
NaCl concentrations (300, 350, 400, 450, 500 mM; Buffers B - F). Densely CpG-methylated 
DNA was eluted with 1000 mM NaCl (Buffer G) and all fractions were desalted using the 
QIAquick PCR purification Kit (Qiagen). The separation of CpG methylation densities of 
individual MCIp fractions was controlled by qPCR using primers covering the imprinted 
SNRPN and a region without any CpGs (Empty), respectively. A schematic presentation of 
the method is given in Figure 5-15. 
 
Required buffers and solutions: 
 TME (10×)  4 ml  (200 mM) Tris-HCl (1 M) pH 8.0 
    400 µl  (20 mM) MgCl2 (1 M) 
    200 µl  (5 mM)  EDTA (500 mM) 
    Add ddH2O to 20 ml 
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 Buffer A  4 ml  (1×)  TME (10×) 
    2 ml  (250 mM) NaCl (5 M) 
    400 µl  (0.1%)  NP40 (10%) 
    Add ddH2O to 40 ml 
 
 Buffer B – H  1 ml  (1×)  TME (10×) 
    600 µl – 2 ml (300–1000 mM) NaCl (5 M) 
    100 µl  (0.1%)  NP40 (10%) 
    Add ddH2O to 10 ml 
 
4.2.5.14 DNA Microarray Handling and Analysis 
Enriched methylated and enriched unmethylated fractions of cell types were labelled with 
Alexa Fluor 5-dCTP (dendritic cells) and Alexa Fluor 3-dCTP (macrophages) using the 
BioPrime Total Genomic Labelling System (Invitrogen) as indicated by the manufacturer. 
Hybridization on 244K Custom-Oligonucleotide-Microarrays (-4000 to +1000bp relative to the 
TSS with a few regions tiled over a large genomic interval; about 17000 annotated genes) 
and washing was performed as recommended by the manufacturer (Agilent). Images were 
scanned immediately using a DNA microarray scanner (Agilent) and processed using 
Feature Extraction Software 9.5.1 (Agilent) and a standard CGH protocol. Processed signal 
intensities were then normalised using GC-dependent regression and imported in Excel 2007 
for further analysis. Probes with abnormal hybridization behaviour (extremely high or 
extremely low signal intensities in one of the channels) were excluded. To detect differentially 
methylated regions (DMRs), Log10 ratios of individual probes from both comparative genome 
pool hybridizations were substracted. 
 
4.2.5.15 Quantitative DNA Methylation Analysis Using the MassARRAY System 
Principle 
EpiTYPER (Sequenom, San Diego, USA) is a tool for detection and quantification of 
methylated DNA based on bisulfite conversion. If genomic DNA is treated with bisulfite, 
unmethylated cytosine residues are deaminated to uracil and transformed into thymine 
during PCR amplification, whereas methylated cytosine residues still appear as cytosines. 
Consequently, bisulfite treatment results in methylation dependent sequence variations of C 
to T after PCR amplification. Amplification products are then treated with shrimp alkaline 
phosphatase (SAP) to dephosphorylate unincorporated dNTPs from PCR. Subsequently, 
in vitro transcription is performed followed by RNase A specific cleavage to produce smaller 
fragments. Cleavage products are now prepared for analysis in the mass spectrometer. 
MALDI-TOF MS (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry) 
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detects the 16 Da mass difference between guanine and adenine residues (resulting from 
C/T variations at the opposite strand) due to methylated and unmethylated DNA templates. 
MALDI-TOF MS data are then processed using the EpiTYPER software generating 
quantitative results for each cleavage product. 
A detailed description of the method is given in (Ehrich et al., 2005) and in the EpiTYPER 
User Guide (www.sequenom.com). 
 
 
Figure 4-1 Schematic outline of the EpiTYPER process 
Genomic DNA is treated with bisulfite and amplified using specific primers with one primer tagged with a T7 
promoter sequence. PCR products are subsequently transcribed into RNA, followed by RNase cleavage after 
every uracil residue. Cleavage products are then analyzed by MALDI-TOF MS. In the example shown here, PCR 
products are transcribed from the reverse strand. In the unmethylated template (illustrated in red), cytosine 
residues are deaminated into uracil and therefore appear as adenosine residues after PCR. Cytosine residues of 
a methylated template (indicated in yellow) are not affected and remain cytosines. The conversion of guanine to 
adenine yields 16 Da mass shifts. Cleavage product 1 comprises 2 CpGs and the mass difference constitutes 32 
Da if both CpGs are either methylated or unmethylated. Cleavage products 2 and 3 each contain only one CpG 
site that is differentially methylated and therefore yield a 16 Da mass shift.  
 
 
Protocol 
Bisulfite conversion of genomic DNA was carried out using the EZ DNA methylation Kit 
(Zymo) according to the manufacturer’s instructions with slight modifications given in the 
EpiTYPER application guide from Sequenom. Oligonucleotides for PCR amplification were 
designed using MethPrimer (www.urogene.org/methprimer/). PCR, SAP treatment, in vitro 
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transcription, RNase cleavage and MALDI-TOF MS analysis were performed as described in 
the Sequenom protocols. Raw data were then processed using the EpiTYPER software 
(version 1.0). 
 
4.2.6 Preparation and Analysis of RNA 
4.2.6.1 Isolation of Total RNA 
Total RNA was isolated using the Qiagen RNeasy Midi, Mini or Micro Kit according to the 
available number of cells. RNA concentration was then determined with the NanoDrop 
spectrophotometer and quality was assessed by agarose gel electrophoresis or using the 
Agilent Bioanalyzer according to the manufacturer’s instructions. 
 
4.2.6.2 Formaldehyde Agarose Gel 
The agarose was dissolved in MOPS/H2ODEPC by heating in a microwave oven and cooled to 
60°C. Formaldehyde was added while stirring the solution under a fume hood and the gel 
was cast, mounted in an electrophoresis tank and overlaid with 1× MOPS as electrophoresis 
buffer. RNA samples were heated to 37°C for 30 min to control RNase contamination and 
placed on ice afterwards. Samples were subsequently diluted with four volumes RNA loading 
buffer (1:4), denatured for 20 min at 65°C and briefly incubated on ice. Following 
centrifugation, the samples were loaded into the gel slots. Gels were run at 40-60 V. 
 
Required buffers 
 MOPS (20×)  42 g (0.4 M)  MOPS/NaOH, pH 7.0 
    4.1 g (100 mM) NaOAc 
    3.7 g (20 mM) EDTA 
    Add H2ODEPC to 500 ml, store in the dark 
 
 RNA loading buffer 10 ml (50%)  Formamide, deionised 
    3.5 ml (2.2 M)  Formaldehyde (37%) 
    1 ml (1×)  MOPS (20×) 
    0.8 ml (0.04%  Bromophenol blue (1% in H2O) 
    0.2 g (1%)  Ficoll 400, Pharmacia (dissolve in 2 ml H2O) 
    Add H2ODEPC to 20 ml, store in 1 ml aliquots at -20°C 
 
    Add 5 µl/ml Ethidium bromide (10 mg/ml) before use 
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4.2.6.3 Reverse Transcription PCR (RT-PCR) 
To quantify mRNA transcripts of genes, total RNA was reverse transcribed using the MMLV 
reverse transcriptase (Promega, Germany) combined with random decamers (Ambion, 
Germany) in a total reaction volume of 20 µl. 
 
 Reaction setup:  1 µg Total RNA 
    1 µl Random decamers (Ambion) 
    1 µl  dNTPs (10 pmol/ml) 
    Add H2OUSB 
 
    Incubate for 5 min at 65°C, cool on ice and centrifuge 
 
    4 µl  M-MLV Buffer (5×)  
    Mix and incubate for 2 min at 42°C  
 
    1 µl M-MLV Reverse transcriptase (Promega) 
    Incubate for 50 min at 42°C followed by 15 min at 70°C 
 
The resulting cDNA was then diluted 1:5 and quantified with specific primers by real time 
PCR (see section 4.2.5.10). The combination of RT-PCR and real time PCR is called RT-
qPCR. 
 
4.2.6.4 Whole Genome Expression Analysis 
Labelling of high quality RNA, hybridization and scanning were performed using the Agilent 
Gene Expression system according to the manufacturer’s instructions. In brief, 200 ng to 
1000 ng high-quality RNA were amplified and Cyanine 3-CTP labelled with the one colour 
Low RNA Input Linear Amplification Kit from Agilent. Labelling efficiency was controlled using 
the NanoDrop spectrophotometer and 1.65 µg labelled cRNA were fragmented and 
hybridized on the Whole Human Genome Expressionarray (4×44K, Agilent). After 17 hours 
of hybridization at 65°C, the microarrays were washed and subsequently scanned with an 
Agilent scanner. Data were then extracted with Feature Extraction 9.5.1 software (GE1 
v5_95_Feb07 protocol, Agilent) and finally analysed using GeneSpring GX 10.0.2 software 
(Agilent). To validate microarray data, several genes were selected and verified by RT-PCR 
followed by qPCR (see sections 4.2.5.10 and 4.2.6.3). 
 
Data Analysis Using GeneSpring Software 
Text files resulting from Feature Extraction were imported to GeneSpring software in order to 
compare gene expression profiles between various differentiation time points or cell types. 
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First, probes showing large variations either between donors or among each other (if more 
than one probe for one gene is available) were excluded. Data were then normalised in two 
steps: 
 
“per chip” normalisation: all expression data on an array were normalised to the 75th 
percentile of all values on that array 
 
“per gene” normalisation: the data for a given gene were normalised to the median 
expression level of that gene across all samples 
 
Generally, only more than 5 fold signal changes were defined as gene induction or 
repression. Finally, using One-way ANOVA (analysis of variance) with a p-value cut-off of 
0.05, the gene list was reduced to significantly regulated genes. Hierarchical cluster analysis 
was used to identify genes with similar expression profiles and to reveal common functions of 
significantly regulated genes.  
 
4.2.7 In Vivo Genomic Footprinting with DMS 
Genomic footprinting experiments allow the investigation of DNA-protein interactions at a 
specific locus including the study of alterations in the underlying chromatin structure. 
Principally, this technique consists of two steps. First, the creation of DNA lesions by DMS 
(dimethyl sulfate) and second, the visualization of those lesions using ligation mediated PCR 
(LM-PCR) (Tagoh et al., 2006). DMS treatment leads to the formation of N-7-methylguanine 
(~ 70%) and, to a lesser extent, to the formation of N-3-methyladenine (~30%). The addition 
of piperidine then results in single strand breaks after every methylated guanine which can 
be detected by linker ligation, region specific PCR and finally by a labelling reaction with a 
Cy5 end-labelled-linker primer (Tagoh et al., 2006). As sequences occupied with DNA 
binding proteins are protected from methylation and cleavage, those sites will not display a 
PCR product. By comparing the PCR products resulting from DMS treatment of living cells to 
the products from naked DNA modified in vitro - where no protection is provided - it is 
possible to draw conclusions about transcription factor binding events in vivo. 
In vivo DMS footprinting was performed as published previously (Tagoh et al., 2006) using 
1.5 µg of purified genomic DNA from DMS-treated cells. In vitro DMS treatment of naked 
DNA was carried out as described by Maxam and Gilbert (Maxam and Gilbert, 1980). 
LM-PCR was then performed by using a LP21-25 linker and sequence specific primers for 
the CCL13 promoter region (oligonucleotide sequences are given in 3.5.3). Differences in 
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DMS accessibility between gDNA isolated from DMS-treated cells and naked DNA that was 
in vitro modified, were visualized on a 6% denaturing polyacrylamide gel after the labelling 
reaction with the Cy5 labelled LP25 primer. Gels were then scanned on a 9200 Typhoon 
scanner. A detailed protocol of the complete procedure including the required solutions and 
PCR parameters is given by Tagoh et al. (Tagoh et al., 2006). 
 
4.2.8 Chromatin Immunoprecipitation (ChIP) 
Chromatin immunoprecipitation is used to determine whether particular proteins are 
associated with a specific genomic region in living cells or tissues. The method is based on 
the principle that formaldehyde reacts with primary amines located on amino acids and the 
bases on DNA molecules, resulting in a covalent cross-link between proteins and DNA. 
Preparation of cross-linked chromatin and immunoprecipitation were performed as described 
previously (Metivier et al., 2003) with some modifications. Briefly, cells were treated with 1% 
formaldehyde solution for 7 min at room temperature and quenched by 0.125 M glycine. After 
washing with PBS including 1 mM PMSF, 2×106 cells were resuspended in 50 µl lysis buffer 
1A (L1A: 10 mM, HEPES/KOH, pH 7.9, 85 mM KCl, 1 mM EDTA, pH 8.0) and lysed by 
adding 50 µl lysis buffer 1B (L1A + 1% Nonidet P-40) for 10 min on ice. Note that lysis 
buffers were supplemented with phosphatase inhibitors (50 mM ß-glycerophosphate and 
1 mM Na2OV4) when phosphorylated proteins had to be precipitated. Cross-linked chromatin 
was sheared to an average DNA fragment size around 400 – 600 bp using a Branson 
Sonifier 250 (Danbury, CT). After centrifugation, 4 µl of the lysate were used as input. After 
preclearing with 50 µl Sepharose CL-4B beads (blocked with 0.2% BSA and 5 µg sheared 
salmon sperm for 1 h at 4°C) for 2 h, chromatin samples were immunoprecipitated overnight 
with 2.5 µg of the appropriate antibody. Before precipitation, ProteinA Sepharose beads (GE 
Healthcare) were treated with 2 µg sheared salmon sperm DNA for 1 h at 4°C. 
Immunocomplexes were then recovered by incubation for 2 h with the blocked beads at 4°C. 
After reverse cross-linking, DNA was purified using the QIAquick PCR purification kit 
(Qiagen) according to the manufacturer’s instructions except that the samples were 
incubated with PB buffer for 30 min and that they were eluted with 100 µl EB. Enrichment of 
specific DNA fragments in the immunoprecipitated material was determined by quantitative 
PCR on the Realplex Mastercycler as described above. 
 
Required buffers and solutions: 
 Glycine    9 .85g (2.625 M)  Glycine 
     To 50 ml with ddH2O 
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 Cell Buffer Mix   20 µl (10 mM)  HEPES / KOH (1 M), pH 7.9 
     57 µl (85 mM) KCL (3 M) 
     4   µl  (1 mM)  EDTA (0.5 M, pH 8.0) 
     To 1.98 ml with ddH2O 
     
     Add just prior to use: 
     20 µl (1 mM)  PMSF (100 mM in Iso-prop, nostalgia) 
     2 µl (1 µg/ml) Pepstatin (1 µg/µl) 
     2 µl (2 µg/ml) Aprotinin (2 µg/µl) 
 
 Nuclear Lysis Buffer (L2) 100 µl (50 mM) Tris/HCl (1 M), pH 7.4 @ 20°C 
     100 µl (1%)  SDS (20%) 
     33.3 µl (0.5%)  Empigen BB (30%)  
     40 µl (10 mM)  EDTA (0.5 M), pH 8.0 
     To 1.98 ml with ddH2O 
       
     Add just prior to use: 
     20 µl (1 mM)  PMSF (100 mM in Iso-prop, nostalgia) 
     2 µl (1 µg/ml) Pepstatin (1 µg/µl) 
     2 µl (2 µg/ml) Aprotinin (2 µg/µl)   
 
 Dilution Buffer (DB)  50 µl (20 mM) Tris/HCl (1 M), pH 7.4 @20°C 
     50 µl (100 mM) NaCl (5 M) 
     10 µl (2 mM)  EDTA (0.5 M, pH 8.0) 
     125 µl  (0.5%)  Triton X-100 (10%) 
     To 2.47 ml with ddH2O 
 
     Add just prior to use: 
     25 µl (1 mM)  PMSF (100 mM in Iso-prop, nostalgia) 
     2.5 µl (1 µg/ml) Pepstatin (1 µg/µl 
     2.5 µl (2 µg/ml) Aprotinin (2 µg/µl) 
 
 Wash Buffer I (WB I)  200 µl (20 mM) Tris/HCl (1 M), pH 7.4 @ 20°C 
     300 µl (150 mM) NaCl (5 M) 
     50 µl (0.1%)  SDS (20%) 
     1 ml (1%)  Triton X-100 (10%) 
     40 µl (2 mM)  EDTA (0.5 M, pH 8.0) 
     To 10 ml with ddH2O 
 
 Wash Buffer II (WB II)  200 µl (20 mM) Tris/HCl (1 M), pH 7.4 @ 20°C 
     1 ml (500 mM) NaCl (5 M) 
     1 ml (1%)  Triton X-100 (10%) 
     40 µl (2 mM)  EDTA (0.5 M, pH 8.0) 
     To 10 ml with ddH2O 
 
 Wash Buffer III (WB III)  100 µl (10 mM) Tris/HCl (1 M), pH 7.4 @ 20°C 
     250 µl (250 mM) LiCl (10 M) hard to dissolve, try 2.5 M 
     1 ml (1%)  NP-40 (10%) 
     1 ml (1%)  Deoxycholate (10%) 
     20 µl (1 mM)  EDTA (0.5 M, pH 8.0) 
     To 10 ml with ddH2O 
 
 Elution Buffer (EB)  450 µl  (0.1 M)  NaHCO3 (1M) 
     225 µl (1%)  SDS (10%) 
     To 4.5 ml with ddH2O 
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4.3 General Protein Biochemical Methods 
4.3.1 Purification of the Recombinant Protein MBD-Fc 
4.3.1.1 Dialysis 
The MBD-Fc containing culture supernatant (see section 4.1.1.2) was harvested by 
centrifugation of the cells at 320×g for 10 min at 4°C. To get rid of remaining (dead) cells and 
debris, the supernatant was centrifuged at 2000×g for 20 min at 4°C before the final 
centrifugation step of 15000×g for 1 hour at 4°C to separate smaller debris. The supernatant 
was dialyzed against 1×TBS (pH 7,4) for 3-4 days exchanging the buffer twice a day. 
 
Required buffers: 
 10×TBS pH 7.4  151.4 g  (500 mM) Tris 
    219.2 g  (1.5 M)  NaCl 
    9.3 g  (10 mM) EDTA 
    125 mg  (0.05%) NaN3 
    Add ddH2O to 2500 ml 
 
4.3.1.2 Affinity Chromatography 
After dialysis, the protein-containing supernatant was purified and enriched using a ProteinA 
sepharose column (Amersham): 
The column was filled with 3 ml rProteinA sepharose beads (Amersham) in 1×TBS. After 
washing the column with 1×TBS, the dialyzed protein supernatant was loaded, followed by 
another washing step with 1×TBS. The MBD-Fc protein was recovered in 1.5 ml fractions 
using elution buffer. To neutralize the low pH of the elution buffer, each collecting Eppendorf 
cup was prepared with 50 µl neutralization buffer. The protein-containing fractions (verified 
by a photometer) were combined and dialyzed again as described above. 
Regeneration was performed by washing the column with 3 M KCl and finally with 1×TBS. 
The column was now prepared for another purification cycle or for storage at 4°C. 
 
Required buffers and solutions: 
 Elution buffer pH 3.0  2.9 g  (0.1 M)   Citric acid 
     Add ddH2O to 100 ml 
 
 Neutralization buffer pH 8.8 18 g  (1.5 M)  Tris 
     Add ddH2O to 100 ml 
 
 Recovering solution   22.4 g  (3.0 M)  KCl 
     Add ddH2O to 100 ml 
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4.3.1.3 Conservation of the Purified MBD-Fc 
To stabilize and preserve the protein, 0.2% gelatine and 0.05% NaN3 were added. The 
MBD-Fc fusion protein was now ready for further experiments or for long-term storage at 
4°C. 
 
4.3.1.4 Quantification and Quality Control of MBD-Fc 
Quality of each protein batch was assessed by SDS-PAGE (see section 4.3.2) followed by 
Coomassie staining (or Western Blot analysis like described in 4.3.3) as well as by 
control-MCIp (see section 4.2.5.13). 
Protein concentration was determined relative to a BSA standard curve using a densitometer 
after SDS-PAGE. 
 
4.3.2 Discontinuous SDS-PAGE 
Protein samples were separated by using a discontinuous gel system, which is composed of 
stacking and separating gel layers that differ in salt and acrylamide (AA) concentration. 
 
Table 4-8 SDS-PAGE stock solutions 
Stock solution Separating gel stock solution Stacking gel stock solution 
Final AA concentration 13.5% 5% 
Stacking gel buffer - 25 ml 
Separating gel buffer 25 ml  
SDS (10%) 1 ml 1 ml 
Rotiphorese Gel 30 (30%) 45 ml 16.65 ml 
H2O Adjust to 100 ml 
 
 
 
Table 4-9 SDS-PAGE gel mixture 
Stock solution Separating gel Stacking gel 
Separating gel stock solution 10 ml - 
Stacking gel stock solution - 5 ml 
TEMED 10 µl 5 µl 
Ammoniumpersulfate 10% 
(freshly prepared) 
50 µl 40 µl 
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The separating gel was prepared the day before electrophoresis and overlaid with 
water-saturated isobutanol until it was polymerized. Isobutanol was exchanged by separating 
gel buffer diluted 1:3 with water and the gel was stored overnight at 4°C. The following day, 
the stacking gel was poured on top of the separating gel, and the comb was inserted 
immediately. After polymerization, the gel was mounted in the electrophoresis tank, which 
was filled with 1×Laemmli buffer. Protein samples were loaded and the gel was run with 
25 mA/110 volts until the sample buffer bands reached the surface of the stacking gel. Next, 
the voltage was increased to 200 V and the gel was run for 2-4 h. Proteins were then 
resolved through the separating gel according to their size. 
 
Required buffers and solutions: 
 Separating gel buffer 90.83 g  (1.5 M)  Tris/HCl, pH 8.8 
    Add ddH2O to 500 ml 
  
 Stacking gel buffer 30 g  (0.5  M)  Tris/HCl, pH 8.8 
    Add ddH2O to 500 ml 
 
 SDS (10%)  10 g   (10%)  SDS 
    Add ddH2O to 100 ml 
  
 Ammonium persulfate 100 mg  (10%)  Ammonium persulfate 
 (APS)   Add ddH2O to 1 ml 
 
 Laemmli buffer (5×) 15 g  (40 mM) Tris 
    21 g  (0.95 M) Glycine 
    15 g  (0.5%)  SDS 
    Add ddH2O to 3000 ml 
 
4.3.3 Western Blot Analysis and Immunostaining 
After separation by SDS-PAGE, proteins were blotted electrophoretically onto PVDF 
membrane (Immobilon-P, Millipore) using a three-buffer semi-dry system and visualized by 
immunostaining using specific antibodies and the ECL detection kit. 
The membrane was cut to gel size, moistened first with methanol followed with buffer B and 
placed on top of three Whatman3MM filter paper soaked with buffer A (bottom, on the 
anode), followed by three Whatman3MM filter paper soaked with buffer B. The SDS-PAGE 
gel was then removed from the glass plates, immersed in buffer B and placed on top of the 
membrane. Another three Whatman 3MM filter papers soaked with buffer C were placed on 
top of the gel followed by the cathode. Air bubbles in-between the layers had to be avoided. 
Protein transfer was conducted for 30 – 45 min at 0.8 mA/cm2 gel surface area. 
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Required buffers: 
 Buffer A  36.3 g  (0.3 M)  Tris, pH 10.4 
    200 ml  (20%)  Methanol 
    Add ddH2O to 1000 ml 
 
 Buffer B  3.03 g  (25 mM) Tris, pH 10.4 
    200 ml  (20%)  Methanol 
    Add ddH2O to 1000 ml 
 
 Buffer C  5.2 g  (4 mM)  ε-amino-n-caproic acid, pH 7.6 
    200 ml  (20%)  Methanol 
    Add ddH2O to 1000 ml 
 
 
Blotted membranes were blocked with 5% milk in PBST for 1 h at RT, washed once for 5 min 
with PBST or TBST before incubation at RT for 1 h with the primary antibody. After washing 
three times 10 min with the appropriate washing buffer, the membrane was incubated for 1 h 
at RT with a horseradish-peroxidase (HRP)-coupled secondary antibody, detecting the 
isotype of the first antibody. Three washing steps of 3×10 min preceded the visualization of 
bound antibody using the ECL kit. Blots were exposed to an autoradiography film 
(HyperfilmTM ECL, Amersham) for 5 seconds to 30 min depending on the signal intensity. 
 
Required buffers and materials: 
 TBS (2×)  9.16 g  (20 mM) Tris /HCl, pH 7.4 
    35.1 g  (150 mM) NaCl 
    Add ddH2O to 2000 ml 
 
 TBST (1×)  500 ml  (1×)  TBS (2×) 
    1 ml  (0.1%)  Tween 20  
    Add ddH2O to 1000 ml 
 
4.3.4 Coomassie Staining of SDS-Gels 
SDS-gels were tossed in ddH2O (three times, 5 min each) and subsequently incubated in the 
Coomassie solution for about 20 – 60 min. After washing overnight in ddH2O, proteins 
appear as blue bands on a transparent background. 
 
Required solution: 
 Coomassie Bio Safe Bio Rad, Munich, Germany 
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4.4 Proliferation Assay (Thymidine Incorporation) 
Proliferation capacity of cells was measured using incorporation of radioactively labelled 
thymidine. Cells were seeded in 96-well microtiter plates (30 - 100×105 cells per well) and 
pulsed with 0.5 µCi [methyl-3H]-thymidine/well (Hartmann Analytics, Braunschweig, 
Germany) for 20 hours. Cells were harvested onto UniFilter plates using a Wallac harvester 
and incorporated 3H-thymidine was determined with a Wallac Betaplate counter (all from 
PerkinElmer, Gaithersburg, MD). 
 
 
4.5 Flow Cytometry 
To characterize phenotypes of different cell types, the cell surface expression pattern of 
several membrane proteins was analysed by flow cytometry. 1 – 5×106 cells per staining 
reaction were washed twice with 1000 µl cold FACS buffer and immunostained for 30 min at 
4°C with appropriate mouse antibodies recognizing human antigens (see section 3.9). After 
another two washing steps, cells were fixed with 500 µl 1% paraformaldehyde/PBS and flow 
cytometric analysis was performed on a BD FACS Calibur. 
 
Required solutions: 
 FACS buffer  5 ml  (600 µg/ml) Immunoglobulins (60 mg/ml) 
    5 ml  (0.1%)  Sodium azide (10%) 
    Add PBS to 500 ml   
 
 Paraformaldehyde 1 g  (1%)  Paraformaldehyde 
    Add PBS to 500 ml, stir O/N at RT 
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5 Results 
5.1 Creating a Tool to Analyse the Effects of CpG 
Methylation within Gene Promoters 
Methylation-dependent repression is well established, especially for hypermethylated 
CpG-island promoters that are characterized by a high density of CpG dinucleotides 
(Costello and Plass, 2001; Esteller et al., 2002; Herman and Baylin, 2003). The effect of DNA 
methylation on CpG-poor promoters is less well characterized, probably due to the lack of 
convenient assay systems, like transient transfection, to test promoter activities in vitro. 
Previous studies used two approaches to analyse the effect of promoter methylation in 
transient transfection assays. The first method includes in vitro methylation of whole reporter 
vectors before transfection (DiNardo et al., 2001; Guo et al., 2002). Consequently, not only 
CpGs within the promoter of interest but also CpGs in the vector’s backbone are methylated. 
The second approach involves digestion, purification, in vitro methylation and ligation of DNA 
fragments into unmethylated reporter vectors before transfection to avoid the methylation of 
backbone CpGs (Lu and Richardson, 2004; Yu et al., 2005). In order to bypass negative side 
effects of backbone methylation as well as the time-consuming and labor intensive 
alternative method, a novel CpG-free luciferase vector was designed. 
 
5.1.1 Effects of CpG Methylation in Vector Backbones on Reporter 
Activities 
Transient transfections provide a relatively simple and robust assay for analysing promoter 
activity. Usually, transfection assays are carried out using unmethylated reporter constructs. 
Since CpG residues can be methylated in vitro with methylases like Sss I, Hha I or Hpa II, 
this approach can be adopted for studying effects of promoter methylation on reporter 
activity. Conventionally used reporter vectors like luciferase vectors of the pGL series from 
Promega contain varying numbers of CpG dinucleotides in their backbone (Table 5-1). 
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Table 5-1 Number of background CpGs in conventionally used luciferase reporter vectors 
Vector Length # of CpGs in the vector backbone 
pGL2-basic 5598 base pairs 285 
pGL3-basic 4818 base pairs 286 
pGL4-basic 4242 base pairs 284 
 
 
Those CpGs are also targeted by methylating enzymes, possibly affecting reporter activity. In 
order to assess effects of methylated CpGs in reporter backbones, a robust, CpG-free 
EF1A-promoter was cloned into the Promega pGL3-basic vector (see section 4.2.3.2). Using 
human and mouse cell-lines, the activity of unmethylated versus Sss I methylated plasmids 
was tested in transient transfections. In vitro methylation with Sss I results in methylation of 
every occurring CpG residue, irrespective of the surrounding sequence motifs. As shown in 
Figure 5-1, methylation of CpG dinucleotides in the pGL3-backbone strongly repressed the 
activity of the CpG-free EF1A-promoter in all cell lines tested. 
 
 
Figure 5-1 Effect of methylated backbone CpGs on promoter activity in transient transfection assays 
The indicated mouse (NIH3T3, RAW264.7) and human (THP-1) cell lines were transiently transfected with either 
Sss I-methylated (red bars) or unmethylated (blue bars) pGL3-plasmids. Luciferase activities were normalised for 
transfection efficiency by cotransfection with an unmethylated Renilla construct (phRL-TK; Promega). Results for 
individual cell lines are shown relative to the activity of the unmethylated, empty pGL3-basic reporter vector. 
Results represent the mean ±SD obtained from three independent experiments. 
 
Consequently, using the pGL3-backbone to analyse methylation-dependent changes of 
promoter activities by in vitro methylation and transient transfection leads to effects not 
necessarily due to methylation of promoter CpGs themselves. 
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5.1.2 Construction and Application of the Novel CpG-free 
Luciferase Reporter pCpGL 
To avoid interfering effects of backbone methylation without using the time-consuming 
ligation of an in vitro methylated promoter fragment into the unmethylated reporter plasmid, a 
completely CpG-free luciferase reporter plasmid was designed (see section 4.2.3.1; Figure 
5-2A). 
 
 
Figure 5-2 Control experiment using the novel CpG-free reporter vector 
(A) Map of the novel CpG-free reporter vector pCpGL-basic. The luciferase reporter vector is completely free of 
CpG dinucleotides. The plasmid is propagated in PIR1 bacteria, expressing the pir gene under zeocin (25 µg/ml) 
selection. All restriction sites of the multiple cloning site (MCS) are unique. (B) The indicated mouse (NIH3T3, 
RAW264.7) and human (THP-1) cell lines were transiently transfected with Sss I methylated (red bars) or 
unmethylated (blue bars) CpG-free pCpGL-CMV/EF1. Luciferase activity was normalised for transfection 
efficiency by cotransfection with the unmethylated Renilla construct. Results were calculated relative to the 
activity of unmethylated pCpGL-basic. Data are shown as the mean value obtained from two (NIH3T3, RAW) or 
three (THP-1) independent experiments including their statistical spread. 
 
 
 
In order to test the usefulness and reliability of the novel CpG-free vector, three pCpGL 
derivatives containing varying numbers of CpG dinucleotides were generated (see section 
4.2.3.2; Table 5-2). The first evidence for the utility of the novel reporter construct was the 
transient transfection of Sss I methylated and unmethylated CpG-free pCpGL-CMV/EF1 into 
the same cell lines used for the pGL3-tests. In all cell-lines tested, there was no significant 
difference in luciferase activity between methylated and unmethylated constructs suggesting 
 Results 
 - 59 -    
that the Sss I treatment does not affect reporter activities per se (Figure 5-2B). For each 
cell-line, three experiments were performed in duplicates and all showed the same 
correlation between methylated and unmethylated plasmids. Because transfection efficiency 
itself was variable in particular cases without changing the described correlation, only two 
experiments were averaged for the mouse cell-lines. 
 
Table 5-2 Number of CpGs in the pCpGL derivatives 
Vector # of CpGs in the insert 
pCpGL-CMV/EF1 0 
pCpGL-CPM 40 
pCpGL-CHI3L1 8 
 
To further characterize the usefulness of the novel reporter vector, the CpG-containing 
constructs pCpGL-CPM (40 CpGs) and pCpGL-CHI3L1 (8 CpGs) were transfected into 
THP-1 cells that are known to endogenously express CPM as well as CHI3L1. As shown in 
Figure 5-3, activity of both promoters was markedly repressed after Sss I methylation, 
indicating that both CpG containing reporter vectors were efficiently silenced by DNA 
methylation. 
 
 
Figure 5-3 Effect of promoter methylation in transient reporter assays using pCpGL 
THP-1 cells were transiently transfected with Sss I methylated (red bars) or unmethylated (blue bars) pCpGL 
vectors with pCpGL-CPM containing 40 CpGs and pCpGL-CHI3L1 containing 8 CpGs. Luciferase activity was 
normalised for transfection efficiency by cotransfection with the unmethylated Renilla plasmid. Results are shown 
relative to the activity of the CpG-free pCpGL-CMV/EF1 control vector. Data are shown as mean value ±SD 
obtained from three independent experiments. 
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In order to test the sensitivity of the designed tool, effects of partial promoter methylation 
were analysed using site-specific DNA methylases. Whereas Sss I methylates every 
occurring CpG dinucleotide, Hha II methylase only methylates the first cytosine residue 
within –GCGC- and Hpa II methylase only those CpG dinucleotides occurring in –CCGG-. 
pCpGL-CPM, pCpGL-CHI3L1 as well as the CpG-free control pCpGL-CMV/EF1 were either 
methylated using one of the described methylases or left unmethylated. Resulting 
methylation patterns of the plasmids are given in Figure 5-4A. Transient transfection into 
THP-1 cells and luciferase measurement revealed variable reporter activities of differential 
methylated plasmids (Figure 5-4B). Furthermore, this effect seemed to be dependent on the 
position of the methylated cytosine residues. Regarding the CPM-promoter, for example, in 
vitro methylation using Hha I methylase caused stronger repression than methylation with 
Hpa II methylase. Methylation of one single CpG dinucleotide (using Hpa II methylase) was 
sufficient to cause a significant reduction of CHI3L1-promoter activity. As expected, in vitro 
methylation of the pCpG-CHI3L1 vector with Hha I methylase did not affect promoter activity, 
because this construct is free of Hha I sites. 
 
 
Figure 5-4 Comparative analysis of differential promoter methylation 
(A) Schematical representation of the CPM- and CHI3L1-promoter vectors. Positions of methylated (black circles) 
and unmethylated (white circles) CpG dinucleotides as well as TATA-boxes and exons are indicated for all 
methylase treatments. (B) Transient transfection of THP-1 cells with differential methylated plasmids. Reporter 
constructs were methylated as indicated and luciferase activities were normalised for transfection efficiency by 
cotransfection with the unmethylated Renilla plasmid. Results were compared to the activity of corresponding 
unmethylated plasmids. Values are the mean ± SD obtained from three independent experiments.  
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To control the completeness of methylation, both methylated and unmethylated plasmids 
were digested using the methylation sensitive restriction enzymes Hha I (cutting 
unmethylated –GCGC-) and Hpa II (cutting unmethylated –CCGG-) as well as the 
methylation insensitive Msp I recognizing the same sequence as Hpa II. As expected, 
CpG-free pCpGL-basic and pCpGL-CMV always showed the same band pattern after 
digestion irrespective of the used enzymes for methylation and digestion. Hpa II methylase 
methylated as well as Sss I methylated plasmids were not cut using Hpa II indicating 
complete methylation of the corresponding sites (Figure 5-5). Similarly, Hha I methylase 
methylated sites were protected from Hha I digestion. Plasmids, methylated with a 
combination of Hha I methylase and Hpa II methylase (1:1) were not cut using either Hha I 
and Hpa II. In fact, digestion with methylation insensitive Msp I should result in several 
digestion products depending on the sequence of the inserts. In some cases, the Msp I-
digest was incomplete, probably a consequence of the exceeded expiry date. Nevertheless, 
complete methylation in every reaction could be demonstrated by digestion with Hha I and 
Hpa II, 
respectively.
 
Figure 5-5 Methylation control 
The methylation status of plasmids was controlled by digesting methylated and unmethylated plasmids with 
methylation sensitive (Hha I and Hpa II) as well as methylation insensitive restriction enzymes (Msp I). 
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5.2 Active DNA Demethylation during the Differentiation of 
Monocytes 
5.2.1 The Cell Model 
Peripheral blood monocytes are characterized by a unique phenotypic plasticity and are able 
to differentiate into a number of morphologically and functionally diverse cell types in vivo: 
the wide range of heterogeneous tissue macrophages (MAC), myeloid dendritic cells (DC) 
and multinucleated osteoclasts (Seta and Kuwana, 2007). The distinct differentiation 
pathways can be recapitulated in vitro. Culturing purified human monocytes for several days 
in the presence of human serum results in the generation of macrophages (Figure 5-6) 
(Andreesen et al., 1983), whereas they develop into myeloid dendritic cells in presence of the 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 4 (IL-4) 
(Sallusto and Lanzavecchia, 1994). 
 
 
Figure 5-6 Schematic presentation of the used cell model 
After leukapheresis and subsequent elutriation, monocytes (MO) were cultured either in presence of IL-4, GM-
CSF and FCS to generate immature dendritic cells (iDC) or with human AB-sera to obtain macrophages (MAC). 
 
Although it is largely accepted that monocytes do not proliferate under conventional culture 
conditions, the proliferation rate of monocytes was analysed during the first four days of 
differentiation by measuring the incorporation of radioactively labelled thymine. 
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As expected, no significant nucleotide incorporation was detected during the analysed time 
period (Figure 5-7). The differentiation of monocytes thus provides an ideal model to study 
epigenetic processes in post-mitotic cells. 
 
 
Figure 5-7 Proliferation assay 
Dendritic Cells (DC) and U937 cells were cultured with [3H] thymidine for 20 h at different differentiation time 
points (d1, d2, d3, d4). Values represent mean ±SD of three independent experiments. The U937 leukaemia cell 
line served as positive control showing high thymidine incorporation rates. 
 
5.2.2 Molecular Characterization of an Actively Demethylated 
Promoter during Monocyte Differentiation 
The DC specific chemokine CCL13 (chemokine (C-C motif) ligand 13; also known as MCP-4) 
serves as prime example for active DNA demethylation. In earlier studies, it was shown that 
the CCL13 gene was strongly induced only in dendritic cells, whereas it was silent in 
monocytes and remained silent during the differentiation into macrophages (Heinz S., 2002). 
Furthermore, DC specific demethylation of two or three particular promoter CpGs adjacent to 
the transcription start site (one located at -80 bp and two in tandem at -20 bp) was observed 
(Figure 5-8). 
 
 
 
Figure 5-8 Schematic presentation of changes at the CCL13 promoter during differentiation 
During differentiation of monocytes towards dendritic cells, two specific CpGs become demethylated. “Lollipops” 
represent CpG dinucleotides, with filled circles standing for methylated CpGs and white circles indicating 
unmethylated CpGs. CpGs (lollipops) in grey were not analysed. Arrows represent transcription start sites. 
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5.2.2.1 Correlation of mRNA Expression and DNA Demethylation Events 
To get insights into the timing of DNA demethylation and mRNA expression, dendritic cells 
were harvested at different time points over a seven day time period. RNA as well as DNA 
were isolated, or, alternatively, chromatin was prepared. Using reverse transcription followed 
by qPCR (RT-qPCR), a detailed time course of CCL13 mRNA expression was analysed 
revealing the continuously strong induction of CCL13 during DC development (Figure 5-9A). 
 
 
Figure 5-9 Characterization of the CCL13 promoter region 
(A) Expression profile of CCL13 during differentiation of monocytes (MO) into immature dendritic cells (iDC) until 
day 7 (7d). Results were normalised for HPRT expression. Values are means ± SD obtained from three 
independent experiments. (B) Time course of demethylation during the differentiation of DCs using MCIp and 
qPCR. Enrichment of DNA for CCL13 and the CCL23 control region is illustrated in grey gradations relative to the 
signal intensity with black representing the strongest enrichment. Highly methylated DNA fragments were eluted 
with higher salt concentrations than weakly methylated or unmethylated DNA fragments. Values of three 
independent donors were averaged. Chromatin immunoprecipitation for RNApol II (C) and the transcription factor 
STAT6 (D). Grey spots indicate the IgG background level. Signals, specific for the CCL13-promoter region were 
normalised to the signals of an unaffected upstream control region. Values are the mean ± SD of at least four 
independent experiments. 
 
The active demethylation event in DCs was further characterized by methyl-CpG 
immunoprecipitation (MCIp). This technique is based on differential elution behaviours of 
methylated and non-methylated DNA fragments from the MBD-Fc fusion protein and 
therefore allowed the fractionation of genomic DNA fragments according to their methylation 
density (Gebhard et al., 2006b; Schilling and Rehli, 2007) (see also Figure 5-15A). The 
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enrichment of methylated and unmethylated DNA respectively was then quantified by 
real-time PCR using specific primers for the CCL13 promoter. As demonstrated in Figure 
5-9B, methylated DNA of monocytes and 6 hour DCs precipitated using 400 mM NaCl. After 
18 hours in culture, more and more DNA eluted with lower salt concentrations indicating the 
initiation of demethylation. Finally, after 42 hours the demethylation process was finished, 
because the signal completely switched to the 350 mM fraction. Regarding the CCL23 
control region, genomic DNA from every analysed time point eluted with the same NaCl 
concentration (mainly 400 mM), indicating that there is no change in the methylation pattern. 
In order to detect factors bound to the CCL13 promoter during the relevant time period and to 
determine the timing of occurring events, chromatin immunoprecipitations were performed. 
Corresponding to the expression data, increasing RNA-Pol II recruitment was detected with 
ongoing differentiation (Figure 5-9C). Furthermore, binding of the IL-4 induced transcription 
factor STAT6 increased slightly until culture day 3, although timing and signal intensities 
varied between different donors (Figure 5-9D). 
 
CCL13 mRNA seemed to be slightly up-regulated before demethylation of promoter CpGs 
was finished. Strongest signals, however, were obtained and maintained after all methyl 
groups were removed, suggesting that DNA demethylation is necessary for stable and 
continuous gene expression. One possibility to prove a direct correlation between 
transcription level and DNA demethylation would be the performance of transfection assays 
with methylated and unmethylated promoter constructs as described in chapter 5.1.2.. 
However, to my knowledge, there is no cell line available expressing the CCL13 gene 
intrinsically. THP-1, U937, HepG2, RAW264.7 as well as NIH3T3 (all lacking CCL13 
expression) failed to transcribe unmethylated CCL13 promoter reporter constructs after 
successful transfection. Therefore, a strict requirement of CCL13 promoter demethylation for 
lasting mRNA expression could not be proven so far. 
 
5.2.2.2 Attempts to Interfere with the Active DNA Demethylation Process 
In order to block DNA demethylation, monocytes were treated with inhibitory substances 
(Table 5-3) using various concentrations for up to three days. The selection of chemicals was 
directed on inhibiting mechanisms that are possibly involved in active DNA demethylation 
(Kress et al., 2006; Metivier et al., 2008; Perillo et al., 2008). During DC development, DNA 
as well as RNA were prepared at different time points followed by bisulfite sequencing to 
analyse the methylation status as well as by RT-qPCR to assess CCL13 expression profiles, 
respectively.  
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Table 5-3 Substances used to interfere with DNA demethylation 
Substance Description Observed effects 
5-me-dCTP 
(5 µM) 
Possible substrate for a demethylating enzyme none 
Aphidicolin 
(2 or 5 µg) 
Inhibitor specific for polymerase alpha and beta; may 
influence repair mechanisms 
none 
Ara-C          
(1 – 200 µM) 
(ß-D-Arabinofuranosyl)cytosine. Inhibitor of DNA 
polymerases; may stabilize single strand breaks 
DNA, RNA degradation; dose and 
time dependent apoptosis 
NAC          
(10 mM) 
N-Acetyl-Cysteine. Scavenger of reactive oxygen 
species. Blocks repair processes induced by radicals 
none 
PJ34    
(0.5 - 10 µM) 
Inhibitor of PARP-1 DNA repair polymerase; might 
stabilize DNA strand breaks 
none 
RG108   
(5 µM) 
Inhibitor of DNMTs none 
TSA     
(1 - 10 µM) 
Trichostatin A. Inhibitor of histone deacetylases toxic  
 
None of the analysed substances showed a significant influence, neither on promoter 
demethylation nor on transcription of CCL13. Especially the missing effect of the DNMT 
inhibitor RG108 was surprising, as DNMT3a/b was shown to contribute to CpG 
demethylation and as this activity could be blocked by RG108 (Metivier et al., 2008). 
Although two independent preparations of RG108 (Calbiochem, Darmstadt, Germany; 
IGBMC, Hinrich Gronemeyer, Strasbourg, France) were tested, no effects of this inhibitor 
were observed. 
 
Beside pharmacological manipulation, the effect of cell adherence during dendritic cell 
development was considered to influence DNA demethylation. Monocytes become adherent 
just after culturing and slowly detach from the culture flask, usually within approximately 24 
hours, depending on the donor. To clarify, if the adherence stimulus provides an important 
step for DC specific DNA demethylation, DCs were cultured in rotating 200 ml Falcon tubes 
in the incubator for three days. The lack of adherence did not inhibit DC development itself 
as verified by FACS staining with the DC specific marker CD1a (Figure 5-10A). To study the 
effect of adherence on CpG methylation, the methylation status of the CCL13 promoter was 
assessed by bisulfite sequencing. If genomic DNA is treated with sodium bisulfite, 
unmethylated cytosines are deaminated into uracil and transformed into thymidine residues 
during PCR, whereas methylated cytosines still appear as cytosines after amplification 
(Frommer et al., 1992). 
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Figure 5-10 Influence of adherence 
Monocytes were either cultured regularly in culture flasks or under rotating conditions in 200 ml Falcon tubes for 
66 hours. (A) FACS analysis. DCs were stained with CD1a (PE) and IgGges as isotype control after 66 hours in 
culture. (B) CCL13 expression of monocytes (MO) and both DC “variants” at the indicated time points. Samples 
were analysed in duplicates and values were normalised to the HPRT housekeeping gene. (C) Sequencing 
pattern of the CCL13 promoter after bisulfite conversion. Primers specific for the anti-sense strand were used for 
amplification. Amplicons were then sequenced by Entelechon. Grey arrows point to guanine residues partly 
exchanged by adenine residues (cytosine by thymine on the sense strand). 
 
 
Bisulfite-treated DNA was amplified using primers specific for the anti-sense strand of the 
CCL13-promoter region. Therefore, methylation differences appeared as guanine-adenine 
transitions. Although the software termed the base at the -20 bp position still as a guanine, 
the sequencing curves showed a drastic reduction of the guanine peaks and elevated 
adenine peaks, indicating ongoing but not fully completed demethylation events (Figure 
5-10B). In concordance with the previous data, demethylation of the -80 bp cytosine as well 
as of one of the -20 bp cytosines was observed during DC development in both flask and 
rotating falcon. Bisulfite conversion of DNA isolated after 18 and 42 h did not show any 
differences between conventional and rotating culture conditions as well (data not shown). 
The lack of adherence rather seemed to induce a stronger demethylation effect instead of 
inhibiting demethylation. Likewise, RNA expression levels of CCL13 seemed to be higher 
under non-adherent conditions (Figure 5-10C). Because cell adherence did not seem to play 
a crucial role for signalling DNA demethylation in the preliminary experiment, this idea was 
not pursued further in order to focus on other approaches. 
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5.2.3 Global mRNA Expression Analysis 
Genome-wide expression analysis were performed to identify groups of genes that may 
influence the active demethylation process as well as to study the correlation between CpG 
demethylation and expression status of candidate genes (see section 5.2.5). For this 
purpose, RNA was isolated at various time points during monocyte to dendritic cell 
differentiation and prepared for microarray hybridization using the Agilent labelling system. 
Raw data resulting from Agilent Feature Extraction software 9.5.1 were processed as 
described in 4.2.6.4. and values of independent donors were averaged for each time point. 
Figure 5-11A demonstrates expression kinetics of all significantly regulated genes relative to 
the expression values of monocytes. More than 7000 genes with an at least 5-fold change 
during the culture period were significantly regulated. According to the hierarchical clustering 
of time points (tree on top of the heat map in Figure 5-11), expression levels after 18 h/27 h 
as well as after 42 h/51 h/66 h were quite similar, whereas highest differences of 
transcription levels were observed between monocytes and DCs cultured for 6 hours. 
 
Based on the complete gene list, two main clusters were defined: genes that were either 
consistently induced (up cluster) or consistently repressed (down cluster) during 
differentiation of monocytes towards dendritic cells (Figure 5-11A). The genes in between did 
not clearly fit in one of the other clusters as their expression profiles showed inconsistent, 
wave-like up- and down-regulation. 
 
Assuming that coregulated genes share similarities in their regulatory mechanisms, their 
promoter regions may contain common motifs that are binding sites for transcription factors. 
The identification of transcription factor classes regulating the bulk of genes, possibly could 
indicate pathways that support the active DNA demethylation process. Thus, a de novo motif 
discovery algorithm (Brenner C et al; in preparation) was used to search for sequences that 
are significantly associated with each main cluster. The used algorithm only determines 
enriched motifs within gene promoters and does not account for other regulatory elements 
such as enhancers. Three binding motifs were highly enriched in the cluster of repressed 
genes (Figure 5-12B). The most significant one corresponds to the consensus binding site of 
the nuclear factor κB (NF-κB), a critical regulator of many cellular processes including cell 
survival as well as immune response and anti-inflammatory actions. Furthermore, a motif 
corresponding to the interferon-stimulated response element (ISRE) was highly enriched 
within the cluster of down-regulated genes. ISREs represent the binding sites for IRF 
(interferon regulatory factor) transcription factors that are activated upon interferon (IFN) 
stimulation resulting in expression of genes important for viral defence. The third one 
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corresponds to the binding site of the repressor ZNF202 (zinc finger protein 202) that 
predominantly binds to elements which are found in genes involved in lipid metabolism and 
energy homeostasis (Wagner et al., 2000). Analysis of the cluster comprising up-regulated 
genes did not reveal any significant enriched motifs within their promoter regions. 
 
 
 
Figure 5-11 Hierarchical clustering of all genes showing significant changes in expression during 
dendritic cell development 
(A) The expression levels of genes showing at least 5-fold up- or down-regulation are indicated by colour. Blue, 
white and red represent low, medium and high expression, respectively. The tree on top demonstrates similarities 
between the indicated time points and the tree on the left represents genes with similar expression patterns. After 
“per chip” and ”per gene normalization” (see section 4.2.6.4), data of two (168 h time point), three (6 h to 66 h 
time points) or six (monocytes, indicated as MO) independent donors were averaged and evaluated relative to 
monocytes. Complete microarray data sets will be submitted with the corresponding publication, which is in 
preparation. (B) Enrichment of the indicated sequence motifs within the cluster of down-regulated genes with p-
values from Fisher’s exact test. The motif discovery algorithm revealed no motif enrichment within promoters of 
up-regulated genes. (C) Gene Ontology (GO) categories that overlapped with either the up- or the down cluster. 
P-values were obtained from Fisher’s exact test. 
 
 
In order to assess their biological interpretation, both gene cluster were searched for Gene 
Ontology (GO) categories that contained a large number of genes from each main cluster 
using the GO analysis tool. As listed in Figure 5-11C, there was a significant overlap 
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between the cluster of repressed genes and two related gene categories contributing to 
immune or stress responses. This is in concordance with the motif analysis that detected 
down-regulation of IFN and NFkB responsive genes. The cluster comprising highly 
up-regulated genes exhibited a slight enrichment of genes that are involved in cell cycle 
processes. Initially, enrichment of those genes was surprising, as dendritic cells do not 
proliferate (Figure 5-7). However, members of this gene category comprise genes that are 
not only implicated in mitosis or other cell cycle processes but are also important for DNA 
damage repair. Replication and damage checkpoints, for example, delay progression into 
mitosis and simultaneously promote transcription of repair proteins (de Bruin and Wittenberg, 
2009). Additionally, DNA polymerases such as POLD1 (polymerase delta 1) or nucleases 
like exonuclease 1 (EXO1) are also involved in DNA repair processes (Hubscher et al., 2002; 
Parsons et al., 2007; Wei et al., 2003). 
 
5.2.3.1 Expression Profiles of Highly Regulated Genes Associated with 
Transcription 
Genome-wide screenings for regulated genes and their classification may help to restrict the 
entity of genes to a smaller list of possible candidates for the active demethylation process 
and to assess the relevance of gene categories within our used model system. The 
combination of already published data and those screenings provides a tool to select putative 
candidate genes for further experiments. 
 
Transcription factors and co-factors are believed to target histone modifying enzymes as well 
as the yet unknown demethylating machinery (Imhof, 2006; Niehrs, 2009; Rice et al., 2007; 
Schmitz et al., 2009). To study, which factors are regulated during DC differentiation, the 
expression of genes associated with transcription was analysed. Figure 5-12 depicts 
transcription factors that are highly regulated, varying in timing and intensity of expression. 
Interestingly, the bulk of genes changed their expression levels drastically within the first 6 
hours in culture whereas only a small number of transcription factors was regulated at a later 
time point. The number of markedly regulated transcription factors emphasizes their 
importance for cellular processes including differentiation and might be a hint for their 
implication in targeting or regulating active DNA demethylation.  
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Figure 5-12 Hierarchical clustering of genes associated with transcriptional regulation 
The expression levels of genes showing at least 16 fold up- (heatmap on the right) or down-regulation (heatmap 
on the left) are indicated by colour. Blue, white and red represent low, medium and high expression, respectively. 
Trees on the left side of both heatmaps represent the degree of similarity of regulated genes. After “per chip” and 
”per gene normalization” (see section 4.2.6.4), data of two (168 h time point), three (6 h to 66 h time points) or six 
(monocytes, indicated as MO) independent donors were averaged and analysed relative to monocytes.  
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5.2.3.2 Identification of DNA Repair Associated Genes Significantly Regulated 
during Dendritic Cell Development 
The DNA repair machinery, or at least individual components of the DNA repair machinery, 
are thought to be involved in the active DNA demethylation process (Niehrs, 2009) (see also 
1.1.1.2). The gene list of all significantly regulated genes was thus filtered for proteins that 
participate in DNA repair processes (Figure 5-13). 
 
Figure 5-13 Hierarchical clustering of genes associated with DNA repair 
The expression levels of genes showing at least 5 fold up- or down regulation are indicated by colour. Blue, white 
and red represent low, medium and high expression, respectively. Clustering on the left represents genes with 
similar expression patterns. After “per chip” and ”per gene normalization” (see section 4.2.6.4), data of two (168 h 
time point), three (6 h to 66 h time points) or six (monocytes, indicated as MO) independent donors were 
averaged and evaluated relative to monocytes. Genes whose products were associated with active DNA 
demethylation in literature are indicated in red.  
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Timing and intensity of gene induction as well as repression were variable, ranging from 
early (6 h until 18 h) regulatory events to rather late effects (between 66 h and 168 h). In 
contrast to the transcription factors, the bulk of significantly up-regulated repair associated 
genes seemed to be highly induced not until a relatively late differentiation time point.  
 
Within the last two years, GADD45 (growth arrest and DNA damage-inducible) genes 
emerged as linking elements between DNA repair machineries and active DNA 
demethylation (Barreto et al., 2007; Ma et al., 2009b; Rai et al., 2008; Schmitz et al., 2009). 
The GADD45 gene family includes GADD45a, GADD45b and GADD45g, whose products 
play a crucial role in cellular stress responses. In order to assess the role of GADD45 
proteins for active demethylation events during dendritic cell differentiation, GADD45 
expression profiles of the whole genome analysis were verified using RT-qPCR (Figure 
5-14). Data of both approaches were highly consistent and revealed continuous 
up-regulation of GADD45a until the 66 h time point, following the decrease just after culturing 
the cells. GADD45b transcription was strongly repressed suggesting that GADD45b is not 
involved in CpG demethylation of dendritic cells. mRNA levels of GADD45g were not altered 
significantly during the analysed time window. Interestingly, macrophages and dendritic cells, 
both harvested after 168 hours in culture, showed comparable expression levels of every 
measured GADD45 gene.  
 
 
 
Figure 5-14 mRNA expression profile of GADD45 genes 
Real-time PCR for GADD45 expression at the indicated differentiation time points of immature dendritic cells 
(iDC) compared to monocytes (MO) and macrophages after 168h in culture (MAC). Results were normalised for 
HPRT expression. Values are means ± SD obtained from three independent experiments. 
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5.2.4 Genome-Wide Methylation Analysis of Dendritic Cells versus 
Monocytes and Macrophages 
Assuming that the identification and characterization of additional examples of demethylated 
regions would help to understand the nature of active demethylation and, perhaps, common 
recruitment machineries, the MCIp (methyl CpG-Immunoprecipitation) approach was refined 
for a global screening of differentially methylated regions (DMRs) on microarrays. Validation 
of microarray data was then carried out using the MassARRAY System from Sequenom.  
 
5.2.4.1 Global Screening for DMRs Using MCIp Combined to DNA Microarrays 
Figure 5-15 represents the schematic work flow of the microarray experiment. Genomic DNA 
of in vitro differentiated macrophages and DCs from two donors was divided into 
hypermethylated (mCpG) and hypomethylated (CpG) pools via MCIp and subsequent qPCR. 
While both alleles of the imprinted SNRPN eluted in different fractions (the unmethylated one 
with a low salt buffer, the methylated one with the highest salt concentration), the bulk of the 
unmethylated CpG empty region is eluted after addition of the 350 mM NaCl buffer (Figure 
5-15B). This salt concentration was therefore defined as “cut off” for the separation of both 
genomes into a CpG and a mCpG pool. Cell type-specific differences in DNA methylation 
were then identified by comparing co-hybridizations of the two (macrophages and DC) 
hypermethylated or the two hypomethylated DNA subpopulations on custom designed 244K 
oligonucleotide arrays. Arrays comprised about 17000 genes, -4000 to + 1000 bp from the 
transcription start site, with a few regions (including the CCL13 and TLR4 loci) tiled over a 
large genomic interval. 
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Figure 5-15 Schematic outline of MCIp for comparative genome-wide methylation analysis 
(A) Methyl-CpG-Immunoprecipitation (MCIp). Fragmented (350 – 400 bp) genomic DNA was bound to 
MBD-Fc-ProteinA-Sepharose for three hours. Each sample was then washed with increasing salt-concentrations 
to separate highly methylated DNA from unmethylated or weakly methylated DNA. Black circles indicate 
methylated CpG residues. (B) qPCR revealed a “cut-off” concentration of 350 mM NaCl used for dividing the 
genome of both donors into an unmethylated (CpG) and a methylated DNA (mCpG) pool. SNRPN is an example 
for an imprinted locus and the Empty region does not contain any CpG residue. (C) After purification, samples 
were labelled and the hypomethylated DC-DNA from DonorA was co-hybridized with the hypomethylated 
MAC-DNA pool of the same donor. Likewise, hypermethylated DNA from both cell types of the same donor were 
co-hybridized. 
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Enriched DNA-fragments from one cell type in the methylated fraction should be depleted in 
the unmethylated fraction and vice versa. Consequently, the signal intensities in CpG pool 
and mCpG pool hybridizations should behave mirror-inverted and thereby allow the 
identification of differentially methylated regions (DMR) (Figure 5-16; Figure 5-17 upper 
panels). In total, microarray analysis revealed 45 regions hypomethylated in dendritic cells 
compared to macrophages. A complete list is provided below, summarizing microarray and 
validation data (Table 5-4). 
 
 
 
Figure 5-16 Representative scatter plots of CpG and mCpG pool hybridizations 
The signal intensities of the unmethylated (CpG) DC pool were plotted against the signal intensities of the 
unmethylated macrophage pool (left side). Signal intensities of the methylated pools (mCpG) were plotted in the 
same way (scatter plot at the right). Probes enriched in the unmethylated pool of DCs (red spots) were enriched in 
the methylated pool of MACs (blue spots) and indicated the presence of DMRs. The reciprocal signal intensity 
ratios served as a preliminary, internal control for the reliability of microarray data. Complete microarray data sets 
will be submitted with the corresponding publication, which is in preparation. 
 
5.2.4.2 Comparison of Microarray Data with MALDI-TOF MS (EpiTYPER) Data 
Validation using mass spectrometry analysis of bisulfite treated DNA (MassARRAY System, 
Sequenom) was highly consistent (validation rate of 83%) with the microarray data in two 
independent experiments and with the established positive control CCL13. Figure 5-17 
shows several examples for the high reproducibility of both approaches. Although the focus 
laid on demethylation events in DCs, macrophages also exhibited hypomethylated regions 
(e.g. CD207 CpG6). In order to systematically identify DMRs in macrophages, comparative 
hybridization analysis between macrophages and monocytes need to be performed. 
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Figure 5-17 Comparison of hybridization and EpiTYPER data 
(A-G) Diagrams at the top show signal ratios of the microarray probes for both independent experiments (DonorA 
in blue, DonorB in red) corresponding to their chromosomal localization. Typical DMRs are enriched in the 
hypomethylated fraction of one cell type and in the hypermethylated region of the other one resulting in a 
mirror-inverted image. Orange coloured zones indicate those sequence regions validated via bisulfite conversion. 
Middle panels represent the chromosomal location of DMRs (orange boxes). Regions analysed by MALDI-TOF 
MS of bisulfite converted DNA are indicated at the bottom. White circles represent detectable CpGs while grey 
circles or boxes show undetectable CpGs. Heatmaps represent the methylation status of individual CpGs 
(coloured boxes) averaged from at least 6 analyses of independent donors. (G) Example for a region without 
DMRs. 
 
 
Eighteen of the hypomethylated sequences in DCs were controlled using MALDI-TOF MS 
(matrix-assisted laser desorption/ionization time-of-flight mass spectrometry) of bisulfite 
converted DNA and EpiTYPER software analysis (for detailed information see also Table 
5-4). Validation revealed three false-positive loci resulting in a validation rate of 83%. In 
addition, 5 loci showing no methylation differences after microarray hybridization were 
verified with the MassARRAY system but were not considered for further analysis. 
Remarkably, the demethylation process was not limited to promoter regions as shown for the 
intergenic region between STAT5A and STAT5B, the upstream/downstream region of 
C9ORF78/Usp20, or the CpGs downstream the transcription start site (TSS) of CLEC10A. 
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5.2.4.3 Characterization of DNA Demethylation Events 
In DCs, the existence of active DNA demethylation for at least 14 loci could be confirmed in 
addition to the initially identified CCL13 promoter. Now, the time dependence of CpG 
demethylation was assessed by performing time course experiments. The methylation status 
of each time point was measured by the MassARRAY system and values of at least four 
different donors were averaged. 
 
 
Figure 5-18 Kinetics of DNA demethylation events 
Mass spectrometry analysis of bisulfite-converted DNA of the indicated culture time points. Heatmaps indicate the 
methylation content through blue gradations with each box standing for one CpG dinucleotide. Grey boxes 
represent CpGs not detected by MALDI-TOF MS. Data of 4 to 7 independent experiments were averaged. 
Indicated CpGs of CCL13 and DNASE1L3 are located within their proximal promoters. CpGs of CLEC10A and 
P2RY6 refer to regions 300 and 500 bp downstream of the TSS and CpGs standing for STAT5 and C9ORF78 
cover regions far upstream of the TSS or within the USP20 gene, respectively (see also Figure 5-17 for their 
chromosomal location). 
 
 
Heat maps in Figure 5-18 reveal that demethylation processes did not occur synchronously. 
STAT5, P2RY6 and DNASE1L3 are examples for late demethylation events, namely 
between 42 hours and 7 days in culture, whereas CCL13 and CLEC10A demethylation 
started after 18 h or 27 h of differentiation. Even within one area of demethylation, CpG 
dinucleotides may be demethylated one after another, providing an explanation why the total 
demethylation process required more than 24 hours occasionally. For example, 
demethylation of CpG 3 within the CCL13 promoter started reproducibly after 18 hours in 
culture, whereas first demethylation evidence for the following CpG dinucleotides was 
detected after 27 hours. 
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The comparison of DNA methylation patterns in various donors showed that the active 
removal of 5-meC reproducibly takes place at the same sites (exemplary shown for three 
regions in Figure 5-19). The high reproducibility demonstrated by the heatmaps below makes 
active CpG demethylation a strictly targeted event instead of being a (random) side effect. 
 
 
 
Figure 5-19 Reproducibility of DNA demethylation events 
Mass spectrometry analysis of bisulfite-converted DNA of the indicated differentiation time points. Heatmaps 
indicate the methylation content through blue gradations with each box representing one CpG dinucleotide. Grey 
boxes indicate CpGs that were not detected by MALDI-TOF MS. Data of four donors are shown in isolated 
heatmaps to demonstrate the high reproducibility between independent experiments. 
 
 
 
Table 5-4 summarizes the chromosomal locations along with the corresponding (annotated) 
genes of all detected and validated DMRs. Note that three loci could not be confirmed and 
were thus not listed in the following table. Six out 15 validated DMRs were related to 
promoter regions whereas the remaining nine ones were located either downstream or far 
upstream of the TSS of the corresponding genes. 
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Table 5-4 Description of detected DMRs; ordered as in Figure 5-20 
Chromosomal location of 
DMR 
Annotated 
Gene  
Offset from 
TSS 
MassArray 
validation 
Alternative 
Gene  
Offset from TSS 
of the alt. gene 
chr14:022422974-022423031 REM2 700   -  
chr6:033151084-033151130 HLA-DPB1 -700 ND HLA-DPA1 -1700 
chr22:036284946-036284994 CDC42EP1 800   -  
chr10:012125841-012125897 UPF2 -800   -  
chr6:161379958-161380005 MAP3K4 -2700   -  
chr11:118457096-118457143 HMBS -3800   -  
chr7:156648162-156648213 DNAJB6 -2600   -  
chr2:201820275-201820325 CFLAR 300   -  
chr15:070866345-070866389 ADPGK -3200 YES  -  
chr1:148780880-148780925 S100A10 -1200   -  
chr17:018024022-018024075 ALKBH5 -2500   -  
chr9:129680760-129680817 C9ORF78 -3700 YES USP20 3500 
chr17:037689148-037689197 STAT5A -4500 YES STAT5B -7200 
chr4:152374670-152374722 RPS3A -3700   -  
chr6:030239347-030239393 TRIM15 100 YES TRIM10 -2700 
chr6:030188405-030188462 TRIM31 200   -  
chr12:050585784-050585841 ACVRL1 -1200   -  
chr5:169062431-169062481 DOCK2 -5700   -  
chr2:113588928-113588987 IL1RN -2900   -  
chr2:070976946-070976999 CD207 -2300 YES  -  
chr8:022464090-022464149 SORBS3 -700   -  
chr20:043421999-043422053 DBNDD2 -3200   -  
chr19:045973172-045973217 MIA -100 YES  -  
chr1:150560005-150560050 SLC27A3 -1000 YES  -  
chr2:088307570-088307628 FLJ10916 -1400   -  
chr18:000606234-000606293 CLUL1 -500   -  
chr6:112148968-112149027 FYN -1000   -  
chr1:209173701-209173760 ATF3 -3100   -  
chr15:072516450-072516498 SEMA7A -3100   -  
chr3:058171761-058171820 DNase1L3 -100 YES  -  
chr21:036427003-036427052 CBR3 -2300 YES  -  
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Table 5-4 continued 
Chromosomal location of 
DMR 
Annotated 
Gene  
Offset from 
TSS 
MassArray 
validation 
Alternative 
Gene  
Offset from TSS 
of the alt. gene 
chr17:006923912-006923971 CLEC10A 400 YES  -  
chr14:020560610-020560669 NDRG2 -700 YES  -  
chr5:134812435-134812494 C5ORF20 -1500  TIFAB -3500 
chr19:057018722-057018781 FPRL2 -100   -  
chr11:072661646-072661702 P2RY6 750 YES  -  
chr1:021742203-021742254 RAP1GAP -1100 YES  -  
chr19:007670583-007670633 FCER2 400   -  
chr14:022693817-022693863 SLC7A8 -400 ND  -  
chr17:029707544-029707588 CCL13 -100 YES  -  
chr4:139520655-139520705 SLC7A11 500   -  
chr14:076362022-076362078 C14ORF166B -500 YES  -   
 
 
 
Gene annotation by the chip manufacturer only refers to that gene, whose promoter is 
located nearest to the relevant locus. In order to guarantee a complete list of all genes that 
may be affected by differential methylation, every demethylated locus was searched for 
alternative genes in its environment using the UCSC genome browser. The distance of each 
DMR is listed for both, the annotated as well as the alternative (alt.) gene in order to group 
DMRs for their location.  
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5.2.5 Correlation between Active DNA Demethylation and mRNA 
Expression 
The combination of global DNA methylation and global mRNA expression data sets now 
allowed a correlation analysis between DNA demethylation and mRNA expression. 
Expression data was extracted from the whole genome time course data described in Figure 
5-11A for all DMR associated genes. About one third of the analysed genes showed strong 
up-regulation during DC differentiation, whereas transcription activity of a bulk of genes 
seemed not to be influenced by DNA demethylation (Figure 5-20).  
 
 
Figure 5-20 mRNA expression profiles of genes related to DMRs 
(A) The expression levels of genes showing dendritic cell specific CpG demethylation displayed as a heatmap. 
Blue, white and red represent low, medium and high expression, respectively. Data of two (DC day 7), three (DC 
6 – 66 h) or six (MO) independent donors were averaged and normalised to monocytes (MO). (B) Validation of 
mRNA microarray experiments using RT-qPCR. STAT5 expression was only controlled in monocytes as well as 
in seven day old macrophages and dendritic cells. Data were normalised to HPRT expression. Values are means 
and ±SD obtained from three independent experiments. 
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5.2.6 Histone Modifications Surrounding DMRs 
Because histone modifications provide information about the chromatin accessibility and the 
gene expression status, the question arises, if there is also a link to active DNA 
demethylation. By means of reporter constructs, it was demonstrated that histone acetylation 
and transcription are necessary for active demethylation (D'Alessio et al., 2007; Detich et al., 
2003). Promoter regions of active genes are characterized by the acetylation of various 
histone H3 and H4 residues as well as by histone 3 lysine 4 (H3K4) methylation (Barski et 
al., 2007; Bernstein et al., 2005; Kim et al., 2005; Pokholok et al., 2005; Schubeler et al., 
2004). Here, it is important that methylation of H3K4 occurs in three different forms: mono-, 
di- and trimethylation (H3K4me1, H3K4me2 or H3K4me3) which are interdependent. 
Heintzman et al. as well as Barski et al. identified different chromatin signatures of promoter 
and enhancer regions, providing new insights into correlations between chromatin 
modifications and transcriptional regulation (Barski et al., 2007; Heintzman et al., 2007). 
Despite of several similarities in their histone modification profiles, Heintzman et al. 
distinguished enhancers from promoters by an enrichment of H3K4me1 but missing 
H3K4me3. Promoter areas, however, were characterized by strong H3K4 trimethylation but 
marked depletion of H3K4me1. In order to determine the timing of ongoing events and the 
relevance of activating histone marks during DNA demethylation in dendritic cells, chromatin 
immunoprecipitations were performed at different differentiation time points. Corresponding 
to the bisulphite data, seven demethylated sites covering upstream, downstream and 
promoter regions were selected for real time PCR analysis.  
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Every analysed activating histone modification was detected quite early within gene promoter 
regions, although acetylation of histone H3 and H3K4me3 seemed to be slightly delayed 
(Figure 5-21). Trimethylation of histone 3 lysine 4, a modification usually connected to 
actively transcribed genes, successively increased with culture time corresponding to the 
CCL13 mRNA data shown in Figure 5-9A. 
 
 
Figure 5-21 Correlation of histone modifications with CpG demethylation at promoter regions 
Activating histone marks were analysed at differentially methylated promoter regions during dendritic cell 
differentiation using ChIP. Grey lines represent the background control IgG. DNA enrichment of the indicated time 
points is normalised to 5% input DNA and shown relative to monocyte (0 h) enrichment. Data represent mean 
values ±SD of at least three independent ChIP experiments. 
 
 
ChIP primers for the transcriptionally active genes CLEC10A and P2RY6 (see Figure 5-20) 
cover a region less than 1000 bp downstream their TSSs. Within this area high levels of 
H3K4me3 were detected whereas H3K4me1 was completely absent (Figure 5-22). 
H3K4me2 was detected at the P2RY6 locus but not at CLEC10A. This is in line with recently 
published genome-wide, high resolution data describing a significant dip in H3K4me3 signals 
between -200 to +50 bp but strong signal peaks at +50, +210 and +360 bp of active genes 
(Barski et al., 2007). In that study, two major peaks for each modification were detected: -900 
and +1000 for H3K4me1, -500 and +700 for H3K4me2 and -300 as well as +100 for 
H3K4me3. 
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Signals of mono- and dimethylation downstream the TSS of highly active genes, that were 
analysed in the context of the present thesis, decreased, probably due to the high levels of 
trimethylation (Figure 5-22). The H3K4me2 signal at the CLEC10A locus seems to flare up 
only at the beginning, suggesting that the mono- and dimethylated states were not captured 
due to the rapid and complete methylation of lysine 4. 
 
 
 
Figure 5-22 Correlation of histone modifications with CpG demethylation at intragenic regions 
Activating histone marks were analysed at DMRs downstream TSSs during dendritic cell differentiation using 
ChIP. Grey lines represent the background control IgG. DNA enrichment of the indicated time points is normalised 
to 5 % input DNA and shown relative to monocyte (0 h) enrichment. Data represent mean values ±SD of at least 
three independent ChIP experiments. 
 
As expected, H3K4 trimethylation was only measured at loci near the transcription start sites 
(TSS) whereas this mark was undetectable in upstream regions (Figure 5-23). The pattern of 
histone modifications at the intergenic sites reflected some characteristics of enhancers as 
described by Heintzman et al.. Certainly, to confirm this hypothesis, further experiments like 
transfection assays have to be done. 
Dimethylated H3K4 (H3K4me2) was the most abundant mark compared to the other 
methylation states because it was detected quite early and at every demethylated site 
irrespective of the investigated genomic region. Acetylated histone 3 and histone 4 (AcH3 
and AcH4) were also found at every demethylated region with AcH3 showing weaker signals 
except for the downstream regions. 
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Figure 5-23 Correlation of histone modifications with CpG demethylation at intergenic regions 
Activating histone marks were analysed at DMRs upstream or upstream/downstream (regarding to the 
C9ORF78-Usp20 locus; see also Figure 5-17) from TSSs during dendritic cell differentiation using ChIP. Grey 
lines represent the background control IgG. Samples were normalised to the 5 % input DNA and evaluated 
relative to monocytes. Data represent means ±SD obtained from at least three independent donors. 
 
Time course experiments analysing DNA methylation patterns and histone modifications 
demonstrated that CpG demethylation succeeded or occurred simultaneously with alterations 
in the histone code. Downstream of the P2RY6 transcription start site, DNA demethylation 
started after approximately 42 hours in culture. Histone marks were already detected after 6 
hours when the locus was still completely methylated. Likewise, histone modifications at the 
DNASE1L3 promoter or at the intragenic CLEC10A region appeared before first DNA 
demethylation events were detected. At other loci like the CCL13 promoter or the intragenic 
C9ORF78 region, it was difficult to determine, whether the appearance of histone marks 
coincided with DNA demethylation or preceded it, on the basis of the present data. 
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5.3 Cell Type-Specific DNA Demethylation 
The distribution of H3K4me2 enrichment at lineage-specific hematopoietic promoters reflects 
the differentiation potential of hematopoietic cell lines (Orford et al., 2008). Furthermore, 
developmentally poised genes may be identified by defined H3K4 methylation patterns. It is 
therefore reasonable that the DNA methylation profile, which seems to be correlated with 
chromatin modifications, also indicates developmentally poised genes. 
Lineage-specific transcription factors play key roles in determining cell fates during the 
differentiation of progenitor cells into mature cell types. Because their tight regulation on the 
transcription level is likely controlled by epigenetic mechanisms, lineage-restricted 
transcription factor genes might represent good candidates for the analysis of cell 
type-specific DNA methylation. 
 
5.3.1 Identification of Cell Type-Specific Transcription Factors 
The hematopoietic system provides a well-defined model, whose distinct cell-types can be 
isolated efficiently. Thus, to identify cell type-specific transcription factors, global 
transcriptome analysis was performed using mRNA of all major mononuclear cell types in 
human blood (monocytes, B cells, NK cells, and T cells) as well as of monocyte-derived 
dendritic cells and macrophages. CD34+ progenitor cells were also included, in order to 
follow the hematopoietic hierarchy. 
 
After leukapheresis, half of the obtained peripheral blood mononuclear cells (PB-MNCs) 
were sorted for CD8+ (T cell), CD4+25+ (regulatory T cell), CD4+25- (conventional T–cell), 
CD19+ (B cell), CD56+ (natural killer cell) and CD14+ (monocyte) surface antigen expression 
using the BD FACSAria by the group of Petra Hoffmann and Matthias Edinger (University 
Hospital Regensburg, Institute of Hematology and Oncology). Cells were prepared for RNA 
and DNA isolation immediately after cell sorting to prevent degradation of nucleic acids. The 
other part of PB-MNCs was elutriated and resulting monocytes were then in vitro 
differentiated into macrophages and DCs until day 7 or directly processed for DNA and RNA 
isolation, respectively. CD34+ progenitor cells from two different donors were purchased 
from Lonza.  
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Figure 5-24 Transcription factor gene expression in human blood cell types 
(A) Heat map of transcription factors with lineage-enriched expression in mononuclear blood cell types. 
Microarray expression data were obtained from two (CD34+ progenitors) to three (all other cell types) 
independent donors and median normalised. Genes were selected based on an at least ten-fold over-expression 
in one lineage (e.g. myeloid or lymphoid) or one individual cell type the median of all other types. Low expression 
signals are illustrated by dark boxes and stronger signals are indicated in bright blue. Complete microarray data 
sets will be submitted with the corresponding publication, which is in preparation. (B) Validation of microarray data 
using RT-qPCR. Results were normalised to HPRT expression. Data represent mean values of two (CD34+ cells, 
CD4+25+), three (CD19+, CD4+25-, CD8+ and CD56+ cells) or six (dendritic cells day 7, macrophages day 7, 
monocytes) different donors measured in duplicates. 
 
Whole genome expression analysis revealed a set of thirty eight transcription factor genes 
that showed at least 10-fold higher expression in either of the cell lineages (myeloid versus 
lymphoid) or cell types (Figure 5-24A). Supportive data for lineage restricted expression of 
most of the identified genes was found in two online reference databases (LSBM RefExA 
[www.lsbm.org/site_e/database/index.html] for monocytes and macrophages or BioGPS 
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[www.biogps.gnf.org] for white blood cells) as well as in the literature. FOXP3 for example is 
known to be a specific transcription factor for regulatory T cells (Treg; CD4+CD25+) (Baron 
et al., 2007; Hoffmann et al., 2009) and SPI1 (also known as PU.1) is absolutely required for 
myeloid and B cell development (McKercher et al., 1996; Scott et al., 1994; Zhu and 
Emerson, 2002). A subset of newly identified lineage-specific factors was selected for 
validation by RT-qPCR. The previously undescribed lineage specific expression of MLXIPL in 
macrophages, TCEA3 in T cells, JDP2 in monocytes and VDR in myeloid cells was 
confirmed by RT-qPCR (Figure 5-24B). As the comparison of elutriated and CD14+ sorted 
monocytes revealed almost identical expression profiles (data not shown), both 
monocyte-types were considered as one population. 
 
5.3.2 Promoter Methylation Profiles of Cell Type-Specific 
Transcription Factors 
After establishing a set of transcription factor genes that were highly enriched in individual 
blood cell lineages or cell types, the DNA methylation status of their promoter regions was 
determined. Genomic DNA samples originating from the same donors and the same day as 
the RNA samples analysed in chapter 5.3.1, were prepared for bisulfite treatment and 
measurement using the MassARRAY system. 
 
Methylation patterns of the non-CpG island SPI1 and SPIB promoters represented prime 
examples for lineage or cell type-specific expression, probably regulated by DNA methylation 
(Figure 5-25). While the SPIB promoter region was free of CpG methylation in CD19+ 
positive B cells, this locus was strongly methylated in all the other cell types analysed. 
Likewise, the SPI1 region was consistently methylated in the non-expressing lymphoid cell 
types and completely unmethylated in progenitor cells as well as in myeloid (monocytes, DC, 
macrophages) and B cells. The analysed region of the GFI1B locus exhibited only slightly 
higher methylation levels in the lymphoid lineage (CD56+ NK cells, CD4+ and CD8+ T cells). 
However, CpGs within the SINE element downstream the transcription start site were largely 
methylated in all cell types. GFI1B was induced specifically in CD34+ precursor cells (Figure 
5-24) indicating that the DNA methylation status of the promoter region is not pivotal for cell 
type specific GIF1B expression. The CpG-rich regions around the TCEA3 and the KLF4 TSS 
were barely methylated and did not show significant differences between the various cell 
types. 
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Figure 5-25 Examples of methylation profiles for lineage enriched transcription factor genes 
gDNA samples of two independent donors were bisulfite treated and prepared for MassARRAY analysis. The 
upper panel describes the chromosomal location of the analysed regions (indicated in red). White circles stand for 
detectable CpGs while grey circles could not have been measured by the mass spectrometer. Heat maps at the 
bottom show the methylation status of each individual CpG of both donors in blue gradations. Grey boxes indicate 
cytosine residues that were not detected by the MALDI-TOF MS. Cell types expressing the corresponding gene 
are highlighted in red. 
 
 
An overview of all promoter regions analysed is given in Table 5-5. Most of the cell type- or 
lineage-specific transcription factors were associated with CpG island (CGI) promoters which 
were unmethylated in every cell type. Cell type-specific differences in the methylation profiles 
were only observed within non-CGI promoter regions.  
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Table 5-5 Methylation analysis of cell type-specific transcription factors  
Ordered according to Figure 5-24 with TSS indicating the transcription start site and CGI indicating CpG islands 
promoters 
Gene  Analyzed region, 
Offset from TSS 
CpG density of the 
associated promoter 
# of 
amplicons 
Methylation pattern 
PRRX2 -640 to +1760 bp  CGI 10 Variable between donors 
FOXQ1 -1500 to +1700 bp CGI 13 No differences 
TRIM15 -160 to +1040 bp Low 9 Partly DC specific 
AHRR -700 to +1100 bp  Low 11 No differences  
OVOL1 -1300 to +1700 bp CGI 13 No differences 
WWTR1 -900 to +1500 bp CGI 13 No differences 
MLXIPL -300 to +1500 bp CGI 13 No differences 
SMARCD3 -1100 to 800 bp CGI 11 No differences 
ID1 -1300 to +1700 bp CGI 17 No differences 
SPI1 -600 to +1600 bp Low 12 Hypermethylation in NK and T 
cells (Figure 5-25) 
KLF4 -1100 to +2200 bp CGI 15 No differences (See Figure 5-25) 
CEBPB -1000 to +1800 bp CGI 13 No differences 
VDR -1100 to +660 bp CGI 11 No differences 
VENTX2 -2800 to +900 bp CGI 22 No differences 
CREB5 -1100 to +900 bp Low 11 No differences 
BHLHB3 -2000 to +3200 bp CGI 27 No differences 
SPIB -780 to +1300 bp Intermediate 14 Hypomethylated in B cells (Figure 
5-25) 
MEIS1 -2300 to +1600 bp CGI 21 No differences 
GATA1 -1600 to +500 bp Low 13 No differences 
MYCN -1100 to +2500 bp CGI 20 No differences 
FHL2 -800 to +1000 bp CGI 12 No differences 
GFI1B -400 to +1500 bp Intermediate 11 Slightly hypermethylated in NK 
and T cells (Figure 5-25) 
MYB -900 to +2200 bp CGI 19 No differences 
ERG -450 to +1800 bp Intermediate, CGI 
directly downstream TSS 
12 No differences 
KLF1 -800 to +3000 bp Intermediate  21 Slightly hypomethylated in CD34+ 
and myeloid cells 
FOXP3 -1000 to +1100 bp Low 13 Demethylated in regulatory T cells 
LEF1 -1000 to +2000 bp CGI 19 No differences 
TCEA3 -800 to +1200 b CGI 9 No differences (Figure 5-25) 
RORA -800 to +1700 bp CGI  15 No differences 
GATA3 -4600 to +1700 bp CGI 34 No differences 
STAT4 -500 to +1500 bp Intermediate 12 No differences 
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However, the finding that the bulk of cell type-specific TFs did not show differences in their 
promoter methylation pattern does not automatically exclude DNA methylation as important 
regulator for cell type-specific gene expression. Functionally important differences in CpG 
methylation may be found at promoter distal sites as described for several other genes such 
as FOXP3, whose activity is controlled by a downstream, methylation-sensitive enhancer 
(Baron et al., 2007; Floess et al., 2007; Kim and Leonard, 2007). In fact, recent studies, 
including work of our group (Schmidl et al., 2009), indicate that differentially methylated 
regions are preferentially found at promoter distal sites and often correlate with enhancers 
(Decker et al., 2009; Meissner et al., 2008; Schmidl et al., 2009; Yagi et al., 2008). 
 
 Discussion & Perspectives 
 - 93 -    
6 Discussion & Perspectives 
Methylation of CpG dinucleotides plays a crucial role in numerous biological processes 
including gene expression, silencing of retrotransposons, genomic imprinting, X-chromosome 
inactivation and cancer (Bird, 2002; Herman and Baylin, 2003). However, surprisingly little is 
known about its impact during differentiation of normal somatic cells. The data of the present 
thesis provide a basis for further investigations on especially CpG-poor DNA stretches, their 
implication in differentiation-dependent gene regulation and the dynamics of methylation 
patterns. 
 
6.1 Transient Transfection as a Tool to Assess the Effect of 
DNA Methylation on Gene Expression 
One aim of this thesis was to develop a tool for studying the influence of promoter 
methylation on gene expression. By means of transient transfection assays, the comparison 
of in vitro methylated promoter constructs and their unmethylated counterparts provides 
insights into the repressive nature of CpG methylation on transcriptional activity. However, in 
vitro methylation of a traditional reporter vector that contains a large number of backbone 
CpGs significantly suppressed the activity of a CpG-free promoter when methylated (Figure 
5-1). The effect of methylated CpGs within the vector backbone was thus sufficient to 
markedly repress the activity of an intrinsically CpG-free promoter. To avoid those unspecific 
side-effects, a novel luciferase vector, called pCpGL, was constructed. Due to the lack of 
backbone CpG dinucleotides, the effects of DNA methylation were entirely limited to the 
promoter of interest instead of being a consequence of unspecific CpG methylation in the 
vector backbone (Figure 5-2 and Figure 5-3). In terms of significance and implementation, in 
vitro methylation of pCpGL constructs has significant advantages over the previously used, 
less specific or time-consuming approaches. 
 
In contrast to the methylation-dependent repression of CpG island promoters, the effect of 
CpG methylation on CpG-poor promoters is less well established. The novel luciferase 
reporter vector will enable systematical studies of methylation-dependent effects of both, 
CpG-rich as well as CpG-poor promoters. However, analyses are not limited to promoter 
regions. In addition to promoter methylation, the methylation pattern of other regulatory 
elements such as enhancers seems to interfere with gene expression (Bretschneider et al., 
2008; Decker et al., 2009). Combined cloning of a candidate enhancer with a CpG-free 
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promoter (such as EF1) into the pCpGL vector and subsequent transfection of the 
methylated and unmethylated plasmids, allows the identification of methylation dependent 
enhancers as shown in a recent publication by our group (Schmidl et al., 2009). The pCpGL 
vector could not be successfully used to study relevant promoter regions described in this 
thesis. However, the vector has been applied in numerous other laboratories documented by 
already released (Dong et al., 2008; Kundakovic et al., 2009) and upcoming publications. 
 
 
6.2 Dynamic Methylation Patterns of CpG-poor DNA 
Stretches as Important Regulators for Differentiation 
During the recent years, the perception of differential DNA methylation and the dynamics of 
the methylation patterns has markedly changed. CpG islands (CGI) were previously thought 
to be almost entirely free of methylation with few exceptions including the second inactive X 
chromosome of females (Goto and Monk, 1998) or the silent allele of imprinted genes (Li et 
al., 1993). Recent global methylation analysis of CGIs comprising promoter regions as well 
as promoter distal sites, however, revealed that 25-30% of CGIs become de novo methylated 
in a tissue-specific manner during development (Straussman et al., 2009). CpG dinucleotides 
outside CGIs are traditionally considered to be methylated and thereby to silence potential 
hazardous genetic elements such as retrotransposons (Robertson and Wolffe, 2000; Walsh 
et al., 1998). However, the methylation status of especially CpG-poor DNA stretches turned 
out to be dynamic and crucial for cell type- or tissue-specific gene expression (Brunner et al., 
2009; Lathrop et al., 2009; Lee et al., 2002; Rouhi et al., 2006). These findings are supported 
by quantitative methylation analysis of cell type- or lineage-restricted transcription factors 
performed as part of this thesis. Cell type- or lineage-specific methylation profiles for several 
of the analysed regulatory factors were only detected at non-CpG island promoters, such as 
SPI1 or SPIB (Figure 5-25; Table 5-5). Although there is a significant number of methylated 
CGIs throughout the genome (Illingworth et al., 2008; Straussman et al., 2009), the great 
majority of CpG island promoters is protected from CpG methylation in normal cells (Bird, 
2002; Eckhardt et al., 2006; Weber et al., 2007). This protection possibly results from the 
presence of special transcription factors like Sp1 (Brandeis et al., 1994) or specific histone 
marks such as dimethylation of histone 3 lysine 4 (Weber et al., 2007). 
Regarding the differentially methylated regions identified in the context of this thesis, the 
influence of specific methylation patterns on gene expression remains to be proven. 
Nevertheless, the presented data argue for a regulating role of DNA methylation at CpG-poor 
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DNA stretches during normal hematopoietic development and emphasize the dynamic 
potential of DNA methylation. 
 
Although CpG-poor regions seem to be more important targets of dynamic DNA methylation 
than CGIs, the extent of cell type- or lineage-specific differentially methylated regions 
throughout the genome has not been completely defined, yet. Likewise, it is unclear how 
these differences are established during development and differentiation. Whereas the 
enzymatic transfer of methyl-groups onto unmethylated CpGs is a well characterized 
process, the removal of methyl cytosines is less well understood. The failure of DNMT1 to 
methylate the nascent daughter strand of replicating DNA represents a non-enzymatic 
passive way for removing the methyl mark. This is a comparatively slow process, as maximal 
50 % of methylated CpGs are demethylated after one replication cycle (Kress et al., 2001). 
On the other hand, DNA demethylation may be achieved through a replication-independent, 
active mechanism, implying the activity of specific enzymes. The existence of such active 
demethylation mechanisms in humans is still doubted (Ooi and Bestor, 2008), although 
numerous studies accounted for the occurrence of actively demethylated DNA and identified 
several candidate factors that may be involved in the demethylating process. Most of these 
were performed in artificial cell systems like (pharmacologically arrested) cell lines 
(Kangaspeska et al., 2008; Metivier et al., 2008) or with embryonic cells (Hajkova et al., 
2008; Lucarelli et al., 2001), questioning the biological relevance of the observations and 
providing reasons to argue for a passive mechanism. The unique model system presented in 
this work allowed the identification and characterization of active DNA demethylation events 
in untreated post-mitotic primary cells. Differentiation of human peripheral blood monocytes 
into dendritic cells (DC) and macrophages (MAC) respectively, occurs without proliferation 
(Figure 5-7), implying that all observed demethylation events have to be active. The 
reproducible detection of multiple demethylated regions in a post-proliferative cell system 
(Table 5-4) thus proves the existence of active demethylation events. Likewise, several 
studies on dividing primary cells or cell lines also argue for the involvement of an active 
enzymatic mechanism, as the kinetics of the demethylation procedure are too fast to be 
dependent on cell proliferation. Demethylation of a specific CpG site within the human IL2 
promoter, e.g., occurs within one hour after activation of CD4+ positive T cells (Murayama et 
al., 2006) and is therefore independent of cell division. Using a rat hepatoma cell line as well 
as E15 fetal hepatocytes, Kress et al. reported DNA demethylation within a 
glucocorticoid-responsive unit of the tyrosine aminotransferase (tat) gene locus upon 
activation by the glucocorticoid receptor (Kress et al., 2006). Within the time frame of one 
cycle of cell division, the proportion of unmethylated cytosines at the tat-locus reached 85 %, 
thereby excluding a purely passive demethylation mechanism. The detection of specific DNA 
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strand breaks next to the methylated cytosine during demethylation suggests the 
involvement of DNA repair machineries and confirms the dependence on an active process. 
Given these and other examples (Hajkova et al., 2008; Kersh et al., 2006; Metivier et al., 
2008), it is doubted that passive DNA demethylation plays a major role in gene-specific 
demethylation (Niehrs, 2009). Moreover, it seems counterproductive that regulatory 
mechanisms which have to adopt rapidly to environmental signals, are based on such a slow 
and indirect process like passive demethylation. The absence of an active demethylation 
process would furthermore imply that differentiated, post-mitotic cells would lack CpG 
demethylation based epigenetic regulation. In other words, those cells would lack a 
regulatory process, which has been shown to be crucial for priming genes as well as for the 
induction of mRNA expression. 
 
Earlier studies in our laboratory supported the existence of active DNA demethylation by 
detecting the first example for differentiation-dependent active demethylation in differentiating 
monocytes (Heinz S., 2002). The CCL13 promoter contains three CpG residues within its 
proximal promoter region that are methylated in monocytes. Two defined residues, -20 as 
well as -80 bp upstream of the transcription start site, were demethylated during dendritic cell 
differentiation, accompanied by transcriptional activation. Although the CCL13 promoter of 
differentiated macrophages remained methylated, short-time expression was observed after 
four hours in culture (Heinz S., 2002). RNA expression profiles over seven days of dendritic 
cell culture demonstrated the continuous, strong up-regulation of CCL13 (Figure 5-9A), 
suggesting that CpG demethylation is necessary for strong and constant CCL13 expression. 
Using chromatin immunoprecipitations, binding of the interleukin 4 (IL-4) inducible 
transcription factor STAT6 (signal transducer and activator of transcription 6) to the proximal 
promoter was detected (Figure 5-9D). Recruitment of STAT6 seemed to occur after initial 
promoter demethylation and continued over the analysed time period. The two STAT6 
binding sites [TTC(N2-4)GAA] of the CCL13 promoter do not contain a CpG residue and are 
therefore not directly affected by CpG methylation. This argues for a model where several 
transcription or co-factors act in concert to provide an accessible chromatin state allowing 
enduring transcription. Possibly, CpG demethylation is a necessary prerequisite for the 
binding of another (sequence-specific) and methylation-dependent DNA binding factor that in 
turn recruits STAT6. As STAT6 binding alone is usually not sufficient to stimulate the 
activation of a specific locus (Hebenstreit et al., 2006), the collaboration of both, the yet not 
identified factor and STAT6, may keep the chromatin architecture of this region in an active 
state and promote transcription. Such a stabilizing role of transcription factors has already 
been shown in other cell models, including e.g. T cells. Following CD4+ T cell stimulation, a 
specific CpG residue within the human IL-2 promoter becomes demethylated (Murayama et 
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al., 2006). Demethylation is crucial for the binding of the constitutive transcription factor 
Oct-4, which is responsible for maintaining the presence of activating histone modifications 
such as acetylation of histone H3. The interplay between demethylation, transcription factor 
binding and the histone code for long-term transcription of CCL13, might be proven by 
blocking the demethylation process followed by controlling STAT6 binding and the presence 
of histone modifications. However, as long as the mechanisms that are responsible for active 
demethylation remain unclear, their inhibition is difficult. Nevertheless, various substances 
such as DNA polymerase inhibitors that block possibly involved DNA repair mechanisms, 
have been applied to freshly prepared monocytes for up to three days (Table 5-3). The 
analysed chemicals were either toxic or did not show any effect either on DNA demethylation 
or on CCL13 expression. Transient transfection assays using unmethylated or in vitro 
methylated pCpGL_CCL13 promoter constructs, could have confirmed a direct correlation 
between DNA demethylation and gene expression. However, a cell line that intrinsically 
expresses the CCL13 chemokine was not identified. All human (THP-1, HepG2) and murine 
cell lines (RAW, NIH3T3) tested, failed to transcribe unmethylated CCL13-promoter 
constructs following successful transfection. 
 
To further characterize active DNA demethylation of especially CpG-poor DNA regions, 
global methylation analysis of differentiating dendritic cells needed to be performed. The 
recent development of techniques that enrich methylated DNA permitted the investigation of 
DNA methylation patterns on global platforms such as oligonucleotide tiling arrays or next 
generation sequencers. Current technologies, including RLGS (restriction landmark genomic 
scanning), DMH (differential methylation hybridization), Methyl-Seq (sequencing of digested 
DNA using methylation-sensitive enzymes) and MeDIP (methyl-DNA immunoprecipitation) 
are particularly suited for the analysis of CpG-dense regions (Brunner et al., 2009; Costello 
et al., 2009; Mohn et al., 2009; Weber et al., 2005). However, they are not sensitive enough 
for the systematic detection of differentially methylated CpG-poor DNA stretches. 
Methyl-Seq, DMH and RLGS are based on the digestion with methylation-sensitive enzymes 
and are thus limited to the presence of the corresponding recognition sequences. 
Consequently, those approaches do not cover every occurring CpG residue. For example, 
only 3.9% of all nonrepeat CpGs in the human genome reside within recognition sites of 
Hpa II, a restriction enzyme that is used for Methyl-Seq and DMH (Fazzari and Greally, 
2004). Moreover, the application of CpG-rich recognition sequences of eight base pairs 
(Fazzari and Greally, 2004; Smiraglia and Plass, 2002) and the requirement of several CpG 
containing recognition sites in close proximity (Brunner et al., 2009) bias those methods 
towards CpG-islands. MeDIP (also called mDIP) circumvents the described motif bias by 
detecting methylated DNA with an antibody directed against 5-methylcytidine (Mohn et al., 
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2009). However, this approach specifically enriches for methylated fragments and is 
dependent on the CpG content of the analysed fragments also resulting in a strong bias 
towards CpG-rich DNA regions (Keshet et al., 2006; Suzuki and Bird, 2008; Weber et al., 
2007). Previously, a technique for the fractionation of genomic DNA fragments depending on 
their CpG density, was established in our laboratory (Gebhard et al., 2006b; Schilling and 
Rehli, 2007). This approach, called MCIp (methyl CpG Immunoprecipitation), is not 
dependent on certain sequence motifs and sensitive enough for methylation analysis of 
CpG-rich as well as CpG-poor DNA stretches. Regarding the objective of the present thesis, 
MCIp was adapted to identify differentially methylated regions between monocyte-derived 
macrophages and dendritic cells by separating the genome into hyper- and hypomethylated 
CpG pools (Figure 5-15). Comparative genome hybridization resulted in the detection of 45 
loci specifically demethylated in dendritic cells (Figure 5-16; Table 5-4), partly validated using 
the bisulfite based MassARRAY approach with a validation rate of 83%. Interestingly, 
differentially methylated regions (DMR) are not only present within proximal promoters but 
also, in large part, at promoter-distal sequences (Table 5-4). These data are in line with 
recent comparative genome-wide methylation analyses performed in our and other groups 
(Illingworth et al., 2008; Song et al., 2009). E.g. in T cells, it was shown that only 
approximately 5% of the DMRs are located at proximal promoters (Schmidl et al., 2009). In 
transient transfection assays, several of the distal DMRs showed methylation-dependent 
enhancer activity. More global studies in ES cells identified promoter-distal loci as the main 
sites of changes in the methylation pattern during cell differentiation (Meissner et al., 2008). 
Investigation of the murine liver revealed that tissue-specific differentially methylated regions 
are localized a few kilobases away from the TSS and that the methylation status of those 
regions correlates with transcriptional activation of adjacent genes (Yagi et al., 2008). Hence, 
the vast majority of dynamic methylation changes is found at promoter distal sites, 
suggesting that a major function of DNA methylation is to restrict the activity of cell 
type-specific enhancers. 
 
The evidence for occurring active DNA demethylation events entails the question about the 
underlying mechanisms and therefore about the identification of enzymes showing 
convincing activity on 5-methylcytosine. DNA mismatch glycosylases including MBD4 
(methyl-CpG binding domain protein 4) and TDG (thymine DNA glycosylase) were shown to 
be involved in DNA demethylation (Kangaspeska et al., 2008; Metivier et al., 2008; Zhu et al., 
2000) but they both have only weak 5-meC base excision activity relative to their activity on 
thymine (Cortazar et al., 2007; Zhu et al., 2000). Consequently, if those mismatch 
glycosylases do really mediate DNA demethylation, there must be an initial process providing 
the appropriate substrate. A study in zebrafish embryos suggests that the 5-meC deaminase 
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AID (activation induced cytidine deaminase) converts methylated cytosine residues into 
thymines which finally can be excised by MBD4 (Rai et al., 2008). Another possibility is 
provided by Tahiliani et al suggesting that cytosine demethylation is carried out via the TET1 
(ten eleven translocation) dependent formation of 5-hydroxymethylcytosine (hmC) as 
intermediate (Tahiliani et al., 2009). The existence of hmC was proven in the genome of 
mouse ES cells, but its universality as well as the affinity of glycosylases or other repair 
associated enzymes for this intermediate remain to be elucidated. 
 
Although base excision repair mechanisms were shown to mediate active demethylation in 
flowering plants, their implication in the active removal of mammalian 5-meC has not been 
definitely proven, yet (Agius et al., 2006; Kapoor et al., 2005; Morales-Ruiz et al., 2006). 
However, there is emerging evidence that components of the base excision repair (BER) as 
well as the nucleotide excision repair (NER) machinery are involved in active demethylation 
of mammalian DNA (Barreto et al., 2007; Ma et al., 2009b; Metivier et al., 2008; Rai et al., 
2008). The involvement of DNA repair mechanisms would imply a momentary occurrence of 
single strand nicks. On the basis of a study that visualized strand breaks during active 
cytosine demethylation (Kress et al., 2006), these nicks were analysed in differentiating 
monocytes via ligation mediated PCR of genomic DNA. The low detection limit of this 
approach, which requires synchronized demethylation events may provide one reason why 
no sample showed indications for occurring strand breaks (data not shown). Therefore, this 
approach seems not suitable for the detection of DNA nicks in untreated, differentiating 
monocytes. Additionally, the presence of stable 5’-phosphate residues at putative DNA nicks 
has to be guaranteed, as this technique is based on linker ligation to free 5’-phosphate ends. 
Another approach to assess the role of repair associated factors during active DNA 
demethylation, might be the identification of possible candidate genes followed by further 
experiments such as knock-down assays. Genome-wide expression analysis revealed 
several repair associated genes that are significantly up-regulated during dendritic cell 
development (Figure 5-13), thus representing potential candidates. Three of those, 
GADD45a, GADD45b and LIG1, have already been described to be involved in active DNA 
demethylation. The GADD45 (growth arrest and DNA-damage induced) family proteins were 
initially identified as stress-inducible factors implicated in cell cycle arrest, DNA repair as well 
as apoptosis (Fornace, Jr. et al., 1988; Hoffman and Liebermann, 2007) and received 
increasing interest in the field of DNA demethylation. Several studies propose an important 
role for GADD45 proteins in linking DNA repair mechanisms with DNA demethylation 
(Barreto et al., 2007; Ma et al., 2009b; Rai et al., 2008). The ability of Gadd45 to oligomerize 
may facilitate the coupling of multiple enzymatic steps that are required for BER or NER 
based DNA demethylation (Ma et al., 2009a). Additionally, Gadd45 proteins are thought to 
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loosen the chromatin structure and might therefore provide access for demethylating 
enzymes (Carrier et al., 1999; Ma et al., 2009a). However, especially the in vivo implication 
of Gadd45a is questioned by a study reporting neither global nor locus specific methylation 
increases in Gadd45a-deficient mice (Engel et al., 2009). Similarly, Jin et al were unable to 
confirm an earlier study (Barreto et al., 2007) claiming that Gadd45a has a key role in active 
DNA demethylation (Jin et al., 2008). The expression profile of GADD45a during dendritic 
cell differentiation potentially supports studies attributing GADD45a a linking role between 
DNA repair and active demethylation, as GADD45a expression is up-regulated during the 
time frame of active demethylation (Figure 5-13; Figure 5-14). A recently published work 
argues for a model, in which the TBP (TATA binding protein) associated factor TAF12 
recruits GADD45a and the NER machinery to promoters resulting in active DNA 
demethylation (Schmitz et al., 2009). A general role for TAF12, however, seems unlikely 
because demethylation events are not limited to promoters (Figure 5-17, Table 5-4), where 
TAF12 binding is usually detected. Nevertheless, these data further indicate the emerging 
role of transcription factors for the recruitment of epigenetic modifiers. 
 
Transcription factors are implicated in targeting histone modifying enzymes to their sites of 
action and may thus additionally recruit demethylating enzymes (Imhof, 2006; Rice et al., 
2007; Robert et al., 2004). Nuclear hormone receptors, e.g., represent well documented 
examples for targeting DNA demethylation (Niehrs, 2009). In order to identify factors that 
come into consideration for mediating DC specific demethylation, genome-wide expression 
analysis were performed revealing numerous genes that are highly regulated during dendritic 
cell development (Figure 5-11). It was questioned whether common recruitment machineries 
are existent for every demethylated site. A de novo motif discovery algorithm was used to 
identify common sequence motifs within gene promoters that are enriched in the cluster of 
up- and down-regulated genes. The algorithm revealed three sequence motifs that are 
significantly enriched within markedly repressed genes. The enriched motifs comprised 
immunregulatory sequences that are responsive to interferon stimulation (Figure 5-11B). As 
IFNgamma and IL-4 are considered to be mutually counteracting cytokines (Paludan, 1998), 
the blocking of IFN signalling probably resulted from the IL-4 stimulation at the beginning of 
cell differentiation. In line with the motif data, gene ontology analysis demonstrated that 
primarily immune and stress response associated factors were repressed (Figure 5-11C). In 
contrast, the cluster of highly up-regulated genes did neither exhibit common binding motifs 
nor clear functional correlations (Figure 5-11B). This suggests that either too many and too 
distinct factors are involved in their induction, or that common motifs for their regulation might 
rather be found at enhancer elements. Furthermore, the diversity of functions does not allow 
any conclusions referring to a regulating role during active DNA demethylation. However, the 
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slight enrichment of cell cycle factors (Figure 5-11C) might represent a weak link to DNA 
repair, as several proteins involved in cell cycle progression such as replication and damage 
checkpoints or polymerases are also implicated in repair processes. 
In order to detect the presence of factors that are specifically recruited to a demethylated 
locus and therefore possibly influence the demethylation event, in vivo footprinting of the 
CCL13 promoter was performed at various differentiation time points. However, significant 
differences in transcription factor occupancy between the analysed time points were not 
detected (data not shown). This might be partly due to the rather long demethylation process 
(about 24 hours), indicating that demethylation does not occur synchronously in every cell, 
so that the occupancy of the promoter was below the detection limit of this approach. 
Chromatin immunoprecipitation (ChIP) experiments are affected by the same limitations. 
Possible candidate factors recruiting demethylating enzymes or mediating this process 
presumably occupy the corresponding locus for only a short time frame. As cells were not 
synchronized, the concentration of factors captured at a certain time point might be below the 
detection limit. Furthermore, ChIP analyses depend on the availability of well working 
antibodies. Several candidate factors such as MBD2, TDG or GADD45a were analysed 
using ChIP but failed to precipitate. Due to the described limitations, it is still open whether 
those factors are relevant for recruiting or mediating dendritic cell specific DNA 
demethylation. The detection of a certain DNA binding factor to demethylated loci does not 
automatically imply its involvement in the demethylating process but may provide a direction 
for further investigations on active demethylation.  
 
Beside sequence specific transcription factors, histone modifications have been proposed as 
candidate factors for promoting selective demethylation (Cervoni and Szyf, 2001; Niehrs, 
2009). In line with this assumption, the setting of activating histone marks seemed to precede 
or at least to parallel the active DNA demethylation and possibly prepares the local chromatin 
for the action of DNA demethylating enzymes (Figure 5-21; Figure 5-22; Figure 5-23). 
Histone modifications thus represent possible candidates for targeting the demethylation 
machinery through histone code reading proteins. Irrespective of the genomic localization, all 
tested demethylated regions shared the presence of activating histone marks such as mono- 
and dimethylation of H3K4 or acetylation of histones H3 and H4. Given the strict association 
of CpG demethylation and histone marks, the active DNA demethylation process could be a 
simple side effect of enzymatic reactions that modify the chromatin structure. E.g. the 
removal of H3K9me2 methylation can be mediated by the lysine specific demethylase LSD1 
through an oxidative process resulting in the production of hydrogen peroxide (Perillo et al., 
2008). The main product of the peroxide is 8-oxo-guanine (8-oxo-G) whose accumulation 
could be inhibited by NAC (N-acetylcysteine), a scavenger of reactive oxygen species. As 
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8-oxo-G is removed by base excision repair (BER), adjacent 5-MeC might be excised as well 
and replaced by cytosine, in the course of such an oxidation induced repair pathway. 
However, such a mechanism would assume at least some randomness in the distribution of 
demethylation effects. The high reproducibility of demethylation events between various 
independent donors suggests that the active DNA demethylation mechanism is a strictly 
targeted process (Figure 5-19) and therefore confutes the argument that active DNA 
methylation is just a stochastic side effect of other cellular processes. Moreover, the 
treatment of monocytes with NAC did not result in alterations of the methylation pattern or 
expression profiles of CCL13 in differentiating dendritic cells (Table 5-3). 
 
 
In conclusion, active DNA demethylation during differentiation of dendritic cells may be 
described as a strictly targeted, highly reproducible process, that is not limited to promoter 
regions. Only one third of the validated DMRs was detected within promoter regions, 
whereas the other differentially methylated regions were observed downstream or far 
upstream the transcription start site. CpG demethylation is accompanied or even preceded 
by the setting of activating histone marks, leading to a more accessible chromatin structure. 
A hypothetical view on the chronological order of events at a demethylating locus is given in 
Figure 6-1. Histone modifying enzymes may be recruited to a specific locus via (sequence 
specific) DNA binding proteins and alter the chromatin structure. Once the chromatin is more 
“open”, demethylating enzymes such as components of the DNA repair machineries, can 
easier access DNA and remove the methyl mark. DNA demethylation leads to further 
relaxation of chromatin and might be a necessary prerequisite for the stable binding of 
several transcription factors. As DNA demethylation is not necessarily followed directly by 
transcriptional induction (Figure 5-20), this process could be important for keeping genes in a 
primed state by stabilizing the chromatin structure. Priming genes for transcriptional 
activation guarantees a fast and effective response to an incoming stimulus, as the time 
consuming process of opening the chromatin has been saved. This model would be in line 
with several other studies proposing that gene activation occurs sequentially (Bonifer, 2005; 
Hoogenkamp et al., 2009). Sequence specific DNA binding factors can recruit chromatin 
modification complexes and thus set the stage for stable complexes that drive transcription 
(Belikov et al., 2004; Kress et al., 2001; Lin and Hsieh, 2001). However, it remains to be 
elucidated, whether all factors are capable to transiently interact with their methylated binding 
sites or, if “pioneer” factors that are able to bind methylated DNA have to act first (Belikov et 
al., 2004; Bonifer, 2005). Although the chronological order of ongoing events may differ 
between different studies, transcription factors seem to hold a key role during the dynamic 
processes of DNA methylation and chromatin remodelling. 
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Figure 6-1 Hypothetical model of successive events accompanying active DNA demethylation during 
differentiation of dendritic cells 
Monocytes display a compact chromatin structure (white cylinders: histone octamer; black lines with “lollipops”: 
DNA with CpGs) with methylated cytosine residues (black lollipop). Recruitment of histone acetylases (HAT) and 
histone methylases (HMT) via DNA binding “pioneer” factors results in the setting of activating histone marks that 
loosen the chromatin structure. Demethylating enzymes such as components of the DNA repair machinery can 
now access DNA and remove 5’-methyl cytosines (white lollipops). DNA demethylation results in further relaxation 
of the chromatin architecture, potentially accompanied by nucleosome loss (indicated by the broken line of the 
cylinders). The open chromatin structure may now be protected from histone demethylation or histone 
deacetylation through stabiliser like transcription factors (TF). TFs may either directly induce transcriptional 
activation or, for the present, just keep the gene in a primed state. Other stimuli like stress signals could then 
induce the binding of more specific transcription factors (sTF) or accessory factors that induce transcription. 
 
 
Numerous studies on active DNA demethylation using distinct (mammalian) model systems 
revealed partly controversial results. It seems that the active demethylation process cannot 
be reduced to one universal mechanism but is rather operated through different enzymatic 
reactions adapted to the functional and structural context of the demethylated DNA region. 
Especially, recruitment actions have to be adjusted to various requirements. Genome-wide 
demethylation events as observed in mouse primordial germ cells (Hajkova et al., 2008) or in 
the male pronucleus (Mayer et al., 2000) probably need other recruiting factors than locus 
specific events. The diversity of involved targeting factors and demethylating enzymes which 
are adapted to the demands of the corresponding cell system or situation, could explain, why 
convincing mechanisms of active DNA demethylation are so difficult to define in mammals. 
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6.3 Perspectives 
Finally, the mystery about the factors mediating active DNA demethylation, still remains 
open. Emerging evidence proposes that GADD45-coupled DNA repair mechanisms are 
adapted to promote the active demethylation of 5-meC. In order to confirm this assumption 
for the processes occurring in differentiating DCs, siRNA knockdown assays could provide a 
helpful tool. Considering the transcriptome data (Figure 5-13) in combination with the 
literature, several candidates such as the GADD45 genes, DNA polymerases or ligases 
could be selected systematically and repressed using specific siRNAs. Controlling the 
methylation pattern of treated versus untreated cells could then give insights into the impact 
of the corresponding gene in demethylation. However, transfection of monocyte-derived 
dendritic cells is generally associated with low efficiency and low cell viability (Lenz et al., 
2003; Tan et al., 2005). Additionally, differentiating monocytes tend to get activated upon 
transfection resulting in altered expression profiles, e.g. the rapid down-regulation of CCL13 
(Heinz S., 2002), and incomplete differentiation (Brugger et al., 1991; Stacey et al., 1996). 
Therefore, before systematic screenings can be applied, an effective transfection assay that 
avoids dendritic cell activation has to be established. In parallel, it would be interesting to 
analyse the interaction of DNA binding factors to sites of active demethylation. Adapting the 
in vivo footprinting protocol to our model system – e.g. via more sensitive labelling 
reactions - may provide insights into the transcription factor occupancy of specific loci. 
Another possibility to identify factors that target or mediate active demethylation is the 
adaptation of the present cell model to the murine system. Using knock-out mice such as 
Gadd45 deficient ones could help to assess the role of individual genes on active DNA 
demethylation as well as its association with global gene expression. The identification of 
DMRs in the murine system would furthermore provide insights into the extent of conserved 
methylation patterns between humans and mice. However, before such analysis can be 
performed, it has to be clarified whether differentiation of isolated blood monocytes also 
occurs without proliferation under similar culture conditions. 
Beside the study of the underlying mechanisms mediating active demethylation, the 
implication of differential methylated regions at promoter distal sites in cell type-specific gene 
regulation deserves further investigation. The strict association of DNA demethylation and 
histone marks, that are also found at enhancer elements (Barski et al., 2007; Heintzman et 
al., 2007) argue for the presence of cis-acting sequences. To identify possible 
methylation-dependent enhancer activities, transient transfection assays using the novel 
CpG free pCpGL vector could be useful. Although preliminary experiments using 
CCL13-constructs failed due to the lack of a human DC-like cell line, reporter constructs 
comprising other gene loci could be more successful.  
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7 Summary 
The methylation of CpG dinucleotides represents an epigenetic mark that is crucial for 
regulating the normal progression of numerous biological processes including development 
and cell differentiation. During the last decade, it became increasingly clear that methylation 
patterns are not static but may adapt to various cellular requirements. Regarding normal 
somatic cells, the dynamic of DNA methylation including its extent throughout the genome as 
well as its implication in cellular differentiation is largely unknown. In the context of the 
present thesis, it was demonstrated that several cell type- or cell lineage-specific genes 
harboured a specific methylation profile. Interestingly, those differences in DNA methylation 
were mostly confined to regions upstream or downstream of the core promoter and 
preferentially affected CpG-poor DNA regions. The gene-regulatory relevance of DNA 
sequences affected by dynamical alterations in the methylation pattern, may be studied by 
means of transient transfection assays. For this purpose, a novel CpG-free luciferase 
reporter vector was designed that provides a simple and robust tool for analysing effects of 
DNA methylation within CpG-poor as well as CpG-rich DNA stretches on gene expression. 
As particularly the regulated and active removal of methyl-CpG marks still remains 
controversial, the major aim of the present work was the characterization of this epigenetic 
phenomenon in a natural setting of post-mitotic cells: the proliferation-independent 
differentiation of human peripheral blood monocytes into dendritic cells or macrophages, 
respectively. Using a global, comparative CpG methylation profiling approach that was 
directed to detect differentially methylated regions in CpG-rich as well as CpG-poor DNA 
stretches, 45 examples for active demethylation were identified. The validation by a bisulfite 
conversion-based technique and the characterization of a selected subset revealed that DNA 
demethylation was not restricted to promoter regions and that the time-course varied for 
individual CpGs. Irrespective of their location, the removal of methylated cytosines strictly 
coincided with the appearance of activating histone marks indicating the presence of 
cis-acting elements. Since demethylation events were highly reproducible between 
monocyte-derived dendritic cells from distinct donors, the present data suggest that active 
demethylation is a precisely targeted process. The comparison of the global methylation data 
with the genome-wide mRNA expression profiles demonstrated that active DNA 
demethylation is not always directly followed by transcriptional activation. Probably, gene 
activation is a multilevel process that is dependent on various genetic and epigenetic factors. 
Thereby, CpG demethylation seems to be a necessary prerequisite for priming the chromatin 
structure for transcription factor binding.  
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Zusammenfassung 
Die Methylierung von CpG Dinukleotiden spielt eine entscheidende Rolle bei der Regulierung 
zahlreicher biologischer Prozesse wie zum Beispiel während der Embryonalentwicklung oder 
der Differenzierung von Vorläuferzellen. Es wird zunehmend deutlicher, dass 
DNA-Methylierungsmuster nicht statisch sind, sondern, dass sie sich an verschiedene 
zelluläre Anforderungen anpassen können. In normalen somatischen Zellen ist jedoch 
vergleichsweise wenig über die Dynamik von Methylierungsprofilen bekannt. Man weiß 
weder in welchem Ausmaß solche Veränderungen des Methylierungsstatus auftreten, noch 
welchen Einfluss diese auf die Differenzierung von gesunden somatischen Zellen haben. Im 
Rahmen der vorliegenden Dissertation konnte gezeigt werden, dass einige Gene, die in nur 
einem Zelltyp oder einer Abstammungslinie exprimiert sind, spezifische Methylierungsmuster 
aufweisen. Interessanterweise waren diese Methylierungsunterschiede hauptsächlich auf 
CpG-arme Regionen außerhalb von proximalen Promotoren beschränkt. Ob die Regionen, 
die von dynamischen Methylierungsprofilen betroffen sind, die Genexpression beeinflussen, 
kann mithilfe von transienten Transfektionsexperimenten geklärt werden. Hierfür wurde ein 
CpG-freier Luciferase-Reportervektor konstruiert, der eine einfache und zuverlässige 
Analyse sowohl CpG-armer als auch CpG-reicher DNA-Sequenzen erlaubt. 
Da vor allem die regulierte Entfernung der Methylgruppen von Cytosinen noch immer 
kontrovers diskutiert wird, stand die Charakterisierung dieses epigenetischen Phänomens in 
einem post-mitotischen Zellsystem (der proliferationsunabhängigen Differenzierung von 
Monozyten zu Makrophagen beziehungsweise dendritische Zellen) im Mittelpunkt dieser 
Arbeit. Mittels Methyl-CpG-Immunpräzipitation, die darauf ausgerichtet wurde, global 
zelltyp-spezifische Methylierungsunterschiede sowohl in CpG-reichen als auch CpG-armen 
Regionen zu detektieren, wurden 45 Regionen identifiziert, die während der Differenzierung 
dendritischer Zellen aktiv demethyliert werden. Die Validierung dieser Regionen mit Hilfe von 
massenspektrometrischen Analysen bisulfit-konvertierter DNA und die Charakterisierung 
einiger ausgewählter Loci bestätigte, dass DNA Demethylierung nicht nur auf 
Promotorbereiche beschränkt ist. Des Weiteren konnte gezeigt werden, dass 
Demethylierungsvorgänge an verschiedenen Loci zwar unterschiedliche Zeitabläufe 
aufweisen, aber immer mit dem Auftreten von aktivierenden Histonmodifikationen 
einhergehen. Da aktive Demethylierungsereignisse bei verschiedenen Donoren 
reproduzierbar nachgewiesen werden konnten, sowohl bezüglich des Zeitfensters als auch 
der Lokalisation der betroffenen CpGs, handelt es sich hierbei um einen streng 
zielgerichteten Prozess. Der Vergleich der genomweiten Methylierungsdaten mit globalen 
mRNA Expressionsprofilen zeigte, dass Demethylierung nicht notwendigerweise mit einer 
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sofortigen Veränderung der transkriptionellen Aktivität korreliert. Die Aktivierung von Genen 
scheint eher ein mehrstufiger Prozess zu sein, der von verschiedenen genetischen und 
epigenetischen Faktoren abhängt. Die aktive Demethylierung ist hierbei vermutlich ein 
wichtiger Schritt, um die Chromatinstruktur für die Bindung von spezifischen 
Transkriptionsfaktoren vorzubereiten.  
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5meC     5-methyl Cytosine 
APC     Antigen Presenting Cell 
bp     base pair 
BER     Base excision repair 
BM     Bone marrow 
BSA     Bovine Serum Albumine 
cDNA     complementary DNA 
CGI     CpG island 
ChIP     Chromatin immunoprecipitation 
CpG     Cytosine-Guanine dinucleotide 
DC     Dendritic Cell 
Dd     Double Distilled 
DEPC     Diethyl Pyrocarbonate 
DMEM     Dulbecco’s Modified Eagle Medium 
DMR     Differential Methylated Region 
DMS     Dimethyl sulfate 
DMSO     Dimethyl Sulfoxyde 
DNMT     DNA methyl transferase 
dNTP     deoxi-Nucleotide Triphosphate 
ECL     Enhanced Chemiluminescence 
EDTA     Ethylenediaminetetraacetic Acid 
ES cell     Embryonic stem cell 
EtOH     Ethanol 
FACS     Fluorescence activated cell sorting 
FCS     Fetal Calf Serum 
FITC     Flourescein isothyiocyanate 
HSC     Hematopoietic stem cell 
GM-CSF    Granulocyte-Macrophage Colony Stimulating Factor 
H3K4me1    Histone 3 Lysine 4 monomethylation 
H3K4me2    Histone 3 Lysine 4 dimethylation 
H3K4me3    Histone 3 Lysine 4 trimethylation 
HAT     Histone acetyl-Transferase 
HDAC     Histone Deacetylase 
HMT     Histone methyl-Transferase 
iDC     immature Dendritic Cell 
IL     Interleukin 
LB     Luria Bertani 
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LM-PCR    Ligation mediated polymerase chain reaction 
LPS     Lipopolysaccharid 
MAC     Macrophage 
MALDI-TOF MS Matrix-assisted Laser Desorption/ionization Ttime-of-Flight 
Mass spectrometry 
MBD     Methyl-CpG-Binding-Domain 
MCIp     methyl-CpG Immunoprecipitation 
MO     Monocyte 
MOPS     3-(N-Morpholino) Propanesulfonic acid 
MPS     Mononuclear Phagocyte System 
mRNA     messenger RNA 
MvA     Signal log ratio vs. average log intensity 
NaOAc     Sodium Acetate 
NER     Nucleotide excision repair 
NK cell     Natural killer cell 
NP-40     Nonidet P-40 
O/N     Over night 
PB-MNCs    Peripheral Blood Mononuclear Cells 
PBS     Phosphate Buffered Saline 
PE     Phycoerythrin 
PEG     Polyethyleneglycol 
PCR     polymerase chain reaction 
qPCR     quantitative PCR 
rpm     rounds per minute 
RT     Room Temperature 
RT-qPCR    quantitative reverse transcription PCR 
SDS     Sodium Dodecyl Sulfate 
TAE     Tris Acetate /EDTA electrophoresis buffer 
TE     Tris-EDTA 
TEMED    N,N,N’,N’,-Tetramethylenediamine 
TNF     Tumor Necrosis Factor 
Treg     regulatory T Cell 
TSS     Trasncription Start Site 
UCSC     University of California, Santa Cruz 
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